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Zusammenfassung
Während Ionen in der Lage sind, strahlenresistente, tief sitzende Tumore effektiv
zu zerstören, muss die Lage des Tumorgewebes im Rahmen einer Hadronentherapie ex-
akt bekannt sein, um die Schonung des umgebenden gesunden Gewebes und die Wirk-
samkeit der Behandlung sicherzustellen. In der klinischen Praxis können Informationen
über die Strahlreichweite in-vivo von größter Wichtigkeit sein, da sie eine Bestätigung
dafür liefern, dass der Tumor effektiv angesprochen wird. Range–Verification–Techniken
wie die positron–emission–tomography (PET) haben ein großes klinisches Potenzial, in-
dem sie die Position des Bragg Peak in der verabreichten Behandlung durch Vergleich
der erfassten Signale mit einem vorher festgelegten Zielbereich überprüfen. Im Falle
der PET ergibt sich die Aktivitätsverteilung aus den Produkten inelastischer nuklearer
Wechselwirkungen zwischen den Ionen und den Atomkernen im Gewebe. Es wird da-
her oft als vorteilhafter angesehen, den PET-Scanner in die Strahllinie integriert zu
haben, wobei das Scannen während oder unmittelbar nach der Bestrahlung (in beam
PET ) erfolgt. Dies ermöglicht es, Erfassungsfehler im Zusammenhang mit Patienten-
positionierung oder biological washout zu reduzieren, während gleichzeitig der Beitrag
der β+–Emitter mit kürzerer Halbwertszeit zum PET–Gesamtsignal beiträgt.
Der Gesamterfolg der Kohlenstoff–Ionen–Therapie–Projekte in Japan und Europa,
zusammen mit den jüngsten Fortschritten in der Beschleuniger–Technologie und medi-
zinischer Bildgebung, trug zu einem erneuten Interesse an innovativen Lösungen für
Hadronentherapie-Anwendungen bei. Im Speziellen zielt diese Arbeit auf eine Un-
tersuchung der Vorteile einer Verwendung der β+–emittierenden, radioaktiven Ionen
11C und 15O in der Hadronentherapie, verglichen mit den erzielten Resultaten der
Nutzung ihrer stabilen Gegenstücke. Zu diesem Zweck wurde der FLUKA–Monte-
Carlo–Partikeltransport– und Interaktionscode verwendet, um radioaktive Ionenstrahlung
in klinischen Umgebungen zu simulieren, einschließlich der Verwendung von PET-Scans
mit äquivalenter Dosisabgabe für verschiedene Online– und Offline-PET Akquisition-
sszenarien.
Die Evaluierung der dosimetrischen Ergebnisse mit FLUKA profitierte von den jüng-
sten Entwicklungen in Modellen für den geladenen Hadronentransport und Fragmen-
tierung bei relativ niedrigen Energien von therapeutischem Interesse. Im Rahmen dieser
Arbeit wurde der Code verwendet, um sowohl monoenergetische als auch Spread Out
Bragg Peaks (SOBP) in Wasser und in einem anthropomorphen Kopf–voxel–Phantom
zu simulieren. In der Modellierung der Bestrahlung mit 12C und 16O wurden Appro–
ximation in der Abgabe der Synchrotronstrahlung und der Strahlführung, angewandt
am Heidelberg Ionen Therapiezentrums (HIT), verwendet. Die Daten des Forschungs–
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Behandlungsplanungssystems wurden dann in einer Extrapolation für radioaktive Ionen-
strahlung benutzt. Das Bildgebungspotenzial, insbesondere für die Reichweitenüber-
prüfung, wurde mit den neu entwickelten FLUKA PET tools bewertet. Dies er-
forderte eine detailliertere Modellierung der Siemens Biograph mCT PET/CT (PET-
Scanner-Modell bei HIT verwendet) Geometrie und Signalantwort. Darüber hinaus
wurden Berechnungen von Annihilations-Ereignissen bei Ruheenergie, die von den β+-
Emittern herrühren, durchgeführt. Die Zeitabhängigkeit entsprechender PET-Signale
wurde ebenfalls in die Berechnungen einbezogen, so dass die Auswirkungen sowohl der
Strahlzeitstruktur als auch der Abtastzeit im Endergebnis wiedergegeben werden.
Mit den Simulationen, die mit Synchrotron–ähnlichen Bestrahlungsschemata und
den approximierten HIT–Strahlführungselementen durchgeführt wurden, konnte veri-
fiziert werden, dass die Bildgebungsresultate der radioaktiven Ionenstrahlen bei einer
vergleichbaren Dosisabgabe bei jedem PET–Akquisitionsszenario die Bestrahlungen mit
stabilen Ionen deutlich übertreffen. Insbesondere wurde bei Verwendung radioaktiver Io-
nenstrahlen eine- im Vergleich mit stabilen Ionen - um etwa eine Größenordnung höhere
Menge an Annihilationsereignissen bei Ruheenergie beobachtet, sowohl fürOnline-PET–
Erfassungen (130 Sekunden, einschließlich Überlaufzeit) mit 15O als auch für die Offline-
PET–Erfassung (5 bis 30 Minuten Erfassung Zeit nach Strahl) mit 11C. Darüber hinaus
wurde nicht nur ein erheblicher Zugewinn an Koinzidenzereignissen beobachtet, sondern
auch die Qualität der Rekonstruktionsbilder verbessert. Die Ergebnisse mit radioaktiven
Ionenstrahlen ermöglichten eine bessere Identifizierung der distalen Kante des SOBP (in-
nerhalb von 1 mm), mit einer besseren Definition der proximalen Anstiegszone bis hin
zur distalen Fallzone (Faktor 2 mit 15O in room und fast ein Faktor von 3 für 11C in
Offline-PET -Akquisitionen).
In einer zweiten Phase wurden experimentelle Daten, die am Heavy Ion Medical
Accelerator in Chiba (HIMAC) gewonnen wurden, verwendet, um sie mit den Simula-
tionsergebnissen zu vergleichen. Diese Daten wurden in Zusammenarbeit mit Kollegen
des Physics Imaging Teams des japanischen Instituts für radiologische Wissenschaften
(NIRS) gewonnen. Die Produktion von radioaktiven Ionenstrahlen von 11C und 15O
wurde mittels Projektil-Fragmentierungs-Separations-Methode durchgeführt. Der FLUKA-
Code wurde zur Berechnung von Bragg Peak -Kurven inWasser und Polymethylmethacry-
lat (PMMA) herangezogen. Der Vergleich mit den experimentellen Ergebnissen in
Wasser zeigte eine gute Übereinstimmung mit den Simulationen und es wurden keine Un-
terschiede über 1 mm beobachtet. Die Dichte und Form der β+ Emitter–Aktivität wurde
ebenfalls berechnet und mit den Werten verglichen, die mit einem Prototyp eines open-
PET–Scanners erhalten wurden, der zwischen den spills und einigen Minuten danach
Daten sammelte. Trotz der verwendeten Produktionsmethode, die Bragg Peak–Kurven
der radioaktiven Ionenstrahlen beträchtlich um einen Faktor 4–5 in Wasser verbreit-
ert im Vergleich zu stabilen Ionenstrahlen, wiesen die in PMMA mit diesen Spezies
rekonstruierten Bilder eine um etwa Faktor 2 bessere Definition der Region zwischen
dem proximalen Anstieg und dem distalen Abfall auf. Diese Ergebnisse wurden auch
durch die FLUKA-Simulationen bestätigt und stimmen mit früheren Beobachtungen
überein. Darüber hinaus weisen die rekonstruierten Signale im Vergleich zu stabilen
Ionenstrahlen einen beträchtlichen Größengewinn von mindestens einer Größenordnung
auf, ebenfalls bestätigt durch FLUKA-Simulationen.
Zusammenfassend weisen die Ergebnisse dieser Arbeit darauf hin, dass β+-emittierende
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radioaktive Ionenstrahlung die für die Strahlreichweitenverifikation und die Behand-
lungsüberwachung verfügbare Bildsignalleistung bezogen auf stabile Ionenstrahlen in
der Hadronentherapie verbessern können.
Keywords: Hadronentherapie, Radioaktiver Ionenstrahl, Dosimetrie, PET imaging, Monte
Carlo, FLUKA.
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Abstract
In the context of hadrontherapy, whilst ions are capable of effectively destroying ra-
dio resistant, deep seated tumors, their treatment localization must be well assessed to
ensure the sparing of surrounding healthy tissue and treatment effectiveness. In clinical
practice, information on the in vivo beam range can be of paramount importance, for it
provides confirmation that the tumor was targeted effectively. Range verification tech-
niques, such as positron–emission–tomography (PET) imaging, hold great potential in
clinical practice, in order to check the accuracy of the Bragg Peak in the delivered treat-
ment by means of the comparison of the acquired signal with a corresponding prediction.
In the aforementioned case of PET, the activity distribution arises from inelastic nu-
clear interaction products between the ion and the tissue nuclei. It is therefore often
deemed more advantageous to have the PET scanner integrated into the beam line, with
scanning occuring during or immediately after irradiation, the so called in beam PET.
This allows to mitigate acquisition errors related to patient positioning and biological
washout, while benefiting from shorter half–life β+ emitters contributing to the total
PET signal.
The overall success of the carbon ion therapy projects in Japan and Europe, along
with the recent advances in accelerator technology and medical imaging, contributed to
a renewed interest in innovative solutions for hadrontherapy applications. In particular,
this work aimed at investigating the advantages of using β+ emitting, radioactive ion
beams of 11C and 15O in hadrontherapy, in comparison to the performance of their stable
counterparts. To this end, the FLUKA Monte Carlo particle transport and interaction
code was used to simulate radioactive ion beams in clinical environments, including the
use of PET scans with equivalent dose delivery for different online– and offline–PET
acquisition scenarios.
The dosimetric performance evaluation with FLUKA benefited from its recent de-
velopments in charged hadron transport and fragment production models at relatively
low energies of therapeutic interest. During the course of this work, the code has been
used to simulate both mono–energetic and Spread Out Bragg Peaks (SOBP) in water
and in an anthropomorphic head voxel phantom. 12C and 16O ion beam dose delivery
was modeled in the simulations using an approximation of the synchrotron beam deliv-
ery and beam line applied by the Heidelberg Ion Therapy Center (HIT). The research
treatment planning system data were then used in extrapolations for radioactive ion
beams. The imaging potential, particularly for range verification, was assessed with
the newly developed FLUKA PET tools. This required a more detailed modeling of
the Siemens Biograph mCT PET/CT (PET scanner model used at HIT) geometry and
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signal response. Furthermore, calculations of the annihilations events at rest ensuing
from the β+ emitters were performed. The time dependence of the corresponding PET
signal was also included in the calculations, so that the effects of both the beam time
structure and scan time could be reproduced in the final result.
In the simulations performed using synchrotron–like irradiation schemes and the ap-
proximate HIT beam line elements, it was verified that radioactive ion beams imaging
results clearly outperform stable ion beam irradiations for every PET acquisition sce-
nario, with a comparable dose delivery. In particular, it was observed approximately
an order of magnitude higher amount of annihilation events at rest occurring when
employing radioactive ion beams, for online PET acquisitions (130 seconds, including
spill time) using 15O as well as for offline PET acquisition (5 to 30 minutes acquisition
time after beam) using 11C compared to the stable counterparts. Furthermore, not
only a considerable gain in coincidence events was observed, but also the quality of the
reconstruction images was improved. Namely, radioactive ion beam results allowed for
a better identification of the the distal edge of the SOBP (within 1 mm), with superior
definition of proximal rise to distal fall–off regions with respect to their stable coun-
terparts by up to a factor of 2 in 15O, in room and almost 3 for 11C, in offline PET
acquisitions.
In a second stage, experimental data acquired at the Heavy Ion Medical Acceler-
ator at Chiba (HIMAC) were used to benchmark the simulation results. These data
were obtained in collaboration with colleagues from the Japanese National Institute of
Radiological Sciences (NIRS) Physics Imaging Team. The synchrotron primary 12C
and 16O ion beam were respectively converted into radioactive ion beams of 11C and
15O using the projectile fragmentation separation method. The FLUKA code was em-
ployed for calculating energy deposition of Bragg Peak curves in water and polymethyl
methacrylate (PMMA). The comparison of simulations and experimental results in wa-
ter showed a good agreement, with range deviations below 1 mm. The amount and
shape of β+ activity were also calculated, and later compared with the ones obtained
with an openPET scanner prototype, which collected data in between spills and some
minutes afterwards. Despite the production method employed, which broadened con-
siderably the Bragg Peak curves of radioactive ion beams by a factor 4–5 in water in
comparison to the stable ion beams, the images reconstructed in PMMA using these
species featured approximately a factor 2 better definition of the region between the
proximal rise and distal fall–off compared to stable ion beams. These findings were also
confirmed by the FLUKA simulations and are in line with previous observations. More-
over, the reconstructed signals indicate a considerable gain in magnitude, of at least
one order of magnitude compared to stable ion beams, which is as well corroborated by
FLUKA simulations.
Concluding, the results in this work indicate that β+ emitting radioactive ion beams
can enhance the imaging signal output available for beam range verification and treat-
ment monitoring with respect to stable ion beams in hadrontherapy.
Keywords: Hadrontherapy, Radioactive ion beams, Dosimetry, PET imaging, Monte Carlo,
FLUKA.
Extended outlines
Chapter 1 – This is an introductory chapter, including the aim of the present work and a short
overview of hadrontherapy, reviewing its physical, biological aspects and a more in–depth
description of HIT and HIMAC facilities. The potential of radioactive ion beams will be
highlighted. A brief description of PET scanner functions and applications will then follow,
with particular emphasis on in beam PET and the motivation for range monitoring techniques.
Chapter 2 – A brief introduction to the Monte Carlo method and its application in particle
transport will be given. Its role in treatment planning will be detailed. A more extensive
description of the Monte Carlo particle transport and interaction code FLUKA will then
follow.
Chapter 3 – Firstly, the methodology employed to generate SOBPs according to user input pa-
rameters, in line with a research treatment planning system (TPS) data used at HIT, will be
described. Secondly, a summary description of the FLUKA PET tools will be also provided,
along with the elements implemented in the simulations for the various PET acquisitions
scenarios studied.
Chapter 4 – Description, supported by FLUKA simulations, of the dosimetric and imaging prop-
erties of β+ emitting radioactive ion beams (RIβ+) and comparison with their stable coun-
terparts in water. These simulations will provide preliminary estimates of the RIβ+ figures of
merit for the following studies in the voxelized phantom geometry and subsequent comparisons
with PET reconstructions.
Chapter 5 – This chapter includes the results of comparisons between stable carbon and oxygen
ion beams with 11C and 15O SOBPs. The first part simulates clinical–like irradiations in an
antropomorphic head phantom. The reconstructed images of SOBPs of comparable dose are
obtained via FLUKA PET tools in various PET acquisition scenario, and subsequently a
quantitative analysis is performed. The second part deals with the comparison between the
experimentally acquired results obtained with NIRS’s colleagues and FLUKA simulations of
dose and β+ activities. The dosimetric performance of these beams was assessed in a water
phantom whereas the reconstructions were obtained via irradiations on a PMMA phantom,
employing an openPET prototype for the acquisition.
Chapter 6 – This chapter includes the major conclusions of this work, as well as some remarks
on future work.

Chapter 1
Introduction
Bloch: “Space is the field of linear operators.”
Heisenberg: “Nonsense, space is blue and birds fly through it.”
— Felix Bloch, Heisenberg and the early days of quantum mechanics
Cancer is a disease characterized by an uncontrolled cellular division, which can propagate
from tissue to tissue. By interfering with regular organ functions, eventually causing them to
cease working properly, it can lead ultimately to death ([WHO]). Its causes are varied and chiefly
associated to environmental, genetic and behavioral factors.
In fact, cancer is today in Europe the leading cause of mortality for people aged 45–64, account-
ing for one quarter of the continent’s total death rate according to [EUR]. In the United States it is
the second cause of death. The growing aging population, unhealthy lifestyle and pollution are the
leading factors as per [WHO12] expected to increase cancer incidence worldwide[Fer13, AOS15]. Re-
cent studies estimate that the number of cancer cases may increase more than 40% from 2014–2035,
despite possible future favorable variations in the incidence and mortality rates[Smi16]. In addition
to that, lower socioeconomic strata of the population are predicted to be the most affected by this
trend ([IAEA–HHR–3]).
However, in spite of being a deadly disease, cancer is presently curable in ∼ 50% of the cases
provided it is early diagnosed and an adequate treatment is applied. Nonetheless, these numbers
are averaged as some types of cancer may be particularly deadly due to their location, type and
stage, (e.g. lung and pancreas), despite the great variety of treatment methods currently available
([NCI]). Nowadays, cancer treatment entails at least one of the modalities below, namely:
• Surgery;
• Radiotherapy;
• Chemotherapy & Immunotherapy.
Since W. Roentgen’s discovery of x–rays in 1895, radiation and medical applications have been
intertwined, laying the basis of what is now denominated Radiotherapy. Although its success
varied greatly at its early stage, presently in Europe, radiation is involved in about 70% of cancer
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treatments according to [IAEA–TRS–461]. Besides its application in diagnostic medicine, it plays a
major role in treatment when surgery is either impractical or not recommended, since it may allow
a rather selective and localized effect within the tumor, relatively sparing the neighbouring healthy
tissue. Radiotherapy is now divided in two categories[Gre12, Moh17]:
→ Conventional - Including Brachytherapy, a technique characterized by the implantation of ra-
dioactive sources nearby or in contact with the tumor; targeted therapy, entailing the use
of radiopharmaceuticals to target the tumor for treatment or imaging purposes; and exter-
nal therapy, involving the irradiation of the tumor with electrons or photons beams, in a
non–invasive manner;
 Unconventional - Includes hadrontherapy which, as the name indicates, consists of “treatment
of tumors through external irradiation by means of accelerated hadronic particles” [Bra09].
The present work will focus on the unconventional domain of hadrontherapy, namely the ap-
plication of radioactive ion beams, that decay by positron emission (RIβ+), in a therapy context
replacing currently available stable ions.
Therefore, the main goal of this thesis is to investigate how the treatment and imaging perfor-
mance of selected RIβ+, such as 11C and 15O, compare to their stable counterparts, and quantify
their merits in scenarios as close to clinical environment as possible.
To this end, the FLUKA MC code was used to compare dosimetric and PET imaging perfor-
mance, using a development version with updated fragmentation models and the recently developed
PET tools package. Also, synchroton–like irradiations, beam line and PET scanner elements were
(approximately) reproduced for realistic simulations. Furthermore, the code was also compared with
experimental data acquired at HIMAC, for both RIβ+ and stable beams.
1.1 Rationale for ion beams in hadrontherapy
The concept of hadrontherapy dates back to 1946 and the work of R. R. Wilson[Wil46]. It has,
especially in recent years, developed considerably, following scientific and technical breakthroughs
that made it more practical and accurate. The general advantages of charged hadrons compared
to conventional therapy forms are: their more localized dose delivery, the finite range and the
lower rate of late toxicity[AK05, Sui10]. Overall, it may lead to higher treatment/radiobiological
effectiveness, with about half the integral body dose of conventional treatment forms and therefore
lower risks of secondary tumors[Lom09, SES10].
Throughout 1950–80’s many types of charged hadrons, from protons to argon ions, were stud-
ied intermittently at the LBNL, in the United States ([LBL77, LBL80]). At the time, it was
the only machine capable of delivering heavy ions with the energy range required by medical
treatments[SES10]. However, it was oriented towards research in nuclear physics and not optimally
designed for therapy purposes. After that period, proton therapy became quickly popular through
the 90–00’s, and it is now considered an advanced clinical modality[Alo96, Pag12, BMM16]. How-
ever, it appeared that some ion species could be therapeutically more effective than the meanwhile
well–established protons, with experimental work evidencing heavier ions lower lateral scattering
for the same range, along with the higher energy transfer to matter and hence a higher biological
effectiveness for tumor tissues[Cas80, Cas82, Alo96]. Consequently, the treatment effectiveness could
be increased with respect to protons, even for radioresistant tumors[Cas80, Alo96, Ohn13].
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On the other side, the use of heavier ions over protons implies some drawbacks, firstly a larger
upfront investment and operational costs initially restricted their usage to research facilities[Sch14].
The physical properties of certain heavier ions, such as their fragmentation dose tail, a residual dose
resulting from ion fragmentation mechanisms occurring during beam–media interactions, hindered
their clinical application[CTL76, Alo96]. Lastly, their relatively high biological impact must not be
overlooked, and dose delivery has to be properly assessed/monitored to preserve healthy tissues
nearby from receiving critical doses. This is a non trivial task in view of the variation of biological
effectiveness of ions in tissue along the beam path[Cas80].
Carbon ions were found optimal because of the balance between their destructive and ballistic
properties, which lays the basis of carbon ion therapy[TK12, Ohn13]. Even though carbon ions
are effective against radioresistant tumors, the destruction of tumors is more easily achieved with
heavier ions, but collateral damage to normal tissue increases abruptly.
Carbon ion therapy was first applied at clinical scale in Japan by NIRS, at the HIMAC facility
in 1994. Since then, HIMAC has treated more than 9 000 out of a total of 12 000 patients treated
with carbon ions in all Japan, which alone hosts five carbon ion therapy facilities[EK16]. Shortly
after its initial success in Japan, carbon ion therapy was introduced in Europe, in 1997 at GSI in
Darmstadt, Germany[Nod14]. The latter operated as a pilot project until 2008, in collaboration with
DKFZ Heidelberg, Radiological University Hospital Heidelberg and FZ Rossendorf. After the GSI
success and pioneering work with carbon ion scanning technique and integration of an online PET
camera, the German carbon ion therapy program was then reallocated in 2009 to a new facility,
HIT, in Heidelberg[Sui10]. In the following year, CNAO started operations in Pavia, Italy. Two
other facilities, albeit more recent, MIT in Marburg (started 2015) and MedAustron near Vienna
(started 2017) complete the list of European carbon ion therapy centers. Finally, the worldwide
listing of carbon ion therapy dedicated facilities is completed by two facilities in China, the HIRFL
in Lanzhou and the SPHIC in Shangai. As of 2017, already more than 20 000 patients benefited
from treatment with carbon ions, as detailed in figure 1.1 ([PTCOG]).
Chronology
1895 Discovery of x–rays (W. Röntgen)
1932 First cyclotron (E. Lawrence)
1946 Protontherapy proposed (R. R. Wilson)
1954 First patient treatment with protons
(LBNL)
1957 First patient proton treatment in Europe
(Uppsala, Sweden)
1969 Start of ITEP, Moscow (Oldest proton fa-
cility still in operation)
1994 First hospital–based facility dedicated to
carbon ions (HIMAC, Japan)
1997 First patient treated with carbon ions at
GSI, Germany
2009 First European proton/carbon ion facility
(HIT, Germany)
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Figure 1.1: On the left, a chronogical overview of hadrontherapy events as given by [ENLIGHT]. A world map
detailing the Particle therapy facilities in operation (as of June 2017) is shown on the right ([PTCOG]).
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Nuclear reactions are very relevant for high energies even though cross sections are lower. How-
ever, scattering is not to be neglected, particularly for lower energies. Nevertheless, the vast majority
(80–90%) of the ion and secondary fragments energy is lost via (inelastic) collisions with atomic
electrons, while atomic (elastic) collisions do not entail considerable energy losses at therapeutic
energies. Also, the paths described by ions in matter are typically straight, making their lateral
energy deposition profiles steeper than those of protons for instance[Bat16].
Energy losses. Most of the ions’ energy is lost in (inelastic) collisions with atomic electrons and to
a less degree with atomic nuclei[BMM16]. The maximum energy transferred to electrons (∆Emax)
in a single collision between a particle of mass M and kinetic energy E with a free atomic electron
with mass me, is dictated by kinematics and given by
∆Emax =
2mec
2β2γ2
1 + 2γmeM +
(
me
M
)2 , (1.1)
with γ =
(
1− β2
)− 12 being the Lorentz factor and β = v/c the velocity of the incident particle
in units of c (c is the speed of light in vacuum). For ions at non relativistic energies, as M  me,
it can be written simply
∆Emax = 2mc
2β2γ2. (1.2)
As a consequence of this, a trail of excited or ionized atoms will be observed throughout the
beam path. Given the multiplicity of collisions in materials it is customary to characterize the
energy loss distribution as an average quantity and its fluctuations. The average energy loss per
unit path length is denominated Stopping Power S(E)
S(E) = −dE
dx
[
MeV cm−1
]
. (1.3)
Alternatively, the concept of Mass Stopping Power is more often employed, for it is almost
independent on the medium density ρ
S(E) = − dE
ρdx
[
MeV cm2 g−1
]
. (1.4)
By exhausting their kinetic energy, ions will eventually come at rest. The distance travelled
up to this point is denominated Range. Energy losses of heavy charged particles were first studied
by N. Bohr through 1913–15[Boh15], by averaging the energy imparted to media electrons across
a distance for different energies, but unaccounting for relativistic and quantum mechanical effects.
Consequently, the mean range (R) of an heavy charged particle is influenced by the particle’s speed,
its mass, and the electron density of the material traversed. For ions it tends to be straight up to
near its end. Assuming the slowing down of heavy charged particles to be a continuous process
with always the average stopping power, the CSDA range can be used to estimate the range based
on the inital energy (E0) loss rate along its path, or the distance beyond which it “shall not pass”
in view of its energy loss rate, as
RCSDA =
∫ 0
Eo
(
dE
dx
)−1
dE. (1.5)
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being re the classical electronic radius, me the electron rest mass, z the projectile charge, Z and
A are the material’s atomic and mass numbers, respectively. NA is the Avogadro’s number, ρ the
material’s density and ∆Emax the maximum energy transfer as given in equation 1.1. As for I, it
is a material–dependent parameter, called the mean excitation energy of atomic electrons and it is
a logarithmic average of all possible excitation and ionization levels[Jan82]. Finally, C/Z and δ/2
are the shell and density correction terms, respectively[Ste84, Bic92]. As the projectile slows down
below few MeV/u (for light ions), it tends to “picks up” electrons from the medium more easily, the
projectile charge in equation 1.6 is then approximately described via its effective charge ze, using
Barkas formula[BBS56, BDH63]:
ze ≈ z
(
1− e−125βz−
2
3
)
. (1.7)
Equation 1.6 was firstly improved with non–relativistic corrections (1930) and then relativis-
tically (1932), since for therapeutic energies β can take values up to 0.7[Bet32, BH34]. Additional
corrections were implemented, due to the fact that H. Bethe’s original formula did not include
terms beyond z2 (leading order in perturbation theory). The full scope of the approximations and
corrections considered in the framework of the Bethe–Bloch equation will be overviewed in chapter
2.
While shell corrective factors are of increasing relevance at low energies, density corrections are
important for relativistic projectiles. The Bethe–Bloch equation performs well between the interval
0.1 < γβ < 100, in which therapy applications are typically included. At energies . 0.3 MeV/u
the particle eventually enters the Lindhard region where equation 1.6 is no longer valid due to the
velocity of the projectile and of the orbital electrons becoming comparable[Kr15b].
The Bragg Peak and the related increase of energy loss as the particle velocity decreases is put
into evidence looking at the z2/β2 factor in equation 1.6. Near the end of its path and according
to equation 1.7, the slowed–down projectile picks up electrons and its charge is reduced, thus
compensating the energy loss as dEdx ∝ z2e , causing the energy loss curve to fall off and resulting in the
characteristic Bragg Peak curve. According to equation 1.6 and without accounting for statistical
fluctuations, the range can be considered to scale approximately with the A/z2 parameter, for a
given β[Kur14]. As for the Bragg Peak ’s relative height to entrance dose, it decreases with increasing
kinetic energy of the beam particle and the straggling effect [Sui10].
Upon losing gradually energy from inelastic interactions with atomic electrons, elastic Coulomb
interactions with nuclei become more likely. This nuclear stopping power contribution is only rele-
vant for very low energies (typically. 10 keV/u), and thus negligible in therapeutic applications[SES10].
Other forms of energy losses beyond collisional ones are radiative energy losses via Bremsstrahlung [PDG14].
A last energy loss mechanism, albeit less relevant than Bremsstrahlung, is by emission of Cherenkov
radiation. For ions at therapeutic energies the radiative energy loss component is totally negligible.
Nuclear reactions. Nuclear reactions and nuclear scattering imply an interaction of a particle or
radiation with a nucleus. In this work non–elastic interactions are vastly more relevant than elastic
scattering since the former induce the nucleus transformation into one or more nuclides. The
consequent transformation is characterized by conservation of total energy, charge, nucleon number,
as well as linear and angular momentum[Ber09].
Concerning hadrontherapy, and even though the stopping process of high energy hadrons is more
affected by collisions with atomic electrons, nuclear reactions will play a major role in the treatment
effectiveness. Interactions between nuclear particles are governed by the strong interaction force. In
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the case of ions, for these reactions to occur, either a kinematic or Coulomb barrier threshold needs
to be overcome in the interaction between projectile and target. If the Coulomb barrier threshold
is surpassed, the kinematic threshold applies and a reaction can occur only if the available energy
is above threshold.
When within the nuclear force range, an interaction is typically very fast and can result in the
exchange of energy or particles between the interacting particles or the fusion of the projectile with
the target. In non–elastic nuclear interactions and at hadrontherapy’s energy range, peripherical
collisions are the most relevant, with ions transferring kinetic energy and nucleons[BMM16].
The abrasion–ablation model is commonly used to describe this process in two steps: firstly, the
nucleons directly involved in the interaction are abrased and lead to the creation of an “hot reaction
zone” (see figure 1.4), while the remaining nucleons that did not take part in the interaction are
almost unnaffected by the collision; subsequently, an ablation process ensues where the fragments
and the “hot reaction zone” de–excite by evaporating lighter fragments and radiation[BMM16].
Figure 1.4: Illustration of the possible outcome of a collision between an highly energetic projectile with momentum
p0 and a target nucleus[BRT90].
In the earlier stage (∼ 10−22 s), preliminary fragments are produced, which are partially excited.
In the second stage the excited nuclei will produce nucleons and heavier fragments via evaporation,
below an energy threshold for nucleon separation, foillowed by γ de–excitation which will expend
the residual excitation energies in a process lasting up to 10−16 s [Som07]. These processes will be
mentioned in more detail in chapter 2.
For ions impinging in matter, nuclear reactions pertaining to the ion, the media nuclei and
subproducts are several and responsible for fragment production, loss of primary beam fluence
and resulting emerging radiation, according to the reaction cross sections[Bat16]. Considering a
monoenergetic ion beam impinging in a medium, the rate of nuclear reactions ṙ [reaction cm−3 s−1]
will intrinsically depend on both the beam flux φ [particle cm−2 s−1] and number of atoms N in the
volume impinged [atoms cm−3]. Given these elements, the reaction rate in a given volume dAdx
will be given by:
dṙ = σφNdAdx (1.8)
with σ (cm2) being the microscopic cross section, essentially quantifying the probability of a
specific reaction occurring. Its value is almost constant down to 100 MeV/u, below which value it
increases as other mechanisms such as deep inelastic or fusion reactions start to contribute[SES10].
On average, about 20% of primary protons and half of the primary carbon ions will undergo
fragmentation reactions in hadrontherapy irradiations[HIS06, Kr15b]. They are subdivided in tar-
get and projectile fragments, although only the former are produced with protons. While target
fragments are approximately static the projectile fragments, due to the high projectile’s velocity,
will appear forward peaked in the laboratory frame as they approximately inherit the projectile’s
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σΘ ≈
13.6 MeV
βpc
z
√
L
LR
[
1 + 0.088 log
(
L
LR
)]
, (1.9)
where p is the projectiles’ momentum and L and LR the target thickness and radiation length
[g cm−2], respectively. The lateral scattering is higher for lower energy projectiles, approximately
following the relationship z/βpc[Krä00, SES10, Kur14].
2 TUMOUR THERAPY WITH ION BEAMS
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Figure 2–5: Lateral deflection in water of several ion beams of therapeutic relevance calculated according
to [Hab94] and adjusted to the experimental data shown in [Lin95].
dependence becomes smoother and cross sections approach above about 1.5 AGeV asymptotic values mainly
determined by geometrical factors and resembling the energy-independent form proposed on the basis of
cosmic ray data [Bra50]:
σR = πr
2
0(A
1/3
p + A
1/3
t − b0)
2 (7)
where Ap and At are the mass number of the projectile and target nuclei, respectively, r0 is the proportionality
constant in the expression for the geometrical nuclear radius r = r0A
1/3 whereas b0 is the overlap or
transparency parameter.
As a consequence of nuclear interactions, the fluence distribution of the primary particles is exponentially
attenuated in depth x according to the expression:
Φ(x) = Φ0e
−NσRx (8)
where Φ0 is the initial fluence and N is the atomic density of the medium. From equation (8) and (3) follows
that the dose delivered by the primary ions is reduced with increasing depth due to nuclear reactions, as
shown in figure 2–6. However, total reaction cross sections alone are not sufficient for a proper description
of nuclear interactions and their impact on therapeutic beams, which is not limited to the attenuation of the
primary particles especially for ions heavier than protons. Whereas nuclear recoils give typically negligible
contributions to the dose delivery [Pag02, Kar02], secondary nucleons, particles and fragments produced in
nuclear reactions can considerably affect the spatial pattern of energy deposition and must be carefully taken
into account.
Fragmentation reactions are the dominating interactions in the energy interval and for the material
composition of interest for therapy. Nuclear fragmentation is a complex process typically consisting of two
steps, where first partially excited prefragments are produced within � 10−22 s in the collision and then
the final products are formed after de-excitation by nucleon evaporation and photon emission in about
10−21 − 10−16 s [Hüf85]. A recent comprehensive work on fragmentation cross sections [Sih93, Sil98, Tsa98]
proposed a semiempirical systematics for proton-nucleus partial cross sections and a scaling approach for
the extension to nucleus-nucleus reactions. The systematic regularities of the partial cross section σpart for
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Figure 1.6: Lateral deflection for various ion beams in depth[Par04].
Moreover, the joint effect of statistical energy fluctuations in the projectile’s slowing down
process is described with Vavilov distributions for thin targets[Vav57]. These fluctuations result
in the widening of the Bragg Peak and contribute to lower peak–to–entrance energy deposition
ratios. Energy loss fluctuations can be approximately described as a Gaussian for thick targets
with variance σ2E
σ2E ≈ 4πNAr2em2ec4ρz2
Z
A
∆s (1.10)
in which ∆s denotes the target thickness[Pön04]. As a result of the above mentioned effects,
a relatively small penetration depth variation in ions’ travelled path can be observed, which is
denominated Range straggling and whose width σR is given by
σR =
R√
m
f
(
E
mc2
)
, (1.11)
with R being the mea range, m the particle’s mass and f an absorber dependent func-
tion. As σR/R ∝ A−1/2, heavier ions tend to have sharper peaks than lighter ions such as
protons[Krä00, SES10]. The range straggling variance is related to the energy loss straggling (σE) via
σ2R =
∫ E0
0
(
dσE
dx
)(
dE
dx
)−3
dE. (1.12)
Relative range straggling in tissue attains 1% of the mean range for protons and 0.3% for carbon
ions[Par04].
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1.1.2 Biological effects of ions in tissue
Every living organism on Earth is subject to both a natural and artificial radiation background.
Natural background comprises terrestrial as well as cosmic sources and is the chief background
contributor. As for exposure to artificial radiation sources, it can have several origins, from atomic
weapon test remniscences to medical treatments.
Radiation–related biological damage is a consequence of the interaction of radiation with biolog-
ical tissue and ionization of cellular atoms, disrupting their activity and chemical balance. Ionizing
radiation effects can be subdivided in two categories by [ICRP–103]:
I Deterministic: Manifested in a short time period, whenever radiation exceeds a threshold, leading
to observable tissue or organ effects.
I Stochastic: The probability of radiation exposure effects’ occurrence increases with dose, but
neither a threshold applies, nor a time period can be set for quantifying its consequences (e.g.
probability of cancer development or heritable disease, triggered by mutations in reproductive
cells).
The International Commission on Radiological Units and Measurements (ICRU) and the Inter-
national Commission on Radiological Protection (ICRP) are the entities responsible for providing
scientific support and guidelines for radioprotection in view of chemical, material and biological
effects of radiation, regulating dosimetric quantities’s application.
Destroying a tumor in hadrontherapy implies destroying its tissue beyond repair through energy
deposition, by attaining a certain dose, and at the same time ensuring that the healthy tissue in its
vicinity is preserved. Absorbed dose ([ICRP–103]) can be quantified as
D =
dĒ
dm
, (1.13)
with Ē being the average energy imparted to a mass m by ionizing radiation. It is expressed in
units of [Gy] ≡ [J kg−1]. Absorbed dose is measured with specific equipment, including calorime-
ters’ measurement via temperature rise and ionization chambers, which measure ionization induced
by the passage of radiation in a gas. The gas is contained in a chamber subject to an electric
field. The ion–electron pairs produced by the beam interaction with the gas will then be attracted
to the electrodes, generating an electric signal proportional to the ionization’s, and thus dose,
magnitude[San12]. Concerning absorbed dose from mono energetic ions, and provided a collimated
beam is being used, it varies in depth as:
D(x) =
1
ρ
(
−dE
dx
)
Φ(x), (1.14)
with Φ representing the (primary) ion fluence, approximately given by the following expression
in depth
Φ(x) = Φ0e
−Nσx [ion cm−2], (1.15)
being Φ0 the entrance fluence, Nt the number of the medium atoms per unit of volume, whereas
σ is the reaction cross section related to the ion interaction with the medium[Par04].
In a radiation protection context, absorbed dose is calculated using the equivalent dose (HT )
notion, which is defined in [ICRP–103] as
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HT =
∑
R
wRDT,R, (1.16)
with DT,R being the average dose absorbed in an organ or tissue T , for radiation R, and w
the corresponding weighting factor for that radiation. Although the units are still [J kg−1], its
measurement unit is the sievert [Sv] instead of gray [Gy] to distinguish it in view of the former
tissue’s weighting factor ([IAEA–TCS–42]). A simplified version of these weighting factors can be
seen in table 1.1:
Table 1.1: Radiation Weighting Factors – [ICRP–103] 103 2007.
Radiation type Radiation Weighting factor wR
Photons, all energies 1
Electrons, muons, all
energies 1
Protons and charged
pions 2
Alpha particles, fission
fragments, heavy ions 20
Neutrons wR =

2.5 + 18.2e−
[ln(En)]
2
6 , En < 1 MeV
5.0 + 17.0e−
[ln(2En)]
2
6 , 1 ≤ En ≤ 50 MeV
2.5 + 3.25e−
[ln(0.04En)]
2
6 , En > 50 MeV
ICRP assumes that, for doses below 100 mSv, the stochastic effect incidence increases steadily
and proportionally to the equivalent dose. Therefore, the dose to healthy tissue while targeting a
tumor, should be kept as low as reasonably achievable, at least below deterministic repair thresholds.
In hadrontherapy, the quantification of the dose delivered to a patient differs considerably, as will
be later described. Before that, a brief mention to the clinical procedure will be given.
Clinical methodology. The decision for the use of any general form of radiotherapy results from a
multidisciplinary medical committee evaluation ([IAEA–HHS–31]). The latter evaluation accounts
for different treatment options for particular cases, defining treatment strategies depending on:
whether the therapy is curative or palliative; the patient status (age, health); tumor location along
with the identification of organs at risk (OAR) nearby, which should be preserved.
An optimal dose delivery in clinical practice is the baseline of conformal radiation therapy (CRT)
and it should obey to five cardinal points: Dose should be sufficient to destroy the tumor; it should
be uniformly delivered; exempt healthy tissue from lethal dose; irradiation should last as short time
as possible and patient movement impact should be minimized.
Failure to cope with those points may result in repercussions to healthy tissue due to radiation’s
exposure, depending on the characteristics of the radiation and sensitivity of the irradiated tissue.
Typically, conventional radiotherapy encompasses daily fractions of 1.8–3 Gy throughout 5–8
weeks, for 5 days a week with dose to the tumor attaining ∼ 75 Gy without secondary effects in
optimal scenarios. However, with carbon ions, the dose delivery is typically of ∼ 60 Gy, but weighted
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with a biological effectiveness factor which will be later described, over 4 weeks in 16 sessions for
skull base tumors, the value varying depending on the tumor type, location and fractionation
protocol[Ohn13].
Regarding the latter, dose delivery should be adequately fractionated in view of different tissues
having distinct responses to dose, with normal cells typically recovering better than abnormal
cells. At present, dose delivery protocols are based on the probability of healthy tissue of 5%
of the population evidencing side effects after 5 years (TD5/5 value). For palliative treatments,
higher doses/fraction can be envisaged ([IAEA–TCS–42]). According to NIRS data, for skull base
chordoma patients, the overall local control rates at 5 years were 88%, and similar values were
reported at GSI, whereas with conventional proton therapy a 73% value is generally attained[Ohn13].
Side effects can be avoided throughout various methodologies: Subdividing dose intake in frac-
tions over a somewhat extensive period of time and allowing healthy tissue to regenerate after
receiving sublethal dose, it reduces the impact of punctual overshooting but it has a negative in-
fluence on the treatment output rate; Also, the dose to adjacent healthy tissues may be kept below
critical thresholds by targeting the tumor through different angles, using multiple irradiation fields
(stereotactical) and/or intensity modulation techniques, with dose being delivered homogeneously
throughout the tumor volume only employing intensity modulation techniques[AK05]. The latter
approach will be mentioned in more detail in section 1.1.5.
The effects of radiation in tissue. Tumor cell destruction in ion therapy is a consequence of radiation
effects over functional DNA segments, generally by secondary electrons in the ∼10 eV energy range,
resulting from the beam particle’s interactions and consequent ionization density[Gre12, LFO13].
As the human body is ∼ 80% water, the majority of the interactions of an ion beam, for
instance carbon, affects water molecules, involving Coulombic but also nuclear interactions such
as 12C(16O,X) and 12C(p,X). Depending of the interaction type it may eventually lead to a
transformation of the molecular structure which can prevent/alter its biological function.
The effects of radiation along particle tracks in tissue (dl) can be more accurately evaluated
using the notion of (restricted) linear energy transfer (LET)
L∆ =
(
dE
dl
)
∆
[keVµm−1], (1.17)
which, by excluding energies above a threshold ∆ for secondary electrons, allows a more detailed
assessment of radiation’s localized effects[BMM16]. Necessarily, the slowing down of charged hadrons
traversing a media implies an increase in ionization density and thus LET up to the Bragg Peak,
increasing its destructive effectiveness ([IAEA–TCS–42]).
Among the various types of ionizing radiation, ions, being both directly and densely ionizing, are
considered high–LET radiation, depositing great amounts of energy in relatively localized spots,
favouring deep–seated tumor destruction. Furthermore, contrarily to protons that are sparsely
ionizing and low–LET, ions are indeed able to treat radioresistant tumors by damaging directly
the DNA[EK16, Sui10]. While protons modestly damage the DNA molecules mostly via singlestrand
breaks, ions are more likely to cause doublestrand breaks, irreparable and usually leading directly
to cell death via loss of reproductive integrity. Since DNA comprises about 5% of a cell nucleus,
these effects take place at a relatively tiny scale, they are categorized in [IAEA–TCS–42] as:
Direct – Breaking up of biological molecules promoting unpaired electrons, due to the direct
action of an impinging particle in a macromolecule involved in biological tasks which becomes
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disfunctional and reactive. High–LET radiation such as ions is extremely destructive in this
way.
Indirect – The free radicals, such as hydroxyl, produced by the radiation in the cell, affect theDNA
collaterally. The mixed field of an ion irradiation creates many indirect effects by interaction
with cellular water in tissue and promoting radiolysis, which leads to highly reactive radicals.
Free radicals are intrinsically related with the oxygen amount in the medium, thus cells with
low oxygen content (hypoxic) are relatively radioresistant, up to a factor of circa 3, than normal
ones and they must be irradiated with higher doses to be destroyed, an effect quantified by the
oxygen enhancement ratio (OER), defined as[Sui10, Sch14]:
OER =
Dh
Da
, (1.18)
with Dh being the dose required to produce a deterministic effect in an hypoxic tissue, and Da
in an aerobic one. For low–LET radiation OER is ∼ 3. Regarding carbon ions instead, OER varies
with LET from 2.5–1 rendering them more effective at killing cells in the hypoxic, necrotic cores of
solid tumors. Since ions with charge equal or above six can provide the same biological effectiveness
using up to a third of the x–rays dose, the radioresistant effect, due to low oxygenation rate (poor re–
oxygenation pattern/high repair capacity), is almost overcome using these ion species[Sui10, Moh17].
However, one needs to take into account also the loss of ballistic selectivity due to fragmentation and
the possible high damage to healthy tissue in order to compare ions’ effect with other radiation. One
way to quantify the sensitivity of biological material, for different particles, with respect to a specific
biological endpoint such as with x–rays, is done by applying the relative biological effectiveness
(RBE) factor[SES10]:
RBEiso =
Dx−rays
Dion
, (1.19)
which is here defined as the ratio between the x–rays (usually 250 kVp) and the test radiation (i.e.
ions) dose required to produce the same biological effect as defined by [IAEA–TRS–461]. This effect
was in fact one of the main driving factor for using high–LET and low OER particles, in cancer
therapy. It becomes then necessary to distinguish between physical dose D and biological dose
Dbio, as these are conceptually distinguishable quantities in view of dose’s microscopic distribution
in tissue, linked through RBE
Dbio = RBE ·D. (1.20)
Moreover, since RBE is a dose dependent factor (among other factors such as particle type and
tissue) its variations may therefore have a considerable impact on the dose delivered near OAR.
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relevant for high–LET radiation. The former strongly varies as a function of LET in vivo, being the
α/β parameter the value used to model cell survival[Sch14]. For densely ionizing radiation its tracks
lead to an higher cell death rate regardless of the cell cycle, type, degree of oxygenation or repair
capacity. It is commonly accepted that RBE increases with LET up to 100 [keV µm−1], then for
too high LET a saturation level occurs, an effect denominated overkill decreasing the RBE value.
The local effect model (LEM), developed at GSI, is a model presently in its fourth version
employed to estimate biological damage due to cell killing by ions, it does so considering: the
energy deposited by the radiation type; microscopic dose distribution in the vicinity of ion tracks;
cell diameter and its sensitivity to x–rays according to α/β parameters. Thus it allows for the
prediction of RBE values in ion therapy[Mai10, SES10, Bau14].
The ion’s RBE will be deeply influenced by the tissue type, ion energy and biological end-
point/ion beam characteristics.[Sch14]. Consequently, ions may not have favorable outcomes with
all types of tumors and the outcome prediction should account for the cell type and traits (e.g. the
biological cycle), the type of tumor and the response of healthy tissue in its vicinity[Sch14]. Finally,
the fragmentation of the ion beam would lead to different RBE values to be evaluated for each of
the species produced, increasing greatly the complexity of the problem[Mai10].
Ions’ LET (and RBE) variations can be very sharp along the beam path, going from 0.15 [keV
µm−1] up to LET > 100 [keV µm−1] before the Bragg Peak [Ura01]. This contrasts with protons,
whose LET varies between 0.4–16 [keV µm−1]. For carbon ions, RBE variation spans from ∼ 1 at
the plateau, where healthy tissue is affected within repair threshold, to more than 3–4 at the peak
(there are reports from 2.5–5), hence maximizing the effect on the tumor site, as observed in figure
1.7[Ter09, Moh17]. As a consequence, 1 Gy of ion dose translates into ∼ 3–4 Gy of a photon beam,
and slightly less for protons.
For ions heavier than carbons, an high LET and RBE is observed already at the entrance,
mitigating the treatments’ efficacy. However, oxygen ions are expected to be more efficient against
some radioresistant tumors. Ideally, a compromise should be sought by evaluating both tumor
response and usage of high–LET radiation, in view of different tissues’ regeneration capabilities.
Eventually, different kind of ions could also be used according to their biological effectiveness and,
in facilities such as HIT, this is technically feasible with protons, helium, oxygen and carbon ions,
combining high–LET and low–LET ions[KMP12].
Despite extensive work in vitro (e.g. NIRS) and the LEM or other models development, it is
extremely important to have in vivo data. For the moment, a conversion factor between absorbed
dose and RBE–weighted dose is used for treatment planning and an optimal model is still to be
found, with several alternatives under study[SES10].
Regarding tissues’ response to high–LET radiation, it is under investigation in which scenarios
“hypofractionation” is preferrable to maximize treatment’s efficacy, as well as the possible advan-
tages of using different ions[Sch14, Ina17]. Clearly the high effectiveness of heavy ions open the
possibility of “hypofractionation”, ideally enabling a reduction of treatment time for some cancer
types, with at least an equivalent treatment efficacy[TK12]. While conventional fractions will ac-
count for 1.7–2.1 Gy (RBE), “hypofractionation” will attain 3–14 Gy (RBE)[Sui10]. Another possible
advantage of “hypofractionation” is the reduction of operational costs, in view of higher number of
patients per year[Sch14].
For such evaluation, it is important to assess the outcome of different clinical protocols with
ions and protons, the effects of OER, as well as other biological variables (e.g. glucose, iron
metabolism)[Sch14]. This should be pursued in such a way that a cost vs benefit and treatment
efficacy record history can be properly established, according to standard protocols[Sui10, Kam15].
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So far, clinical outcomes of carbon ion beam facilities in Japan and Germany have been very
promising [Ter09, TK12, Ohn13, EK16, Moh17]. The experience with high–LET radiation is expected
to lead to an international consensus for converting physical into biological dose, assessing both
deterministic and stochastic effects, especially important in ions[Sch14]. Finally, the study of steep
RBE variations, cell survival rate and the improvement of biophysical models along with the as-
sessment of tumor types and response, would be helpful to define the treatment approach, including
“hypofractionation” effectiveness[Ohn13]. Overall, these studies have also opened a gateway to the
therapeutic application of other ions species[Kit10].
1.1.3 Hadrontherapy with radioactive ion beams
Due to ions’ favorable energy deposition profile, their clinical efficiency could be improved if opti-
mally exploited. Still, entrance dose and the fragmentation dose tail, which is absent in protons,
are limiting factors in clinical scenarios. At the entrance, heavier ions’s RBE values are similar to
protons but, because of fragmentation, the dose values may change according to the different frag-
ments’ biological effectiveness[Har17]. The fragments’ energy transfer is much lower than the peak
value, but still relevant considering that RBE could attain relatively high values in that region.
Even though ions are more hardly deflected in their paths than protons and consequently have
better ballistic properties, their range uncertainties can have a more deleterious impact on the dose
delivered to the patient in view of their enhanced biological effect and steep dose profile[Alo00]. This
is a clear drawback in view of their suitability for treating deep–seated tumors or tumors located
near sensitive organs, requiring an appropriate range assessment.
Overall, after dwelling over the physical and biological aspects of hadrontherapy, the three
cardinal advantages of ions with respect to protons can be summarized as:
1. Less scattering and consequently better lateral dose profile while traversing tissue in depth;
2. Higher biological effectiveness, destroying cancer cells beyond repair threshold;
3. Sharper Bragg Peak, although with a “fragmentation tail”.
However, the radiation from nuclear reactions involving the primary beam and its fragmentation
products can be also useful. Since typically no primary beam particle emerges from the treatment
in hadrontherapy, the detection of such secondary radiation will be the only source of information
on the treatment effectiveness, during or afterwards. In fact, the β+ emitter fragments produced by
ions, prompt γ and even secondary protons, can still be used as peak’s position indicator e.g. using a
PET apparatus in–situ, to take advantage of the autoactivation of the beam through the β+ emitting
radionuclides generated by the impinging ions[Mac69, TCS71, Tob77, Eng92, Eng99, PE00, PEH2b].
The nuclei generated in fragmentation processes are generally depleted of neutrons, hence ra-
dioactive and decaying through either electron capture or positron emission[Tom03]. In fact, one of
the leading fragmentation modes is the stripping of neutrons from the ion projectile. This occurs as
a nucleus is “pushed” beyond the line of stability, increasing its proton–to–neutron ratio, originating
a β+ emitter (fi). The latter emissions may contribute to the signals that can be of relevance for
imaging characterization, as will be described later. Generally, the mixed field will mostly consist
of neutrons, gammas and other light secondaries, proceeding from inelastic nuclear interactions and
consequent fragmentation of either the projectile and/or target nucleus[Eng92, Tom03, Ina08].
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Projectile fragmentation. As the chief mechanism of autoactivation, projectile fragments (e.g. p,
He, Li, Be, B) are very energetic as they approximately inherit the primary particle velocity, and
direction, at their current reaction point x0. Due to the R ∝ A/z2[Eng92] relationship for equal
velocity, they may travel longer distances than the projectile (p) Bragg Peak. If the interaction
leads to a loss of neutrons in nuclei while not affecting the charge of the nuclei, a shorter range
can occur instead[Som07]. Fragment’s (f) stopping position will change in depth (x) due to variable
impact points, along with energy losses in various interaction. Although this poses constraints on
range monitoring with ions (e.g. for 12C irradiation, 11C and 10C will come at rest before the Bragg
Peak), it could be overcome using RIβ+, as it will be later described[Pa12a]. The number of β+
emitters of a certain ith type (dNp,fi), originating directly from a number of primary ions N0 in a
target (t), can be characterized at depth x by
dNp,fi(x) = N0(x)Ntσ [Ep(x), Ap, At, Af, Zp, Zt, Zf] dx, (1.22)
where Nt, σ, A and Z denote the number of target nuclei in volume, partial cross section for
projectiles of energy E at depth x, mass and atomic number, respectively[Ina05]. On the other hand,
the stopping position of these fragments will depend on the range of these fragments (Rp,fi), after
the reaction point x0, and can be described as
Rp,fi = x0 +
∫ Ex0
0
(
dE
dx
)−1
dE, (1.23)
with Ex0 being the initial energy at the reaction point, the average overall stopping position
xp,fi will be then approximately given as a result of x0 +Rp,fi[Ina05]. For the β+ emitter production
through projectile fragmentation, ion beams with Z ≥ 5 are required.
Target fragmentation. It consists of the nuclides which will travel very short distances, being thus
indicators of the interaction location and the only mechanism responsible for β+ emitter fragments
production in therapy with ions with Z<5[Fie06]. If dNt,fj is the number of β+ emitters of certain
jth type, then their evolution in depth x is given by
dNt,fj(x) = N0(x)Ntσ [Ep(x), Ap, At, Af, Zp, Zt, Zf] dx. (1.24)
However, please note that besides the production ascribed to the primary ion beam described
in equations 1.22 and 1.24, secondary particles could also further induce β+ emitter production in
tissue[Ina05].
β+ emitters. Such species, some highlighted in figure 1.9, decay through the following mechanism,
denominated β+ decay:
A
ZX −→ AZ−1 X ′ + β+ + νe +Qe− .
In the above reaction, X denotes the parent nucleus, usually a neutron deficient radioactive
nucleus, while X ′ is the daughter specie, in which a proton was converted into a neutron[Cur34].
The β+ and νe are the ejected positron and electron neutrino, respectively. The latter is required for
lepton number and momentum conservation. As for Qe− , it denotes the energy required to expell
an extra orbital electron, to compensate for the positive charge lost[Bai05]. The β+ is emitted with
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a continuous spectrum of energies up to a maximum endpoint energy, depending on the differences
in atomic mass of parent and resulting isotope excited levels[SF02, CD06].Sheet2
Page 1
14F 15F 16F 17F 18F 19F 20F
1 ns 4.1E-22 s 1.1E-20 s 1.075 m 1.8288 h 100 11.03 s
12O 13O 14O 15O 16O 17O 18O 19O
5.8E-22 s 8.58 ms 1.1768 m 2.041 m 99.757 0.038 0.205 26.91 s
10N 11N 12N 13N 14N 15N 16N 17N 18N
2E-22 s 5.9E-22 s 11 ms 9.967 m 99.632 0.368 7.13 s 4.17 s 622 ms
8C 9C 10C 11C 12C 13C 14C 15C 16C 17C
2E-21 s 126.5 ms 19.25 s 20.37 m 98.93 1.07 5.7 ky 2.449 s 747 ms 193 ms
6B 7B 8B 9B 10B 11B 12B 13B 14B 15B 16B
1 ns 3.5E-22 s 770 ms 8E-19 s 19.9 80.1 20.20 ms 17.33 ms 12.5 ms 9.87 ms 1.9E-10 s
5Be 6Be 7Be 8Be 9Be 10Be11Be 12Be 13Be14Be 15Be
1 ns 5E-21 s 53.22 d 7E-17 s 100 1.6 My 13.81 s 21.3 ms 5E-10 s 4.35 ms 200 ns
3Li 4Li 5Li 6Li 7Li 8Li 9Li 10Li 11Li 12Li
9.1E-23 s 3.7E-22 s 7.59 92.41 838 ms 178.3 ms 2E-21 s 8.75 ms 10 ns
3He 4He 5He 6He 7He 8He 9He 10He
0.000137 99.999863 7E-22 s 808.1 ms 2.9E-21 s 122 ms 7E-21 s 2.7E-21 s
1H 2H 3H 4H 5H 6H 7H
99.9885 0.0115 12.33 y 1.4E-22 s 9.1E-22 s 2.9E-22 s 2.3E-23 s
Figure 1.9: Adapted chart of nuclides with the β+ emitting isotopes coloured in pink and outlined in red
([IAEA–NDS]).
Irrespective of the parent isotope, the positron emitted will annihilate with an atomic electron
within few mm in range, upon exhausting its kinetic energy. At such point, it will capture an
ambient electron, forming instantaneously (∼ 10−10 s) a bound state named positronium that will
annihilate shortly afterward. A positronium has two configurations, ortho– or para–positronium,
with spin values of 1 or 0 and half–life in vacuum of ∼ 140 ns and ∼ 0.125 ns, respectively. The
ortho–positronium formation is more probable (75%) but due to its much longer half–life compared
to the para–positronium, the latter ends up being the dominant form annihilating by swiftly inter-
acting with an atomic electron. Since the positronium rest mass is E = 2mec2 and its momentum
approaches zero it will typically generate two 511 keV photons travelling in approximately opposite
directions (∼ 180± 0.5o) if in the para–positronium form, as described in figure 1.10. Alternatively,
other decay configurations with at least three photons emitted for ortho–positronium are also pos-
sible, although highly unlikely (0.003%)[Bai05]. Coincidence photons are neither exactly opposing
nor energetically similar due to the shell electrons having a significantly higher momentum than
the positron, which typically reaches thermal energies at the annihilation moment[Böh12].
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The interest in this topic was, however, not lost. Studies were carried out at GSI in the 90’s,
using secondary RIB[Eng92, Paw96] and at HIMAC since early 2000’s, with experiments in imaging
and range verification[Sud00, Kan02, Ina05]. These studies concluded that signal from doses as low
as 10 mGy could lead to range monitoring results within 1 mm, while peak doses of 96 mGy
(RBE) rendered range uncertainities to as low as ±0.3 mm in a 15 cm diameter homogeneous
PMMA phantom. The use of 11C and 10C as probes was also investigated, with in situ signal
detection, just prior to treatment with 12C[Ise04]. More recently, tests highlighting the possible
advantages in using 15O for imaging gain and efficacy in treating hypoxic tumors have been carried
out[Moh16]. All studies so far performed with RIβ+ have indicated a potential advantageous effect in
treatment quality by allowing the tracking of the beam in a more efficient manner[Kit06]. However,
it remains still challenging to produce, accelerate and deliver those beams with clinical standard
quality[MAT14, Aug16].
1.1.4 Positron emission tomography
PET designates a nuclear medicine imaging technique characterized by the indirect detection of
β+ emitting radionuclides, through their annihilation coincidence photons, and subsequent com-
putation of a digital image representing the distribution of β+ emitter activity[Tur11]. It is now
well–established and characterized by a relatively high efficiency, high sensitivity even with nanomo-
lar concentrations, relative non–invasiveness and a 3D imaging capability. PET has a broad range
of applications, due to β+ emitters from low–Z radionuclides that take part in metabolically rel-
evant processes. Recent research has focused either on brain related pathologies (e.g. Alzheimer
and Parkinson) or pinpointing cancer tissue locations in the body.
Since the first PET prototype, dating from 1975, the technique underwent many conceptual
changes, leading to the modern PET design and functional specifications[Phe75, Zan04]. In its cur-
rently most widespread form, denominated PET/CT scanning, it consists of both a PET and CT
scanners mounted in series (see figure 1.12-a), each with their respective field of view (FOV) and with
images coregistered[Bey00, To08a]. It was originally developed in the United States, in 1998 and be-
came commercially available in 2001, quickly replacing standalone PET solutions[Bey04, To08a, To08b].
The “fused” PET/CT concept allows the visualization of the inner body structure and, at the same
time, identify the approximate location of positron annihilation, further improving the imaging
accuracy[Bey00, To08b].
The major advantages in having the tomographs integrated in a single system is the needlessness
of patient repositioning at a different device and that it allows CT images to be used for the
attenuation correction of PET data. The need for these corrections derives from linear attenuation
coefficients, that are measured with CT for the x–ray energy range (80–140 keV) and must be
readjusted for γ (511 keV), allowing for a quantitative assessment via PET imaging[CD06].
Currently, PET/CT scanners are manufactured by five companies: GE Healthcare, Hitachi,
Philips, Toshiba and Siemens. Among these, one can highlight the state of the art models Siemens
Biograph mCT, Philips Gemini series and GE Discovery series. For the PET image reconstruction
simulations in chapter 5, the Biograph mCT (TruePoint TrueV option) was modelled, in an attempt
to reproduce possible PET acquisition scenarios[STP08]. Its parameters are included in the appendix.
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(a) (b)
Figure 1.12: PET/CT scanner schematic, adapted[To08b], in a common gantry and with a single patient couch
(a). Artistic depiction of an in beam PET acquisition scenario (b) [ENVISION].
PET role in Hadrontherapy. In recent years, imaging techniques that are PET–based have improved
greatly, benefiting hadrontherapy and the development of online, in situ, treatment monitoring
modalities. These are considered as very advantageous in view of the fact that autoactivation’s
signal does not entail extra dose to the patient. At the moment, it is the most extensively clinically
investigated technique for treatment monitoring and range verification in proton and carbon ion
therapy.
Upon ion beam irradiation, two signal components can be distinguished, namely a prompt
component, originating from nuclear reactions in a sub ns time scale, including photons, hadrons
and leptons (e.g. prompt γ in the 1–10 MeV energy range) and a decay component with radiation
emissions due to radioactive isotopes (e.g. β+). In the latter case, the signal quality will depend
on the amount of radioactive species’, their half–life and β+ range.
Additionally, PET can be exploited in diagnostic applications in a 4D framework, studying
the tracer dynamics in time. In a hadrontherapy context, this allows for the characterization
and follow up of lesions related to treatment. This feedback could be used to improve the target
definition as a function of organ motion and even to refine the treatment approach in view of the
irradiation consequences’ effect, ideally, in real time. This is the main principle behind in vivo beam
range verification, to ensure tumor–dose conformality and thus maximize hadrontherapy treatment
success[Vyn93, OLA96, PE00]. A very promising technique to accomplish treatment monitoring and
confirmation is to use PET–based systems in situ and fully integrated with the beam line as depicted
in figure 1.12-b, denominated in beam PET [Paw96, En04a]. This method will be mentioned in greater
detail in the next section.
PET/CT Scanning. Scanning procedure starts with the CT being used to computerize and as-
semble a picture of the target zones from x–rays data for anatomical information, within seconds.
In this process, whole body effective doses within 20 mSv can be delivered, although for correc-
tion/verification purposes the exposure is lowered down to 3 mSv[To08b].
A PET scan will consist of the collection and reconstruction of 511 keV coincidence γ, produced
in the annihilation events. After escaping the body these signals can be detected by the PET
scanner, typically a cylindrical assembly of crystals, within an (ideally short) time and energy
coincidence windows[Bey04].
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image[Zan04]. Consequently, a PET scanner performance is maximized by both higher count rates
and lower noise from background (R + S) events[Tur11]. The noise equivalent count rate (Ṅeq),
a parameter used to assess PET performance in view of the different types of events detected, is
defined as
Ṅeq =
T 2
S + T +R
. (1.27)
The maximum value of Ṅeq corresponds to a particular scanner’s optimized count rate[Tur11].
Such optimization can entail the use of simulations to understand the influence of different physics
mechanisms involved in background coincidence generation and maximize the true count rate[Hir14, Poo15].
Noise is of particular relevance for in beam PET if not properly mitigated, as this technique
sees a high rate of secondary particles that can affect image quality, as their LOR will not coincide
with the annihilation site. Noise will originate from single counts, neutron induced events and the
overall γ–ray background, along with the activated detector itself[Hir14].
PET image reconstruction Whole body imaging requires either the use of multiple detector rings
for a 3D assessment of β+ activity distribution or using multi–ring, septa separated, 2D PET, in
which coincidences are compiled from a limited ring number. The former type is characterized by
a larger solid angle and higher amount of true coincidences, but requires a more challenging image
reconstruction procedure.
The acquired raw data, consisting of coincidence event counts and respective LOR, is typically
stored in either lists or sinogram format[Def97]. The count number assigned to a LOR is proportional
to a line integral of the β+ activity along that LOR. It corresponds to a 2D matrix in which line
integrals are arranged in parallel subsets, each representing a projection angle as a row in an image.
Every LOR is identified as a specific pixel, whose value is incremented everytime a detection occurs.
In the end, the sinogram’s pixel value will actually indicate the number of coincidence detections
between the detector pair of the respective LOR[Fah02].
In list mode, a coincidence is recorded individually, preserving both time and spatial information
of LORs. Conversely, a sinogram representation is obtained within a certain time interval. Thus,
the former allows for greater flexibility in image generation but requires handling large datafiles.
Sinograms are much lighter, but lack temporal and spatial resolution information.
For image reconstruction, one can resort to analytical (e.g. FBP) or iterative methods (e.g.
MLEM), in which algorithms are employed to extract sinogram data in cross sectional images with
the β+ activity distribution[CD06, Tur11]. Subsequent normalizations can be applied, as corrective
measures related to scanner specific parameters (i.e. efficiency) and to convert count rate into β+
activity values. Also, the CT scan can be used to estimate attenuation and scatter corrections, so
that a quantitative result is obtained while highlighting physiological information[Fah02, Zan04].
PET scanner characteristics. The detector in a PET scanner typically consists of scintillator mate-
rials transforming the coincidence signals into optical photons (≈ 1 eV), using photomultiplier tubes
or the more recent avalanche photodiodes and silicon photomultipliers to convert these scintillation
photons’ into electronic signals. The detector material should be characterized by a high photo-
electric effect cross section for 511 keV photons, high absorption (high Z and ρ) and efficiency (low
dead time) with high light output yield in short time intervals. However, no material excels in all
these aspects, for instance absorption is relatively high for Discovery ’s BGO, while the luminosity
for Biograph’s LSO can achieve values as high as 29 photon/keV, with a 40 ns decay constant. Also
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GSO, in some versions doped with zirconium, and Gemini ’s LYSO are other commonly used PET
scintillator materials[Bai05, To08b, Hir16].
PET systems are in continuous evolution as the demand grows for higher sensitivity, and spa-
tiotemporal resolution, properties that depend on crystal material and electronics. The sensitivity
of a scanner is typically improved by increasing the scintillator thickness and density, providing
more detector material, or extending the FOV.
Generally, photons will take few ns to reach the detector and their time–of–flight (ToF) will de-
pend on the annihilation position along the LOR. An optimal time resolution requires both fast elec-
tronics for signal processing and low scintillator material decay time varying within 10–100 ns[Zan04].
The availability of LSO and LYSO materials with low coincidence timing resolution (. 450 ps) led
to ToF–PET, an enhanced PET modality which allows a more direct pinpointing of annihilation
event location by calculating the ToF difference between the annihilation photons[Lop16]. This
modality is featured in commercial Gemini TF and Biograph scanners, the latter attaining time
resolutions lower than 500 ps and coincidence timing resolution of 4.1 ns[STP08]. This information
can then be implemented in the PET reconstruction to improve the image quality[To08b].
Spatial resolution of a PET scanner, on the other hand, is instrinsically limited by two factors:
the β+ endpoint energy, which depends on the isotope, and the photon pair non–collinearity, tech-
nically limiting resolution to at least 1.5 mm and resulting in a blurring effect that is more relevant
for larger diameter PET rings[CD06, Zan04, Bai05]. Presently, PET/CT systems spatial resolution
varies slightly among different PET scanners, achieving ∼ 4.2 mm transaxially/axially for Biograph
mCT and slightly higher values for Gemini TF and Discovery STE, but it can reach values as low
as circa 2–3 mm using point spread function information.
1.1.5 Dose delivery and overview of range monitoring techniques
While intensity modulation of photon beams typically uses beamlets from different directions to
target the tumor (IMXT), it still produces high entrance and exit dose levels. Intensity modulated
particle therapy (IMPT) with charged hadrons allows for higher levels of dose conformity and
homogeneity, achieved even within a single field SOBP[Krä00, Sui10]. A SOBP takes the shape of a
dose “plateau” instead of a single peak, as in figure 1.14, allowing for the targeting of deep–seated
tumours. The final shape is achieved throughout the use of multiple pristine Bragg Peaks of different
energies, with overlapping dose profile leading to the delivery of high levels of dose along a given
depth. As for the dose values, they are modulated by each peaks’ intensity, their cumulative effect
resulting in the aforementioned “plateau” shape.
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Figure 2.1 shows a comparison of depth-dose profiles in water of photons, protons and
carbon ions with clinically-relevant energies. The enhanced ballistic properties yielded
by ions when compared with photons is shown, as well as the higher broadening of the
Bragg peak of proton beams in respect to carbon ion ones. Such a physical phenomenon
is related to the energy loss processes of the particles composing the beam along the
target, namely to the statistical fluctuations in the energy loss in the large number of
collisions of the slowing-down process, which result in a broadening of the Bragg peak
for an ion beam consisting of many particles. These fluctuations give origin to the range
straggling observed. Proton beams have a higher range straggling when compared with
carbon ion beams, since the relationship that governs the range straggling process has a
1/
√
M dependence, where M is the particle mass [8].
Figure 2.2: Creation of a SOBP by superimposing several Bragg peaks from carbon
ions with different energy and beam intensity. Adapted from [9].
In any case, such sharp peaks cannot provide full tumour volume coverage with the
required dose, so the beam delivery system must extend the Bragg peak over a bigger
volume, creating the so-called spread-out Bragg peak (SOBP). Figure 2.2 shows how the
SOBP can be formed by superimposing several Bragg peaks in the case of carbon ion
irradiation. The same procedure is applied for the case of proton beams. There are two
main ways to do it (although each approach may have several technical variations). The
first is the passive delivery, which employs mechanical structures to shape and tailor the
beam to the intended dose distribution. It makes use of one or more scatters (to broaden
the beam), range modulators (to produce the actual SOBP), range shifters (to move the
SOBP in depth), collimators (to collimate the beam), and compensators (to shape the
beam to cope with the distal contour of the tumour volume). Figure 2.3 depicts the
different mechanical structures utilised for a passive shaping of the beam, as well as the
effects on the transversal and longitudinal profile of the beam. The range modulator,
instead of a flat structure as seen in figure 2.3 top, may be a modulator wheel that rotates
at a given frequency in order to produce the SOBP, as in figure 2.3 bottom. Furthermore,
it can also be observed in the top illustration of this figure that the beam shaping process
Figure 1.14: Depth dose distribution of charged hadron beams in the form of a SOBP resulting from the cumulative
effect of 18 different pristine Bragg Peaks[Pin14].
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The range of each particular beam can be set directly at accelerator level or by moderating
the beam with attenuators, so as to target the tumor in depth. Range can be defined down to
sub–mm accuracy in well defined media in quality assurance (QA) scenarios. However, in patients,
multiple factors will add up to the range uncertainities, which should be addressed with mitigation
strategies, particularly in the presence of OAR in the vicinity of the tumor[Pri12]. In fact, range
uncertainties may amount to as much as 3.5% of the prescribed range +1 mm for protons, as
reflected in MGH safety margin protocols[Pag12]. For this purpose, the use of gantries to deliver
the beam from multiple angles is highly desirable to further ensure conformity to tumor volume.
These gantries are equipped with a nozzle at their end for beam shape and monitoring.
The quality of the dose delivery in range will be affected by the beam energy spread, straggling,
patient biological factors, CT QA and RBE variation. In practical terms, the range is defined at
the Bragg Peak curve distal fall off to 80% of its maximum for a pristine Bragg Peak and 90% for
a SOBP. Furthermore, a detailed knowledge of the range of different ions and subsequent Bragg
Peak, as a function of energy, is relevant in order to evaluate SOBP biological dose delivery and
treatment efficacy[Sui10].
Treatment Planning. Treatment planning and simulation consist of using an “inverse plan optimiza-
tion approach”, as it starts by defining a set of constrains that need to be fulfilled with an optimized
procedure, iteratively[PMS13]. In hadrontherapy it includes ideally the following steps:
1. Anatomical imaging acquisition fused with tomographical information using MRI and/or CT.
This generates a digital model of the region to be irradiated. Raw CT data, without enhanced
contrast, will essentially represent the density of electrons in tissue.
2. Definition of tumor’s dosage and fractionation plan. Also, boundary limits and OAR toler-
ances for irradiation by clinical practitioners are then set, corresponding to the regions of
interest to be targeted and/or spared by the beam.
3. Simulation reproducing both the patient and setup geometry. Diagnostic x–rays are used
to pinpoint OAR. The optimal tumor targeting paths are then defined with respect to OAR
in the vicinity. The absorbed dose to be applied is then computed in 3D, either in the CT
directly or in water–equivalent coordinate system. Subsequently, if heavier ions than protons
are being used, the biological effect in the tumor and healthy tissue in its vicinity needs to be
evaluated using a radiobiological model.
4. The radiation treatment planning is then established if a clinically acceptable solution is
found, accounting for the data from the previous step using: the TPS database, the clinical
data and specific models and algorithms for RBE and dose conversion.
Hounsfield Units (HU) conversion protocols translate the CT results into a map of relative
stopping power. Such protocols are based on CT scans of tissue/phantom materials with known
density/elemental composition. The photon attenuation factor is expressed in HU, quantified via
HU = 1000×
(
µ− µH2O
µH2O
)
, (1.28)
where µH2O is the attenuation coefficient in water and µ the attenuation coefficient of the
material. Once a stopping power ratio map is defined, a detailed plan can be calculated, typically
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iteratively. However, conversion errors may result in some millimeters uncertainities in range as
reported for protons[Pag12].
Most comercial TPS are still based on fast–performing analytical pencil–beam dose calculation
algorithms and range predictions using the water–equivalent’s stopping power estimates from CT
scan data (e.g. Syngo PT Planning from Siemens)[Pa12b]. These systems project ranges based
on the water equivalent depth in the patient, nuclear reactions and scattering effects are therefore
accounted for in water only and subsequent corrections are necessary for heterogeneities in the
beam path[Pa12b]. Although the proton therapy mixed field is relatively less complex than that of
heavier ions, the uncertainities deriving from heterogeneities (e.g. at bone/soft tissue interfaces, air
cavities), as well as different I from tissues, may result in higher under–/over-dosage for protons
due to their larger scattering[Sui10].
A more in depth evaluation of the biological and physical consequences ascribed to complex
physical processes in hadrontherapy is indeed the major motivation for current ongoing work aiming
at employing MC codes to aid inverse treatment planning[Krä00, Bau14].
Dose delivery systems. In hadrontherapy, dose should be delivered accurately and homogeneously
to a target volume. Two methods, employing active and passive techniques are employed for that
effect[Kit10]. The latter are simplier to implement, since they adapt the existing beam to the target
volume, using[Sui10, SES10]:
I Beam–scattering – The lateral tumor outline is covered using double scatterers with an apper-
ture. The range is modulated with ridge filters and/or a range modulator. In both ways
an homogeneous SOBP with appropriate width and depth, is achieved. However, degraders
such as ridge filters widen the physical dose distribution in range, but also laterally, requiring
compensators which are patient specific. Distal conformity to the tumor often produces a
proximal overdosage with this method.
I Layer–stacking – Similar to the above referred method, but it attains a better dose delivery
“shaping” and consequently higher conformity to tumor’s volume. Wobbling/uniform scan-
ning is followed by further elements, such as rotating wheels of variable thicknesses for both
range/shape compensation. Multiple SOBPs are then collimated and attenuated to comply
with the tumor shape.
Passive methods tend to lose efficacy at the tumor’s boundaries and have a more limited max-
imum range. Plus, the use of energy degraders lead to additional nuclear reactions, altered RBE
values and produce secondaries such as neutrons that disrupt dose delivery/imaging quality. Ad-
ditionally, vendor information may actually differ in the equipment provided, leading to additional
uncertainties[Pag12].
On the other hand, active scanning techniques rely on magnetic steering of ion beams, possibly
with different intensities and/or over other modulating devices, as well as energy modulation for
a better conformity to the tumor. These can attain mm–level precision, without employing de-
graders and therefore with less debris production, allowing for a more accurate LET quantification.
Beam targeting position is controlled transversally with a pair of dipole magnets and longitudinally
through change of beam energy in steps[Bou08, Par10]. Two modalities are generally included in this
method[Sui10]:
I Spot scanning: Achieves an uniform dose distribution employing multiple discrete dose spots of
a particular energy/direction. After usage, a spot is switched off and both the scan magnets
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and the accelerator energy are adjusted for the next irradiation. It was developed in Japan
but first clinically applied at PSI[Ped95].
I Raster scanning: Uses pencil beams to cover the tumors’ volume in layers. Each layer corresponds
to a particular energy, range and intensity in a certain area. It requires the beam to be scanned
quickly transversally. This methodology was first developed at HIMAC, later being introduced
at GSI and subsequently HIT[Hir90, Hab93].
An intermediate method between passive and active techniques, which will be here denominated
semi–active, can be considered as well:
I Wobbling: Beams are scattered and then scanned magnetically in predefined paths, without
intensity modulation but with varying energy. It was first developed at NIRS[Sui10].
Despite the favorable evolution of dose delivery accuracy, its adaptation to dynamic patient
target volumes is most desirable to ensure precision treatments. In clinical usage, adaptive radiation
therapy (ART) denotes the adaptation of dose delivery to tumor changes during treatment session
or throughout the whole treatment (e.g. tumor shrinkage/regression; weight loss/gain; interference
of cavities and respiratory motion of organs).
As these anatomical changes may result in range uncertainties, the TP should be updated
accordingly and often CT rescanning would have to be performed. This approach is made possible
by technological advances which can be put into effect at TP level for a more efficient treatment.
Range verification in hadrontherapy. In the framework of hadrontherapy, getting information from
irradiation effects is limited by the fact that the beam is stopped inside the patient. Therefore, only
secondaries can be used for obtaining information on the treatment, via imaging[Kr15b]. Range ver-
ification techniques require radiation dose calculations, and (ideally) MC to describe dose delivery
and nuclear fragmentation. This is highly desirable in the context of IMPT, where the consequences
of over/under shooting are more drastic than in conventional IMRT, even if properly fractionated.
Furthermore, it allows feedback upon variations detected by imaging in the TP. This can eventu-
ally lead to a more efficient exploitation of charged hadrons’ advantageous dose delivery, a better
monitoring and confirmation of treatment.
Ideally, the consequences of anatomical changes (e.g. position, motion) over the predicted dose
and range should be assessed not only in between treatment fractionation (inter fraction) but
during treatment (intra fraction), with in vivo range verification and dose monitoring. The two
most promising beam delivery monitoring techniques currently exploit the detection of:
β+ emitters – Employing PET–based solutions (e.g. in beam PET and offline PET ), as well as
planar positron cameras[Paw96, En04b]. The use of a commercial PET scanner implies having
the patient moved, after treatment, in a different room (offline) or in the same room (in–room
PET ), which can lead to significant signal losses[PBH08, Kr15b, Bis17]. Offline PET solutions
have as major disadvantage the need for a relatively long acquisition time after beam delivery
and consequently degradation caused by physiological/metabolic effects, as well as a non–
linear correlation between signal and delivered dose[Par04]. Contrary to commercial PET
scanners, in beam PET solutions can be used in situ during or after irradiation. However, for
planar positron cameras this can imply the loss of 3D imaging capability and more complex
image reconstruction techniques[PEL03].
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Prompt γ – Originating from the de–excitation of target nuclei along the particle path or from
the projectile itself. These γ rays are characterized by energies up to circa 10 MeV, yields
of 10−4 photons per primary carbon ion and ten times less for primary proton are produced
almost instantaneously (up to few ns) during the irradiation, theoretically overcoming some of
the inherent limitations of the PET technique[Kr15b]. The use of this radiation in monitoring
is enabled by correlating the fall off of the dose distribution with that of γ emission typically
detected at 90o from the beam direction[Ag12a]. Several detectors have been developed for
hadrontherapy monitoring, since standard Single Positron Emission Computer Tomography
(SPECT) is unsuitable for such high photon energies[BMM16]. Some of these detectors include
collimated gamma cameras in various geometries and functional forms[Rob13]. Despite that,
prompt γ detection is still challenging and considerably affected by the high background from
neutrons and delayed photons, requiring complex detector customization[Pol14].
Additionally, studies were also conduced on secondary charged particle detection[Ag12b] and ion
radiography and tomography[Par14]. Although these are easier to detect than neutral particles, the
scattering and energy loss will affect signal acquisition, making it difficult to establish a correlation
between the measured secondary charged particle profile and the primary beam range[BMM16].
Although recently prompt γ clinical use has been reported[Xie17, Ric16], PET–based techniques
are still the most investigated method for in vivo range verification and treatment monitoring[CSE06, Bau13, Kr15a].
Nevertheless, PET techniques clinical use is limited to retrospective information after fraction de-
livery due to the high background during irradiation, this also implies loss of range information if
multiple treatment fields are employed[PBH08, Com12].
As already mentioned, dose deposition is chiefly ascribed to electromagnetic interactions with
tissues’ atomic electrons. On the other hand the β+ activation profile derives from delayed emissions
from the decay of unstable nuclei formed by nucleon–nucleus or nucleus–nucleus interactions. As
these species, resulting from the beam interactions, have different ranges, their contribution will
not reflect exactly the positions of the dose distribution directly at the Bragg Peak, as illustrated
in figure 1.15 for carbon ion beams and protons.
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planted radioactive beams [7], has been extensively investigated 
in the case of therapy with the more easily accessible stable ion 
beams. To date, several examples of clinical implementations of 
PET-based treatment verification have been reported worldwide, 
exploiting different typ s of installation to measure the signal in-
duced by actively- or passively-shaped ion treatment fields during 
or shortly after irradiation. This contribution will review the basic 
principle of the method and give an exemplary overview of different 
implementations and clinical experiences. These include in-beam 
and offline PET monitoring of carbon ion and proton therapy at the 
GSI Helmholtzzentrum für Schwerionenforschung in Germany, the 
Massachusetts General Hospital in USA, and the Heidelberg Ion 
Beam Therapy Center in Germany.
Material and methods — the principle  
of pet-based treatment verification
The unconventional application of PET imaging to the monitoring 
of ion therapy with stable beams is based on the detection of the 
transient b+-activation which is induced in nuclear interactions be-
tween the ions and the irradiated tissue. Depending on the primary 
ion beam species, the mechanism of b+-activation may include either 
target fragmentation only or the formation of both target and projectile 
positron-emitting fragments. The mechanism of production mainly 
affects the shap  of the i n-induced activity a d its correlation to the 
deposited dose (Figure 3). In fact, activated target nuclei stay almost 
at rest in the place of interaction, while positron-emitting projectile 
fragments travel further and accumulate at their end of range, result-
ing in a peaked activity signal. The latter is located shortly before the 
Bragg peak for the most frequent positron-emitting isotopes of the 
primary therapeutic ion beam, such as 11C and 10C from a primary 12C 
ion beam. Regardless of the formation mechanism, dose deposition 
and irradiation-induced activation remain different quantities due to 
the different underlying electromagnetic and nuclear processes, 
respectively. Hence, tre tment verification ca  be obtained either by 
comparing the actual PET measurement with a reference measur -
ment taken at the beginning of the treatment course to assess repro-
ducibility [9], or with an expectation based on the treatment plan and 
the time course of irradiation and imaging to assess accuracy [10]. 
Due to the intrinsically delayed radioactive decay according to 
the half-lives of the typical reaction products (e.g. 10C, 15O, 11C), rang-
ing from few seconds up to several minutes, the PET signal can be 
measured during or shortly after beam delivery. In particular, three major 
implementations have been so far clinically explored, which utilize either 
dedicated limited angle detectors integrated in the beam-delivery, or 
full ring scanners located inside or outside the treatment room. In par-
ticular, “in-beam” implementations refer to data acquisition during the 
irradiation, which has been so far only achieved in the pauses of pulsed 
beam delivery due to the considerable prompt radiation background 
Figure 2. Calculated 2D dose distributions for a collimated photon 
beam (top, square transversal profile of 4 mm edge) with respect to 
proton (middle) and carbon ion (bottom) Gaussian-shaped pencil-like 
beams (3 mm FWHM) in the therapeutically relevant energy range (cf. 
the corresponding laterally integrated depth-dose distributions in  
Figure 1). The beams enter the water target from the left. The colour 
map indicates percentages of the maximum dose. The less sharp 
lateral penumbra with respect to the steeper distal fall-off at the Bragg 
peak is evident for ion beams, especially for protons. Taken from [1]
Figure 3. In-beam PET measurements of b+-activity depth profiles (solid line) for proton (A) and carbon ion (B) irradiation of Polymethyl  
methacrylate (PMMA) targets at 110 MeV and 212.12MeV/u, respectively. The different pattern of activation either due to positron-emitting target 
fragments only (left) or including also the peaked contribution from positron-emitting projectile fragments (right) is evident. The dotted line shows 
the corresponding calculated dose distributions. Adapted from [8, 18]
Figure 1.15: 12C (212.12 MeV/u) and proton (110 MeV) pristine Bragg Peak measured β+–emitter activity
in depth in PMMA, on the right and left side, respectively. The calculated dose distribution is shown in dashed
lines[Pa12a].
The detection of β+ activity is a particularly important topic in ion therapy since the activity
levels are generally lower, by a factor of 2–3 orders of magnitude, than in nuclear medicine PET
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modes. In view of this, it is highly desirable to have the scanner integrated with the beam line,
to provide a deeper insight on the efficacy of treatment and monitoring irradiation effects (i.e. in
beam PET ) online or slightly after irradiation, without compromising much the treatment time by
doing the acquisition in situ [PEH2a, PPE05, CSE06, PBH08, Pa07a].
By using in beam PET and in vivo range verification, one could get information on patient
specific stopping power or low dose image guidance at the region of interest[Fie10, Pa12a]. This
would open the possibility to adjust the treatment inter fraction (e.g. using probes), and even
at some point during fractionated dose delivery, for range corrections as a function of mismatches
detected against the plan. A disadvantage of using probes is that the incoming signal will be
too weak due to the short irradiation time, requiring advanced detection and signal processing
techniques.
However, if enough beam particles are delivered and the detectors efficiency is adequate, a
valid signal could be acquired and processed with PET techniques, leading to a clearer assess-
ment of dose distribution, and a more direct comparison with the prescribed dose in the TPS.
Although studies with proton irradiations of PMMA phantoms denote a sub mm range monitoring
accuracy[PPE05, Kr14a], the offline range monitoring in patients with protons reported deviations
within 2.0 mm in between measured and calculated PET profiles in head and neck tumors, particu-
larly in the presence of bony structures[Pa07b]. Online acquisitions are expected to benefit from the
existence of short lived β+ emitters, such as 8B, 9C, 10C, 14O and especially 15O, whose produc-
tion/position can be correlated with fragmentation and dose delivered in shorter time, mitigating
the biological washout deleterious effect on imaging[PBH08]. Still, some organs, particularly those
in the abdominal cavity, move as a function of the body position/breathing, along with blood flow
or other metabolic elements. This affects the co–registering and CT stoichiometric calibrations for
tissue classification in CT–based MC simulation of the expected activity patterns, being one of the
main reasons limiting application of in vivo in humans[PEL03, Pa12a].
However, the most considerable drawback of these in beam solutions is the high integration cost,
as they need to be custom made since they are not yet commercially available[Att09, Hir14]. Also,
much effort is required in suppressing background and coping with the inherent angular detection
limitation when resorting to dual–head configurations (figure 1.12-b). In fact, noise interference
likely due to background radiation deterred the first prototype planar coincidence camera developed
at LBNL from clinical application ([LBL77]).
Eventually, this limitation was overcome with BASTEI at GSI, consisting of dual–head positron
camera integrated with the beam line for in beam PET imaging and treatment[Eng92, Eng99, Paw96, En04a].
It successfully correlated some β+ emitters, particularly 11C produced by fragmentation of 12C, us-
ing MC calculations, later applying this information in clinical practice using in beam PET imaging
for verification against MC calculations based on TP[En04b]. It was therefore the first example of
in vivo verification procedures based on in beam PET and its clinical feasibility in reducing range
uncertainities for carbon ions[En04a]. The scanner was essentially used to detect the distal edges of
the irradiation, and verify the positions of air filled cavities, washout zones and bones based on the
activity levels. PET monitoring was employed during treatment of more than 400 patients with
carbon ion beams in head/neck and pelvic tumors between 1999–2008. A similar approach was fol-
lowed for NCC Kashiwa but with protons, monitoring beam range or lateral position shifts[Nis06].
Notable research done by NIRS in Japan has focused on PET scanner development for in beam
PET, aiming for range verification of RIβ+ probes with planar positron cameras[Kou98, Sud00].
More recently, integrated in beam PET solutions included (planar) positron cameras developed
in Italy, one example being the INSIDE collaboration setup, envisaging (proton) treatment mon-
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itoring at CNAO[Bis17, Fer17]. Another example of recent in beam PET developments is the more
complex full ring solutions, such as NIRS openPET prototypes, detailed later in this chapter and
in chapter 5, which demonstrated the feasibility of signal acquisition from 11C irradiation with a
full ring PET[Yam08, Att09, Yos12, Tas12, Hir14, Yam17].
Online verification is technically very challenging as it requires the ring of detectors to be either
opened or shifted so that the beam can pass through the ring in its way to the patient, losing
detection efficiency with the reduced detection coverage and requiring often more complex image
reconstruction procedures[CSE06, Sha11, An12].
Considering an 1 Gy irradiation, signal acquisitions with online PET and a synchrotron or
cyclotron based facility, the former employs a pulsed beam and can typically deliver a field in
2–3 min, the latter in even shorter time (< 2 min) with a continuous beam. For synchrotrons,
the chief requirements are still random coincidence suppression, which makes PET acquisition
in–spill (“beam on”) often deemed unfeasible due to high background (e.g. prompt γ, neutrons)
affecting image acquisition quality and performance of some scanners[Sha11, Bis17]. On the other
hand, inter–spill acquisition implies a loss of very short lived β+ emitters, albeit dealing with
less background[Hir14]. For cyclotrons, since it features a continuous beam, the acquisition will
be affected by substantial noise levels (e.g. activated elements in the beam line). Noise effect
mitigation and integration of the scanner with the beam line increase considerably the cost of these
solutions.
Comparing with in room or offline acquisitions, typically starting 5 min after treatment and
lasting for up to 30 min, and provided noise is mitigated, online acquisitions can attain even 10
times more signal than offline, provided the in–spill component is accounted for.
For the present work, in beam PET will refer to an online PET acquisition coinciding with
beam time. However, whenever acquisition continues beyond the treatment time, as in the case
of the approach at GSI, also lasting 40 s afterward or at the HIMAC’s experiment described in
chapter 5, without the patient/target being moved it will still be considered an in beam PET
scenario, but not an online PET acquisition. Therefore, for the HIT–based simulations, performed
for different PET acquisition scenarios in chapter 5, online PET acquisition refers to acquisition
during beam time only. In addition to that, this work will consider that online PET includes the
sum of inter–spill (in–between spills) and in–spill (during spill) as acquisition’s sub–modalities.
Later in chapter 5, this distinction will be employed to investigate whether the use of RIβ+ could
potentiate acquisitions in in–spill or inter–spill acquisition scenarios.
In room PET. An immobilized patient is moved few minutes (∼ 2.5 minutes) after treatment to a
PET scanner, located in the same room where irradiation occurs[Zhu11, Min13]. It is preferable to
do so mechanically and with computerized precision, avoiding patient re–positioning. Furthermore,
the performance can be enhanced using a mobile PET/CT scanner, avoiding errors due to the co–
registration between the CT scan taken for TP’s CT and the PET images’ CT. Its merit compared
to in beam PET technique lies in the balance between decay effect and acquisition efficiency gain.
It greatly benefits from the possible use of commercial PET scanners, meaning a full ring can be
applied and few minutes suffice for an acquisition, the maximum acceptable time allocated for an
in–room measurement generally corresponds to one field’s irradiation time, or ∼ 3 minutes, which
does not delay greatly the image acquisition time[Zhu11, Sha11]. There is also an economical impact
associated with the required access control/interlocking, extra space and all software guaranteeing
movement precision, but much lower than in beam PET [Sha11].
On the other hand, the short delay and acquisition time contrarily to the offline acquisiton
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allows for the collection of short lived isotopes’ signals from 15O, mitigating biological washout
effect. Additionally, it also leads to lower positioning related uncertainities.
Using protons, MGH employed an in room PET approach, requiring 5 minutes starting from
2 minutes end of beam (EOB). In its earlier stage, the project reported results equivalent to a 20
minute–long scan offline and range agreement within ± 3 mm of the predicted activity. At that
time, 2 mm co–registration errors with robotic couch and radioactive markers, as well as the scanner
bore size, limited its application to pediatric and cranial treatments[Min13].
Offline PET. The patient is moved into a different room after irradiation, for an acquisition that can
last 15–30 minutes[PBH08, Sha11]. Ideally, the irradiation and acquisition location should be within
a short walking distance. Patient preparation/installation usually leads to acquisition starting 5–
12 minutes after EOB[Bau13]. Maximum benefit is attained with acquisition starting as close as
possible to the irradiation, and have it lasting as long as logistically feasible, taking into account
patient confort and treatment throughput. Its major advantage lies in the lack for the need to install
a scanner in the irradiation room, which entails non–negligible costs. On the other side, induced
activity levels will be much lower than in conventional nuclear medicine[Pa12a] (mostly 11C) with
only a fraction of this value being actually acquired. Furthermore, the superimposition of the
activity of different irradiation fields delivered will also lead to considerable image deterioration,
making it difficult to disentangle the uncertainties ascribed to each irradiation field.
In addition to that, it is most affected by biological washout and anatomical changes due to
patient transportation and repositioning. Nevertheless, it is a relatively economical choice and has
been investigated in many centers such as MGH (protons) and HIT[Pa07a, Bau13]. At HIT, a full
ring, commercial PET/CT scanner is used with relatively low integration effort, although with
considerably high cost. PET/CT imaging is performed in a special room nearby the treatment
rooms. CT images are used for attenuation corrections, improving accuracy but leading to extra
dose. Patient repositioning is reported to delay 5–20 minutes from irradiation to imaging acquisition,
which can promote washout and decrease statistics. In such cases the image may only be recovered
applying specific reconstruction algorithms[Com12, Kur13]. Still, good QA and imaging results with
carbon ions and protons have been reported for distal edges where activity from the long–lived 11C
concentrated, enabling range verification typically within ± 3 mm and good correlation with dose
delivery[Han17].
1.1.6 Hadrontherapy facilities and state of the art
Despite the fact that carbon ion therapy continues to grow steadily, its complexity, high upfront cost
and unclear clinical benefits still hinder its expansion compared to proton therapy[AK05]. However,
given its superior dose distribution and biological effectiveness, it is envisaged that favourable
histological and longterm clinical data from tumor control, along with the lowering costs, could
make ion therapy more viable in the future[Sch14, Kam15, Moh17].
Whereas in the past ion therapy was primarily explored in research centers, nowadays hadron-
therapy facilities are essentially “hospital–based” centers, consisting of both a conventional and
technical area. The former includes the patient, personnel and medical zones while the latter hosts
the accelerator, beam line and all aspects involved in the conversion of a beam into a clinical in-
strument. To this effect, a beam line should be capable of selecting and deliver beams up to 30
cm depth, which translates into particle energies up to 230 MeV for protons or 430 MeV/u for
carbon ions. Moreover, the accelerator should be capable of delivering a maximum dose rate of
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1 [Gy min−1] with an accuracy within 2% over a 25 × 25 cm2 field for a Bragg Peak at 30 cm,
thus implying the use of 15 nA of protons or 0.48 nA of carbon ions[EWA11]. In clinical practice,
treatments typically require 2 [GyE dm−3 min−1], with beam intensities at the target attaining at
least 1 nA and 0.1 nA for protons and carbon ions, respectively[Bra09, AB11]. Fractions are often
delivered in a couple of minutes[EWA11]. In the case of proton therapy centers, this translates into
an annual output of 15000−25000 irradiation sessions, encompassing 20–30 minutes each, totalling
an yearly throughput of ∼ 1000 patients[AK05]. In carbon ion therapy, HIMAC currently reports a
throughput of 900–1000 patients per year, using an average of 11–12 fractions per patient, depend-
ing on the clinical case[EK16]. Irrespective of the particle employed in the treatment, beam size,
emittance, energy modulation step and repetition rate are all key technical aspects ensuring tumor
conformity during treatment, reducing side effects.
Achieving ion beam energies and intensities of therapeutic relevance implies a substantial cost
due to its technical complexity. A typical carbon ion therapy center can cost more than 100 M€,
30% higher than proton therapy facilities[AK05, Sch14]. One example of the complexity in using
carbon ions, instead of protons, is that accelerator (synchrotron) diameter must be increased from
about 8 to 25 m.
In terms of accelerator technologies, all existent proton and heavier ion beam facilities rely on
cyclotrons (proton only) and synchrotrons (all ions). A cyclotron is a circular accelerator in which
the particles perform a spiral path and is characterized by having a continuous duty cycle at a fixed
energy, high reliability, compactness and being relatively easier to operate than a synchrotron[SES10].
A synchrotron is a circular accelerator ring usually linked with a linear accelerator (linac) for pre–
accelerating particles up to several MeV/u[VAF11]. Due to the ions’ relatively high momentum,
substantially high magnetic beam rigidities are required, attaining 6.3 Tm for 400 MeV/u ions
whereas only 2.2 Tm are needed for proton beams of 250 MeV, requiring larger and hence more
costly magnets. The latter factor greatly hinders the avaliability of carbon ion gantries, which
amounts to only two worldwide, at HIT and HIMAC, since they need to be much bulkier than for
protons.
The first hospital based proton therapy center equipped with a synchrotron was LLUMC in
1990. It was the first center with a gantry and was capable of delivering a pulsed beam every 2.2 s,
with energies from 70–250 MeV to the treatment rooms. Additionally it also featured one research
room.
Contrarily to cyclotrons, in a synchrotron the beam is delivered in spills every few seconds, with
intensities of 2×1010 protons/cycle or 109 C ions/cycle, a feature which can be exploited for clinical
purposes. For instance, synchrotrons’ beam delivery stratification in spills, lasting fron ms to few
seconds, punctuated by a few seconds pauses (inter–spill) makes it ideal for in beam PET [EWA11].
Also, beams of different energies are more easily achievable in a synchrotron, adjusting the cavity
frequency and the magnetic field accordingly, although it may take up to 1 s to attain the desired
energy. This energy–changing ability also avoids the use of complex attenuation components to
achieve tumor conformity, mitigating beam quality loss after extraction and shielding needs. As for
cyclotrons’, movable absorbers can be employed for beam energy changing, and they can be faster,
within tens of ms, than cycle changes in a synchrotron. Since a cyclotron still produces a continuous
background, it can limit the application of in beam PET [Bou08]. At present, synchrotrons are
considered the only viable solution to accelerate ions heavier than protons to therapeutic energies,
with cyclotrons remaining the proton therapy standard chiefly for economical reasons[SES10].
Currently, proton cyclotrons are provided by IBA, Sumitomo and Varian/Accel, whereas Op-
tivus, Hitachi, Protom andMitsubishi provide synchrotrons, the latter with a smaller HIMAC model
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for proton and carbon ions. Also in combined carbon ion and proton therapy, synchrotrons were
manufactured by Siemens, with exclusive licences of the GSI patents and know–how up to 2012,
while IBA and Varian/Accel are developing carbon ion superconducting cyclotrons[AK05]. Fur-
thermore, recently single–room facilities featuring synchrocyclotron proton therapy were also made
available. Another product, an optimized medical synchrotron – PIMMS, can provide both types
of particles for therapy applications. It results from a proof of concept design study consortium
between CERN, TERA foundation, Oncology 2000 and MedAustron, with know–how input from
GSI. This solution was partially adopted at CNAO and MedAustron[Bry00, AK05].
The main challenges of hadrontherapy with ion beams can be summed up as: the collection of
treatment outcome history and comparison of treatment protocols between the different existing
facilities; improve techniques for dose delivery with respect to tumor conformity and dose delivery
verification; optimize the cost of the whole facility and R&D in biological effectiveness; range
monitoring in real time and evaluation of the therapeutic effects of different ion species such as
RIβ+ or ions lighter than carbons[Kit10, AB11]. Regarding accelerator development, research has
focused on more efficient devices, to downsize costs[AB11, MAT14, Aug16, BMM16].
Among the various hadrontherapy facilities existing worldwide, HIT and HIMAC are held in
high regard due to their role in both clinical and technical developments in carbon ion therapy.
Due to these factors and their relevance to this work they will hereby described in greater detail.
HIT. After the overall success of the GSI pilot project, an entirely dedicated facility was justified,
thus HIT was proposed and approved in 2001. Its irradiation system and the medical equipment was
supplied by Siemens and the total cost amounted to 119M€[AK05]. It “inherited” the accummulated
expertise at GSI, upgrading it in scale and equipment, an example being the first worldwide carbon
ion gantry[Pa12b]. The gantry has a diameter just below 15 m, 670 tons in weight and 25 m in
length. This huge size is justified because of the increase of efficacy in therapy achieved throughout
the 360o angular coverage, while the patient is immobilized and the tumor targeted within sub–mm
accuracy.
The facility hosts three treatment rooms, two equipped with horizontal beam lines and one with
a gantry. Up to the end of 2016, it treated almost 4000 patients ([PTCOG]). A room for QA and
experiments is also included, with horizontal beam line and the beam scanning technology. Up to
May 2017 it was the only facility with a carbon ion gantry, allowing 360o rotation as visible in figure
1.17. It has the capability to perform treatments with protons, helium, carbon and oxygen ions,
albeit with an energy limitation for the latter. From a clinical point of view, its results have been
remarkable, with some neck and head tumors attaining excellent control and survival rates[Moh17].
From the main synchrotron, it is capable of delivering carbon and oxygen ion beams of up to
430 MeV/u, and protons and helium ion beams up to 221 MeV/u. These maximum beam energies
correspond to particle ranges in water from 2 until up to 30 cm (23 cm for oxygen ions)[Har17, Tes17].
Helium and oxygen ion beams are currently in pre–clinical stage, as research is ongoing for clinical
translation[KMP12]. A pulse can be delivered every 3 s, and the extraction spill can be maintained
up to 10 s. Extraction cycles can also vary in time, their period generally in the 5–10 s range[Par10].
1.1 Rationale for ion beams in hadrontherapy 37
2.5 The Heidelberg ion beam therapy center  
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  The Heidelberg ion beam therapy center 2.5.
The HIT center is a synchrotron based clinical facility with an active beam scanning delivery 
system similar to the prototype at GSI. In addition to two horizontal beam clinical treatment 
rooms, a third room is equipped with an isocentric gantry (figure 2.12). A third horizontal 
beam room is available for experiments. In addition to the clinically used protons (1H) and 
carbon ions (12C), two other ion species are available, 4He and 16O.  
For each ion species, the synchrotron can accelerate 255 discrete energies (205 for oxygen) up 
to ~220MeV/u for protons and helium ions, and up to ~430 MeV/u for carbon and oxygen 
ions, each with ~32 cm range, except for 16O with a range about 23 cm. A detailed description 
of the beams characteristics are presented in Chapter 3. The beam spot size (i.e., lateral size in 
air at isocenter) and intensity is adjustable for each energy from a library of 6 foci and 12 
beam intensities. In clinical practice, 4 foci and 10 intensities are most commonly used 
(Parodi et al 2012). The so-called “Beam applications and monitoring system” (BAMS), 
situated at the end of the beamline, consists of three ionization chambers (IC) to monitor the 
fluence delivered per raster point and two multiple wires proportional chambers (MWPC) to 
verify and give feedback loop controls on the position of the beam and the its size during 
irradiation. 
Treatment rooms are equipped with a 6 degrees of freedom robotic treatment table, granting 
sub-millimetric patient positioning before irradiation and verification with 2D-kV x-ray 
imaging systems.  
 
 
 
 
 
 
Figure 2.12: Layout of the HIT facility adapted from https://www.klinikum.uniheidelberg.de/, 
with (1) ion sources, (2) linear accelerator, (3) synchrotron, (4) high energy beam transfer 
line, (5) horizontal treatment rooms, (6) x-ray positioning control system, (7) gantry, (8) 
gantry treatment room, (9) PET-CT room and, (10) experimental room. 
 
1 Ion sources
2 Linac
3 Synchrotron
4 High energy beam transfer
line
5 Horizontal treatment room
6 x–ray positioning control
system
7 Gantry
8 Gantry treatment room
9 PET/CT room
10 Experimental room
Figure 1.17: An artistic depiction of the [HIT] facility and its description[Tes17].
Similarly to GSI, raster scanning is applied to all treatments at HIT, adjusted at accelerator level
in 255 steps (205 for oxygen ions) to cover the range desired with initial beam energy, typically 2–30
cm in water. In clinical practice, 4 foci, or beam sizes, and 10 intensities from 2× 106− 8× 107 12C
ions/s are typically employed. For protons, intensities from 8× 107 up to 2× 109 protons/s can be
attained[Par10, Pa12b, Tes16a]. The beam intensity in an experimental framework can be regulated to
as low as 106 particle/s. High level of accuracy is attained using almost monoenergetic pencil beams
with ∆p/p ≈ 0.1%[Par10] laterally covering the tumor volume using scanning magnets for optimal
conformity and homogeneity. Beam delivery quality is ensured in real time by feedback in intensity–
controlled raster scanner. This is provided to the magnet units handling the dose delivery via the
ions passing the vacuum exit window into a beam and application monitoring system (BAMS,
Siemens AG), monitoring beam fluence and position with ionization chambers and MWPC. If
abnormalities are detected, beam extraction can be interrupted within 250 µs[Par10] in the case
of carbon ions or protons. A ripple filter (Siemens AG) can be placed after the aforementioned
elements, to smoothen the dose delivery at the SOBP plateau for 12C ions or very low energy
protons. A schematic of the beam line elements is provided in chapter 3.
Treatment planning is performed using the first commercial CE–labelled TPS for ions – Syngo
PT Planning (Siemens AG) – which was based on a TRiP98 code created and clinically applied in
the GSI framework. It has been improved in the meantime using FLUKA simulations for patients,
including a realistic description of the HIT beam line. Considerable simulation work resulted in
the generation of basic input data for TPS and its validation, accounting for the ripple filter effect
for all these energy steps in water, for proton and carbon ions dose delivery, fragment spectra and
lateral profile[Mai07, Pa12b, PMS13, Bau14].
HIMAC. An heavy ion synchrotron complex, designed and commissioned by NIRS, HIMAC is not
only the first, but also a flagship among carbon ion facilities worldwide, having undergone multiple
and innovative improvements since the starting of its clinical operation in 1994[Yam98]. Clinical out-
come has been excellent so far, with cancer therapy applied effectively on various organ types with a
90% local control, including bone and soft tissue sarcoma, which are typically radioresistant[Kam15].
It featured a strong research focus towards the increase of beam intensities and accuracy over the
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years, with pioneering studies on “hypofractionation” success rate, in particular early stage lung
cancer. Experience with carbon ions let to a broad clinical history accumulated over time, provid-
ing data on which types of tumors and organs were more efficiently treated, dose fractionation and
records of re–incidence/late toxicity and other side effects[Tak00, Nod14, Alo00, EK16].
Figure 1.18: Artistic depiction of the HIMAC facility[Kam15].
Among its remarkable achievements, one can highlight the extremely fast raster scan implemen-
tation, respiratory motion control as well as RIβ+ studies in biology and treatment verification. Its
new treatment facility is entirely dedicated to ART technology and it is also notably equipped with
a 4–magnet superconducting rotating gantry system (Toshiba Corp.) as from May 2017, visible in
figure 1.18. It is relatively compact, with 5.5 m in radius and length of 13 m[Iwa12].
The facility contains six treatment rooms as depicted in figure 1.18, they operate during daytime
on normal clinical schedule. Beam switching between rooms can be done within ∼ 5 minutes. There
are two rooms for physics irradiation purposes and four rooms, dedicated to experimental activities
also available, accounting for: Secondary beams’ irradiation with online isotope separators for
RIβ+ production, a low energy experimental room with the 6 MeV/u from the injector linac and
a biology irradiation room that replicates treatment conditions for experimental purposes[Kit16].
The synchrotron consists of a dual ring with ∼ 40 m diameter. In an experimental framework,
and due to recent improvements, the synchrotron ring can accelerate ∼ 2 × 1010 C6+ ions during
a single synchrotron cycle, enough to perform single–fractional irradiation for most tumors treated
with 3D scanning method. However, in a clinical environment, the dose rate required is established
as 5 [GyE dm−3 min−1] with average 14 fractions and intensities of 3.6× 108 particles per second
(pps), as weekly–averaged value, with pulses every 3.3–2 s. Note that typically 1.8 × 109 carbon
ions/s yield an average dose rate of 3 [Gy min−1] in a diameter of 10 cm and thickness of 6 cm
at the SOBP plateau. Regarding the production rate of secondary/radioactive beams, a minimum
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biological effectiveness are of two kinds: irradiation of cell samples to investigate radiation effects
at microscopic level, as well as the study of highly energetic heavy ion beams biological effects in
the framework of space or hadrontherapy applications.
New developments in the experimental area are being performed with RIβ+ to facilitate range
assessment, particularly in situations involving OAR[Kan04, Kat15]. Although production of RIβ+ is
still not optimal and currently resorts to a projectile fragmentation “in–flight” separation method,
one can convert ∼ 0.1 − 1% of primary beam into RIβ+ (e.g. 11C), by means of a secondary
beam line acting as an online RIβ+ separator[Kou98, Kan98, Sud00, Kan02, Ise04]. Despite having
approximately the same velocity as the projectile, and being in general forward directed, fragmented
beams obtained with such method are characterized by relatively wide momentum spreads and large
size/emittance[Ura01, Moh16]. Consequently the primary beam needs to be well shielded around the
fragmentation target and other relevant beam line segments. More details on this secondary beam
line will be provided in chapter 5.
The main limitation in the projectile fragmentation approach is the RIβ+ beam intensities and
purity. Due to the low reaction yields, the secondary beam can achieve intensities of up to 7× 106
ions/s, which is enough for PET tests, TP verification and even preliminary treatments[Tom03].
However, for a treatment, one would need to achieve a total of ∼ 109−10 11C ions, ideally with
intensities of 108 ions/s. This would require intensities of 1011 for the primary beam[Fie11]. Still,
the secondary beam purity needs to be improved to reach clinical standard. Relatively high purity
levels, over 90%, and activities of about 103 − 105 [Bq Gy−1 cm−3] for 10C and 11C beams have
been reported in an irradiated volume[Ura01, Kan02, Kit06, Fie11]. These values are comparable to
PET tracer imaging, but require highly efficient and not commercially available PET solutions for
monitoring in the framework of in beam PET. This research topic has been very promising, with
15O and 11C beams being observed to indicate within 0.7 mm and 2.3 mm the Bragg Peak in an in
beam PET test in PMMA, respectively[Moh16, Yam16].
Recent studies have attempted 11C production with higher purity with a more direct, albeit
challenging approach, consisting of injecting 11C in the linac connecting to the synchrotron after
application of an isotope separation online (ISOL) technique. The aforementioned technique implies
a molecular separation process, followed by an isotope separation process, so as to attain high
purity yields of 11C, to be used as ion source. Considering the overall efficiency losses involved, it
is expected that this alternative ISOL technique could deliver ∼ 109 11C ions in few seconds, with
high purity for therapy with online PET monitoring[Kat13, Kat15, Boy15, Nod17, Kat16].
Investigations with in beam PET at HIMAC culminated in the conceptual design and construc-
tion of various openPET prototypes[Yam17]. In its early stage, the system consisted of two full
rings setups separated axially, with the beam passing in between them, hence allowing collection of
signal with full rings[Yam08]. However, since only oblique LOR were collected and reconstructed,
the image quality was somehow hindered, also multiple noise sources during in–spill limited its ap-
plication to inter–spill and offline only[Hir14]. A small, single ringed, openPET prototype followed,
collecting signals for phantom and mouse brain irradiation[Yam11]. This second generation, with
a single full ring, but slanted, allowed for the collection of some direct LOR. Moreover, its geom-
etry allows for more space and rotation for the beam passage[Tas12]. This new model was found
to have a sensitivity improvement of a factor 1.2 compared to its predecessor[Hir14]. The latest
version consists of a human sized, single ringed and axially shifted openPET[Yam17]. This latest
version was employed in the data collection analysed in chapter 5, and subsequent comparison of
experimentally acquired PET images with FLUKA simulations of stable ion and RIβ+ beams in a
PMMA phantom.
Chapter 2
The Monte Carlo particle interaction and
transport code FLUKA
“Then are you so certain that your roulette–playing will get us out of our difficulties?”
— F. M. Dostoyevsky in The Gambler
2.1 A brief introduction to the Monte Carlo method
The Monte Carlo (MC) method applies probability theories and statistical methods to model phys-
ical/mathematical systems and processes that are stochastic in nature[Vas17].
Its official invention dates back to 1946, in the framework of theManhattan project at Los Alamos
National Laboratory, where S. Ulam devised it for thermonuclear weapons research. Recognizing the
significance of this invention, von Neumann attempted to implement the method computationally,
using rudimentary “pseudo random numbers” generation techniques and the early computer eniac
to model thermonuclear reactions[Eck87].
As the project was under governmental secrecy, a code name had to be attributed. N. Metropolis
suggested naming it “Monte Carlo”, alluding to the method’s random nature and the gambling
addiction of S. Ulam’s uncle. Despite its official date of discovery, E. Fermi had already been
applying it successfully to neutron moderation for the prior 15 years, albeit in a limited manner
due to the unavailability of heavier computational power[Met87].
In fact, even before the advent of computers the method was already applied. Some histori-
cal examples being Buffon’s needle problem in 1777 and later Laplace’s π determination method.
With the growth of computational power, MC methods became more popular for different research
topics[Bie].
The first stage of MC method application is the definition of the problem in mathematical terms,
so that one can calculate the quantities of interest. In order to do so, a statistical interpretation of
the problem is performed. The MC mathematical core is the notion of moments of a distribution
and the Central Limit Theorem [FFS11]. The former states that, for a variable x and probability
density function f(x), the mean of a function g(x) over an interval [a, b] is
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ḡ(x) =
∫ b
a
g(x)f(x)dx∫ b
a
f(x)dx
. (2.1)
By applying the normalized probability density function F(x) as
F(x) = f(x)∫ b
a
f(x)dx
, (2.2)
and for ḡ(x)
ḡ(x) =
∫ b
a
g(x)F(x)dx, (2.3)
where if g(x) = x, one directly obtains
x̄ =
∫ b
a
xF(x)dx. (2.4)
In a similar manner, the mean of a distribution can be extended to multiple dimensions, ac-
cording to various probability density functions, e.g. integrating over g(x, y, z)F(x)G(y)H(z) . . .
This is often advantageous considering that calculations of multidimensional integrals are usually
impractical, but necessary for solving physical problems.
The sampling SN of N values of g, for example gi(xi, yi, zi), while averaging over the number
of times this process occurs
SN =
∑N
1 gi(xi, yi, zi)
N
, (2.5)
leads to a mean value for the solution. In the event that these terms follow the distribution of
g, then the integration process corresponds to an analogue MC simulation.
Regarding the Central Limit Theorem, it is the centerpiece for the MC method. It states that
if N is sufficiently large, the normalized SN value of N independent random variables identically
distributed will tend to a normal distribution (except in cases when the second central moment is
infinite), with mean ḡ and variance σ2g/N . Therefore:
lim
N−→∞
SN = ḡ, (2.6)
hence,
lim
N−→∞
P(SN ) =
1√
2π
N σg
e
− (SN−ḡ)
2
2σ2g
/N
. (2.7)
Consequently, MC can be used to solve integrals with multiple dimensions throughout sam-
pling from appropriate stochastic distributions, becoming in a sense a “mathematical experiment”.
Convergence will eventually not depend on the number of variables n, as in general integration
methods, in which convergence is governed by N−1/n, but on the number of samples as σ ∝ N−1/2
instead[Jam90]. Therefore, for problems with n > 2, which is the rule in particle transport, MC
becomes extremely convenient and is often the most advantageous technique for scenarios of di-
mensionality above four[Bie].
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2.2 Application of Monte Carlo to particle interaction and transport
The MC method is particularly well suited for particle transport problems, as these are systems of
great complexity and radiation interaction is ultimately stochastic in nature. MC allows the user to
set up a virtual framework where particle detection can be performed in a controlled environment
and with access to all physics processes, with the possibility of repeating the virtual experiment as
often as required[FFS11].
Irrespective of the particle type, the baseline of either particle beams or radiation source prod-
ucts’ transport should always be sound physics models, in order to replicate all physical mechanisms
involved. This of course assuming that the geometry, materials and hence the real experimental
setup, is properly defined and its properties replicated[FFS11].
When applied to particle transport, the MC method relies on “pseudo random numbers” and
sampling techniques to model the transport of particles throughout media. Random sampling tech-
niques are paramount in MC codes, since given a probability density function F(x) of a variable
x, samples of x should be generated accordingly. True random numbers can neither be predicted
nor reproduced, being generated by random physical processes (e.g. nuclear decay events). MC
codes resort instead to sequences of random numbers generated by algorithms named “pseudo ran-
dom numbers”, while they are practically random with respect to the correlation they are still
reproducible[Jam90]. They still exhibit periodicity, albeit with prolonged periods (e.g. 1061), pro-
ceeding from an initial number or “seed”, whose changing implies a different random number se-
quence generation[MT04]. Regarding the MC method’s application, since it dwells with stochastic
problems, it requires modeling of random variables. In particle transport this becomes essentially
an integration problem of probability density function in a phase space with multiple variables.
As a primary particle travels throughout matter it is evaluated at certain steps, its “fate” (e.g.
fission) is then decided by random selection from the given F(x). For an oversimplistic case,
concerning the photon beam attenuation, one may attempt to exemplify based on
p(x)dx = Σe−Σxdx, (2.8)
where p(x) is the probability density function of the photon travelling a distance x. In its turn,
x varies between 0 < x < ∞, governed exponentially by the macroscopic cross section Σ. By
integrating, an estimation of the mean free path λ(x) can be obtained as
λ(x) =
∫ ∞
0
xp(x)dx =
1
Σ
. (2.9)
In a MC approach, the problem would be rewritten as∫ x
0
Σe−Σydy = ζ (2.10)
with 0 ≤ ζ < 1 being a randomly generated number. Solving the integral, one would obtain
1− e−Σs = ζ ⇔ s = − ln (1− ζ)
Σ
.
Thus, starting from a “pseudo random number” ζ ∈ [0, 1[ the distance travelled by a photon can
be computed[Lui13].
However, the aforementioned example is oversimplistic as MC methods should reproduce the
different phenomena during particle transport (e.g. solving the Boltzmann transport equation) from
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where n is the number of times the condition was verified. Naturally, the estimated result will
converge to the exact result for N −→∞. The example could also be extended to an arbitrary num-
ber of dimensions. The method’s application would be equally valid, even though the complexity
of the problem would increase significantly.
In the context of particle physics the number of particles in a phase space, or phase space density
n(x,y,z,px,py,pz,t), is the key parameter to describe particle transport. Other components (e.g. spin)
could also be added to those dimensions, if deemed relevant. The product n~v translates into the
angular flux Ψ:
Ψ =
dΦ
dtdEd~Ω
= Φ̇E~Ω. (2.13)
The above mentioned notion is a building block for particle transport, being essentially the
fluence (Φ) derivative carrying the information on time, energy and direction over the phase
space[FFS11]. The resulting fluence is given as∫
E
∫
~Ω
∫
t
Φ̇E~Ωdtd
~ΩdE. (2.14)
Evaluating the quantity 2.13 using the MC method requires considering not only the transport
of particles, but also the interaction and consequently secondary production. This is accomplished
using the Boltzmann transport equation, which can be regarded as a balance equation that, for any
phase space point, evaluates the particle density as a result of ingoing and outgoing terms[FFS11].
1
v
dΨ(x)
dt
+ ~Ω · ∇Ψ(x) + ΣtΨ(x)− S(x) =
∫
Ω
∫
E
Ψ(x)Σs(x
′ −→ x)dx′dEdΩ (2.15)
On the left side, the first term describes the variation of angular flux (e.g. altered as a con-
sequence of decay). As for the second term, it accounts for flux changes through motion without
change of energy/direction, while the third term denotes absorption by accounting for the total
macroscopic cross section (Σt). The particle sources contribution is accounted for with the negative
term S(x). On the other side, scattering is considered using Σs, the macroscopic scattering cross
section. This latter represents the changes in flux due to either energy or directional changes of
particle position. The evaluation of cross section data in MC codes often resorts to data libraries,
for different energies, particle types and materials.
Depending on the phase space of interest and the quantity to be evaluated, various estimators
can be considered and some examples will be provided in the next section. Various detector elements
can be used to provide a result (estimate), in a mesh, for instance.
The variance of the mean of x thus calculated, in N batches, comes as
σ2<x> =
1
N − 1
∑N1 nix2i
n
−
(∑N
1 nixi
n
)2 , (2.16)
with xi representing the average of x and ni being the number of particle histories in the ith
batch. On the other hand, n =
∑N
i ni is the total number of histories in the N batches. As a result
of the Central Limit Theorem, if the system convergence criteria are met, the sample average will
tend to the actual distribution if N −→∞.
In the domain of medical physics and hadrontherapy in particular, MC has gained popularity
and its models have contributed to[BMM16, Vas17]:
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1. Detector development for image monitoring (e.g. prompt γ, PET) and dose delivery opti-
mization purposes;
2. A better understanding of ion beam interactions with matter and their secondary particle
production;
3. Improvements of radiobiological models;
4. General accelerator design and beam line development;
5. TP validation and optimization.
Monte Carlo role in Treatment Planning. Besides its use for design and commissioning of a clinical
facility, MC simulations are nowadays considered the tool of choice for an accurate description
of physical dose in hadrontherapy[Pa12b]. This recognition results from its enhanced physical ca-
pabilities for reproducing ion interactions in complex geometries in comparison to predictions of
most commercial TPS relying on analytical dose calculation engines[PPE05, Mai13, Bau14]. Some
examples of TPS are TRiP (GSI), HIPLAN (HIMAC), the Syngo PT Planning (e.g. HIT) and
RaySearch RayStation (e.g. Medaustron)[Bat16]. Provided with adequate anatomical data, a MC
code should be able to:
• More accurately reproduce the heterogeneous composition of human tissue in the simulation
model based on CT images[Pa07b];
• Adequately describe radiation transport and interaction[Rob13];
• Properly assess primary beam and secondary particle production, leading to a possibly better
intensity modulation as well as in vivo range and dose delivery verification[En04b, Bat16].
Regarding the volume elements in tridimensional space (voxel) density/composition conversion
from CT scan data, in a MC code, it can be made directly with density and material composition
instead of relative stopping power ratio maps in water as used in analytical TPS[Pa07b, Pa07c]. This
also allows for the adjustment of the stopping power calculation to follow the clinically established
HU to stopping power ratio conversion. Also, MC codes are able to estimate physical dose within
few percent accuracy, since they handle nuclear interactions, tissue composition and energy losses
more realistically[Kr15b, Bat16]. However, MC simulations often entail large execution times, which
can be prohibitive in clinical applications context. Still, MC codes can provide basic data for
representative settings (e.g. beam energy) to be employed in the TPS, for fast TP recalculation,
using databases to accomplish a SOBP over the tumor volume[Bau14].
MC codes are also very relevant in treatment monitoring for example, evaluating β+ emitter
activities and subsequently compare them against measurements to infer the correctness of the
treatment delivery as done for instance at HIT, supported by FLUKA calculations[Som09, Pa12b].
As mentioned in chapter 1, the spatial distribution of β+ emitters or de–excitation products varies
in time according to beam–target and secondaries interactions, due to non–elastic nuclear reac-
tions. MC codes can model these reactions, the acquisition time, detector setup and disentangle
the signal from background, thus being very useful in either in beam PET monitoring or prompt γ
studies[Kr14b]. An [INSIDE] collaboration proposed workflow, including FLUKA calculations for in
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generate the beam library parameters (e.g. energy, focus values), including physical basic data to
be used as input in the commercial TPS[KMP12]. This culminated in an extensive validation of
TPS dose calculations based in water equivalent thicknesses and FLUKA CT–based recalculations,
resulting in comparisons between MC dose with TPS predicted dose[Tes16a, Bau14, Pa12a]. Dosimet-
ric calculations were validated by dose measurements in water, whereas β+ activity simulations
were subsequently compared with measured radiation for treatment verification[Kr14b]. The CT–
based FLUKA MC calculations of physical and biological dose are implemented in clinical routine,
for QA but also in physics experiments and biological dose assessment, for example via predic-
tions through an interface with the Local Effect Model dose effect, extensively applied at HIT and
CNAO[Mai13, Bau14, Bat16]. Recently, FLUKA was also compared with NIRS analytical TPS and
biological dose calculation system[Mag17].
In recent years, FLUKA underwent various developments and validation of ion fragmentation
and secondary particle emissions for imaging studies, with intensive investigations on the produced
fragmentation tail dose and spectra, including repercussions on biological dose calculations[Mai10, Böh10, Rob13].
In addition to these investigations, the introduction of a framework enabling PET studies con-
tributed to the decision for its use in this work[Ort13]. FLUKA nuclear models will be detailed in
the next section of this chapter, whereas the PET tools will be described in chapter 3.
As a consequence of the growing reliance of hadrontherapy on MC codes, several groups are
studying nuclear fragmentation processes occuring during irradiation, as well as their angular dis-
tribution, in order to further improve the reproduction of the β+ emitters’ activity yield and
spatial distribution, which is very relevant for in beam PET [Pri08]. In 2005, fluence and LET of
various fragments have been studied at HIMAC to assess their impact in the depth dose profile
and compare with calculated fluences[Mat05]. Recently, a remarkable effort has been carried out
at GANIL (Grand Accélérateur National d’Ions Lourds)[Sal16], obtaining cross section information
for some β+ emitters of interest. However, the study covered a limited energy range. Also, the
Medipix–Timepix collaboration succeded in obtaining experimental data via ion identification
from fragmentation[Har17].
Given the limited direct availability of experimental cross section data at clinical relevant en-
ergies, the comparison of β+ emitter distribution against the signal detected originating from sec-
ondary emissions can be used not only to identify the species produced, but also benchmark and
improve the underlying nuclear models available in MC codes. This process is still ongoing as it
requires a large amount of data to be properly validated[PPE05, LIK10, Böh10, Rob13, Kr15b].
2.3 The FLUKA code
FLUKA is a fully–integrated, multipurpose, Monte Carlo particle transport and interaction simula-
tion code[Fer05]. In its present version (2011.2x.0) it can transport more than 60 different particles
and handle complex geometries. The code benefits from a versatile graphical user interface – flair –
providing an user–friendly environment regarding many routine tasks (e.g. input editor, interactive
geometry builder)[Vla08]. FLUKA functionalities can be further extended, by linking user routines,
enabling additional features for specific calculations.
The code is propriety of CERN and INFN, and is freely distributed (http://www.fluka.org)
for academic purposes, with its development being carried out in the framework of an international
collaboration with dozens of institutes. Its applications vary greatly, including space, medical
applications, accelerator & particle physics, shielding, dosimetry and general radioprotection, among
many others[PCF01, Bal06, Böh14, Bat16].
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Its history can be traced back to the work of J. Ranft in the 60’s to assess the implications
of high energy proton induced cascades in shielding studies at CERN[Ran65]. The challenges of
proton colliders up to the TeV energy range renewed the interest in FLUKA and its capabilities,
hence leading to a total redesign of the code to face more complex radiation physics domains. The
present generation of FLUKA dates back from 1989 and has been undergoing development up to the
present day, during this period the code became a multipurpose particle code, now applied in a wide
range of fields and energies[Bat15]. Since 1989, the present generation saw the addition of major
features such as: magnetic fields, energy deposition in limited volumes, high–energy effects and
low-energy neutron interactions, as well as an original Multiple Coulomb Scattering algorithm for
all charged particles, enhanced electromagnetic and hadronic parts, low–energy neutron transport,
extended usage of Combinatory Geometry package and introduction of new scoring and biasing
functionalities[Fer92, Fas97b]. This code version is characterized by extensively benchmarked and
tested microscopic physical models, being designed and structured to ensure self–consistency, which
is particular evident in its handling of various components of the hadronic and electromagnetic
cascades, where mutual interaction between the different components, and respective correlations,
are preserved[Fer05].
In particular, heavy ion transport in FLUKA and interaction models were subject to many
upgrades, due to their importance in hadrontherapy and space applications problems[Bia99, Bal06].
A collaboration with NASA contributed to the development related to FLUKA heavy ion transport
and interaction models[And04, Bal07].
Considering all its models, it is today one of the few codes able to simulate transport of parti-
cles in matter, dealing with hadron–hadron, hadron–nucleus, nucleus–nucleus, neutrino, neutrons,
electromagnetic, µ and γ interactions over wide energy ranges (from TeV to the Coulomb barrier
for charged particles). Also, since 2004 a model for electromagnetic ion dissociation, of relevance
for highly energetic and heavy ion interaction, has been added[Bal05, Fer06, Bra14]. Another model,
particularly relevant to this work, has been added in 2012 which allows for a better description
of Compton scattering and positron annihilation[Böh12]. Regarding the latter, the code effectively
distinguishes between annihilation events in flight or with the electron at rest, even though annihi-
lation events in flight are by far less frequent than at rest. The distinction is made via the proper
sampling of atomic electron momentum values, with the acollinearity of the photons emitted in the
annihilation being therefore reflected in the model[Böh12].
Nuclear reactions
Nuclear reactions modeling with an MC code starts with sampling the probability of a nuclear
event occuring, according to the incident particle and energy. Then the nuclear interaction is
sampled using the MC code’s internal models or database informations. In FLUKA, it can be
subdivided in the following categories[FS96, Bat05]:
Hadron–nucleon interactions. Up to 5 GeV, the code uses models based on individual resonance pro-
duction and decays. At higher energies, and up to 20 TeV/u, parton string models are used[FS96, Fas03].
Beyond 20 TeV/u, DPMJET-III is employed instead[RER01].
Hadron–nucleus interactions. Below 20 TeV, the PEANUT model is applied, whilst above that en-
ergy the DPMJET-III model takes over[FS97]. PEANUT features both a detailed (Generalized)
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Intra–Nuclear Cascade (G)INC, describing multiple independent nucleon–nucleon interactions in
the target nucleus and subsequent transition to pre–equilibrium models[Ser47, Ber74, Fer06]. The
transition is continuous and the compound nucleus excitation energy is handled by the “exciton”
formalism, where the excitation energy is shared among the presently excited nucleons and holes.
Particles and light fragments (from coalescence) are emitted from the excited nucleus until a con-
figuration where equilibrium is attained[Bla83, Fas03]. These models are responsible for reproducing
interactions involving nucleons (and various exotic particles) at a wide energy range, including
modeling proton and neutron interactions in hadrontherapy[Böh14]. Different generators will apply
based on the projectile energy in case of heavier ions, as will be briefly described later[Böh10].
Nucleus–nucleus interactions. Contrarily to nucleon–nucleus reactions, in nucleus–nucleus interac-
tions the incoming nucleons are not free[BMM16]. Three event generators are used depending on the
energy range:
DPMJET–III – It is interfaced with FLUKA for energies E ≥ 5 GeV/u for ions and 20 TeV
for hadrons, based on the Dual Parton and Glauber–Gribov approaches[RER01]. It is the
event generator applied to high energy hadron–nucleon, hadron–nucleus and nucleus–nucleus
interactions, featuring also a photo–production off nuclei event generator.
rQMD-2.4 – It is based on an original “relativistic quantum molecular dynamics” model, ex-
tensively modified from the original code[SSG89, Sor95]. It is interfaced with FLUKA in its
faster cascading version for ion interactions at intermediate energies, from 125 MeV/u . E <
5 GeV/u, where DPMJET-III takes over[And04, Bat05]. Its modifications led to energy/mo-
mentum balance accounting for experimental binding energies, and accurate calculations of
excitation energy, with the evaporation and de–excitation processes being handled by FLUKA
modules[And04, Aig05, Gar07].
BME – This model covers the lowest energy range, from the Coulomb barrier to ∼ 125 MeV/u.
It deals with the thermalization processes in compound nuclei created in the complete or
incomplete fusion of two ions, using a MC event generator, incorporating as input the results
of the numerical integration of the Boltzmann Master Equations [Bat03, Cer06] (equation 2.15).
In such scenarios, MC would have to use as input pre–equilibrium particles’ evaluated angle–
energy multiplicity spectra, including those emitted both in the primary and the secondary
interactions along the nuclear reaction chain. Such calculations are too lengthy to be made at
run–time, therefore an internal database is used for interpolation, covering the pre–equilibrium
emissions throughout the reaction chain for many pairs of interacting ions. In this process,
accurate computation of double differential cross–sections of all residuals created in a reaction,
involving a projectile with variable energy, is performed. Moreover, momentum distribution
of the residual particles produced, their decay properties and respective emissions, are also
calculated[Cav01, Bat03].
Given the hadrontherapy energy range, ion interactions are mostly handled by BME and rQMD
modules and thus DPMJET–III will be henceforth excluded from the present discussion. These
models play an important role in simulating heavy ion interactions with matter, ensuring the
correct reproduction of double differential cross–section for all particles emitted in the reactions. If
in hadron–nucleus interactions radioactive products originate generally from the target nucleus, in
nucleus–nucleus interactions both target and projectile nuclei are produced[Fas03, Fer06].
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In the framework of hadrontherapy, simulating the interaction of an ion beam with tissue requires
describing various projectile–target pairs within a broad energy range. RQMD–2.4 and BME models
and their interplay are relevant for they will eventually govern the fragmentation build–up and β+
emitter production[Som09].
For intermediate energies, the original rQMD–2.4 assumes, in its initial condition, that the
projectile and target can be described as two Fermi gases. The Fermi momentum (pF ) is given by
pF = ~
(
3π2
A
2V
) 1
3
, (2.17)
with V = 43π
(
r0A
1
3
)3
and ρ = AV , where r0 = 1.12 fm and ρ0 = 0.17 [nucleon fm
−3]. The
nucleon momentum can then be described as:
p = pF
[
ρ(r)
ρ0
] 1
3
ζ
1
3 , ζ ∈ [0, 1] (2.18)
Where ζ is a “pseudo random number”. The final momentum states in every coordinate system
will then be characterized by
px = p sin θ cosφ, py = p sin θ sinφ, pz = p cos θ,
with φ = 2πζ and cos θ = 1 − 2ζ, with the condition that the sum of momenta values in each
of the coordinate frames is null. To identify projectile and target like nuclei, one needs to account
for the experimental binding energies, nuclear potentials and both attraction and repulsion effects
in the formation of spectator nucleon clusters[And04]. These functions, which are relevant in the
overall nuclear stability, are not present in the rQMD original version but are included in the module
interfaced with FLUKA[SSG89, And04].
Regarding low energy ion interactions, these are gradually handled with BME event generator
as rQMD becomes less reliable below 125 MeV/u. In a first step, the reaction cross sections (σ) are
calculated based on models, defining the probability of either complete fusion (Pf ) or peripheral
collision (P = 1− Pf ) occuring as[Kar75, CCG05]:
P = 1− σf
σ
, (2.19)
where σf is the complete fusion partial cross section and P the probability of a peripheral
collision taking place[Man15]. Peripheral collisions are typically the most probable for higher ion
bombarding energies, in which complete fusion is less likely. Consequently, as depicted in figure
1.4, this results in an “hot reaction zone” along with projectile and target fragments.
Subsequently, the thermalization process of a compound nucleus thus produced is described
with the BME theory[Cav98]. It consists of using the transport equation to find the momentum
distribution variation in time, as a result of mutual interactions. However, this is made in volume
partitions of the nucleon interaction phase space ∆V = 2πm∆E∆pz, where m is the nucleon mass,
E its energy and pz its momentum in the beam axis reference frame. The occupational probability
n in a bin i hosting a number of states g, for proton states (a variation of it can be applied for
neutrons), evolves in time according to the following set of differential equations:
2.3 The FLUKA code 53
d(ni,gi)
P
dt =
∑
j,l,m
[
ωPPlm→ijg
P
l n
P
l g
P
mn
P
m
(
1− nPi
) (
1− nPj
)
+
−ωPPij→lmgPi nPi gPj nPj
(
1− nPl
) (
1− nPm
) ]
+
+
∑
j,l,m
[
ωPNlm→ijg
P
l n
P
l g
N
mn
N
m
(
1− nPi
) (
1− nNj
)
+
−ωPNij→lmgPi nPi gNj nNj
(
1− nPl
) (
1− nNm
) ]
+
−nPi gPi ωPi→i′gPi′ δ
(
EPi − EPF −BP − EPi′
)
− dD
P
i
dt ,
(2.20)
with P and N indicating the proton and neutrons, respectively[Cav01, Gad03, Man15]. As for
the coefficients ωij→lm and ωi→i′ , these correspond to the transition probability in time of two
interacting nucleons, from an initial bin configuration (i, j) to the next one (l,m), and the emission
probabilities into the continuum. Integrating equation 2.20, one can obtain the nucleon evolution
in time through the phase space. Regarding the last term in equation 2.20, it is denominated the
“depletion term” and it pertains the proton emission bound in a cluster c. The latter is formed
as nucleons coalesce into a system, in which the momentum of a constituent nucleon lies within
the compound nucleus’ sphere center of mass momentum[Cer92]. A cluster of N ′ neutrons and P ′
protons is therefore formed with an energy Ec and at an angle θc from the beam axis and bin i,
with a probability in time Pc:
Pc(Ec, θc, t) =
∏
i
(
nPi
)Vi(Ec,θc)P ′ ·∏
i
(
nNi
)Vi(Ec,θc)N ′
, (2.21)
in which Vi(Ec, θc) is the volume fraction of the ith bin within the compound nucleus’ sphere
center of mass momentum, with center Ec, θc in the phase space[Man15]. The multiplicity M spec-
trum can then be calculated up to the equilibrium time (te), for the emitted nucleons with energy
E′ and at angle θ:
d2M(E′, θ)
dE′dΩ
=
1
2π sin θ
∫ te
0
n(E, θ, t)
σ′v
V
ρ(E, θ)dt. (2.22)
As well as for a cluster (Mc):
d2Mc(Ec, θc)
dEcdΩ
=
Rc
2π sin θ
∫ te
0
Pc(Ec, θc, t)
σ′vc
V
ρc(Ec, θc)dt. (2.23)
Rc corresponds to the probability of a cluster being emitted after it is formed, while Ω is the
solid angle[Cer92, Gad03]. As for v and vc, these are the nucleon and cluster velocities, relatively
to the residual nucleus, respectively. Regarding σ′, it refers to the inverse process cross section
(i.e. absorption), while V is the laboratory volume which cancels with a similar factor appearing in
the density of nuclear or cluster states in the continuum (ρ), depending on whether a nucleon or a
cluster is being considered, respectively. The integral of equation 2.23 allows one to find the number
of fragments produced in time. However, given the large multiplicity and complexity of emissions,
a database with pre calculated parameterized results from the original BME code is called, with
predetermined emissions’ double differential spectra, to enhance the calculation speed as previously
mentioned[Cav98].
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Overall, the evaluation of the nucleons involved in the pick up, stripping, break up or incomplete
fusion scenarios is based on the impact parameter selection, while the kinematics and excitation
energy sharing is found via break up studies.
At the very end, when the nuclei are in equilibrium, BME transits to the FLUKA common
de–excitation modules, as depicted in the schematic of figure 2.4[Bat16].
A-A collision (GeV/u)
E < 0.125 0.125 < E < 5 E > 5
↓ ↓ ↓
BME rQMD–2.4 DPMJET-III
FLUKA
Particle transport
h-A collision (TeV/u)
E < 20 E > 20
↓ ↓
PEANUT DPMJET-III
Excited pre–fragments
Evaporation, Fermi Break–Up, Fission, γ de–excitation
EM dissociation
↓
FLUKA
FLUKA
Particle transport
Figure 2.4: Schematic view of the major FLUKA modules for particle transport. h–A refers to hadron–nucleus,
A–A denotes nucleus–nucleus and EM to electromagnetic.
De–excitation modules. These modules describe the last stages of a nuclear interaction, after the
precedent collisions and emissions, when fragment production takes place from a thermally equi-
librated system. At this point, the system is characterized by its excitation energy U , residual
momentum and number of protons/neutrons. The constituents of the final compound nucleus
de–excitation can be summarily described as:
A≥17 – Depending on the mass and excitation energy, fragments can undergo:
• Evaporation, where de–excitation will occur mainly with emission of low kinetic energy
(few MeV) nucleons and light fragments (d, t, α). It is handled throughout a version
of Weisskopf–Ewing formalism[Wei37, Dre62, Fas01]. It states that a system has an equal
probability P of evolving in between stage 1 and 2, as a function of the density of states
ρ of the two systems: P1→2ρ(1) = P2→1ρ(2). Conversely, P2→1 refers to the probability
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of capturing a particle and forming a composite nucleus. The evaporation probability
Pj of a particle j and spin S · ~ is obtained by
Pj(E)dE =
(2S + 1)m
π2~3
σ′
ρ2(U2)
ρ1(U1)
EdE, (2.24)
with U1 ≡ U and U2 = U − E −Qj being the excitation energy of the evaporating and
evaporated nucleus, respectively, while σ′ is the inverse process cross section. Qj refers
to the reaction Q for emitting a particle j from the original compound nucleus[FS96].
• Fission, which may occur in excited heavy compound nuclei, whenever the excitation
energy is greater than the fission barrier Bf , when considerable deformations may take
place with eventual splitting. The probability of its occurrence competes with that of
evaporation, and is given by
P = 1
2π~
∫ (U−Bf )
0
ρ(U −Bf − E)
ρ(U)
dE, (2.25)
with ρ being the nuclear level densities[FS96]. Bf varies according to the fissibility pa-
rameter Z2/A and can be practically neglected for Z < 70 and thence is of no relevance
in hadrontherapy.
A<17 – Statistical evaporation of excited lighter residuals is not feasible given the sparse and wide
excitation levels, therefore requiring a more detailed treatment. This process attains a high
relevance in hadrontherapy for most biological tissue consist of nuclei with A<17[Kr15b].
• To this effect, a modified version of the Fermi Break–Up Model is employed for de–
excitation of an excited nucleus[Fer50]. The disassembling into n ≥ 2 fragments of a
residual nucleus is characterized by a probability P [Böh14, Man15]:
P = Sn
G
[
V
(2π~)3
]n−1(
1
M
n∏
i=1
mi
) 3
2
(2π)
3(n−1)
2
Γ
[
3(n−1)
2
]E 3n−52 , (2.26)
where V is approximately the volume of the initial residual nucleus, M is the total mass
(comprising U and the nucleon mass – MP,N ), mi the ith fragment mass and E the
total kinetic energy of the nucleus at the breaking up. S and G correspond to the spin∏n
i=1 2Si + 1 and permutation
∏k
j=1 nj ! factors, respectively. Regarding nj , it is the
number of identical jth particles. As for Γ, it denotes the gamma function[FS96].
The resulting fragment is then obtained by computing equation 2.26 for all possible
combinations and then randomly selecting one. In this process, Coulomb barrier (Bc) is
accounted for in the total kinetic energy calculation at the breaking up, via
E = U −
(
n∑
i=1
mic
2 −MA,Zc2
)
−Bc. (2.27)
The final state is obtained using a MC procedure over equation 2.26[FS96]. If the fragment
is radioactive, decay will apply and the subsequent fragment(s) configuration(s) will be
evaluated according to kinematic quantities.
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γ de–excitation occurs at the last stage, with cascades of γ–rays being produced as a by–product
of the nuclear de–excitation process whenever the excitation energy is below the threshold for
particle emission. It includes a statistical treatment for various transitions at high excitation
energies, and a discrete treatment for low excitation levels. The probability of emitting a
γ–ray with energy Eγ is given by
P(Eγ)dEγ =
ρ2(U2)
ρ1(U1)
∑
L
f(Eγ , L)dEγ , (2.28)
with L being the multipolarity of the γ transition, and f functions either calculated or derived
from photoabsorption cross sections[FS96]. The data employed follows the photon energies and
branching ratios as given in the Reference Input Parameter Library (RIPL-3) database from
IAEA[Bat16].
The cumulative effect of the above mentioned processes ensures the physical consistency of
remaining residuals. In addition to that, the mass spectrum of residuals is further constrained by
the excitation energy distribution at each step leading up to de–excitation. The accurate production
of these residuals is extremely relevant for treatment monitoring, due to the modelling of β+ emitting
fragments, prompt γ and fast secondary charged particles[BMM16]
FLUKA implementation of transport and energy–loss mechanisms for charged hadrons
FLUKA accurately accounts for continuous energy losses of heavy charged particles, energy loss
straggling, δ—ray production, and Multiple Coulomb Scattering [Fer92, Fas97b, Bat16].
Bethe–Bloch formalism in FLUKA. The energy loss mechanism for charged hadrons in hadronther-
apy is based on the Bethe–Bloch theory [Bet30, Bet32, BH34, Blo33a, Blo33b] with higher order correc-
tions, summarily described in chapter 1. In FLUKA, electronic stopping powers are computed based
on an improved Bethe–Bloch formalism, starting from 1 keV energies onwards, ranging out particles
below the energy cut–off. Higher order corrections accounts for Barkas, Bloch and Mott correc-
tions, effective charge parameterizations and a sophisticated straggling. Also, it includes nuclear
form factors, at high energies, and charge exchange effects, for lower energies.
The major correction factors and their effect on the accuracy of stopping power calculations
by FLUKA will be discussed. For the sake of simplicity, equation 1.6 will be rewritten, omitting
explicitly the correction factors later derived using relativistic quantum mechanics perturbation
treatments[Bic92]: (
dE
dx
)
e−
= −4πNAr2emec2ρ
Z
A
z2e
β2
(L+M). (2.29)
For large velocities or light ions, the projectile charge approaches the atomic charge number, as
all the atomic electrons are stripped off. However, for light ions . 10 MeV/u the description of av-
erage quadratic charge state decreases as the projectile slows down and it is partially neutralized by
capturing electrons[BBS56, BDH63]. FLUKA follows a previous implementation, modified to include
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the effect of various L and M corrections[HBG89]. Regarding L, it consists of the dimensionless
stopping number term per target electron and contains three major subterms:
L = L0 + zeL1 + z2eL2. (2.30)
Each of whose will be evaluated individually:
L0 is the Bethe term and includes the basic stopping power formula, namely[Por99]:
L0 =
1
2
ln (2mec
2β2γ2∆Emax)− β2 − ln I −
C
Z
− δ
2
. (2.31)
It includes the following correction factors:
C – The sum of target shell corrections, used to correct for atomic binding effects, as
electrons are not at rest[Zie99]. Its importance increases as the projectile slows down (E <
100 MeV/u), no longer yielding velocities larger than the atomic electrons, rendering the
Bethe–Bloch approximation no longer valid.
δ – Density effect corrections, introduced by E. Fermi, are mainly important for relativistic
projectiles with E > 1 GeV/u, and they are needed due to the polarization of the electric
field, leading to a decrease in distant–collision contribution factor, as ln (βγ)[Zie99]. Thus,
the energy loss is reduced due to the polarization of the medium and the electrons getting
screened farther[Ste84].
I – Target mean excitation energy, as well as density effect parameters in FLUKA, derive
from [ICRU–37] data[Ste84]. Variations in range arise from uncertainties on the mean
excitation energy. For instance, a change of 5 eV in I (from 75 → 80 eV) can result in
a 0.8 − 1.2% difference in the predicted stopping power in water[Pag12]. Even changes
of 2 eV can lead to ∼ 1 mm variation in range for 400 MeV/u carbon ions. In 1993,
[ICRU–49] issued a recommended a value of 75 ± 3 eV for water, which is the default
in FLUKA. Experimental data and recent ICRU publications point towards a slightly
higher I values (∼ 78 eV), which can be input in FLUKA[Pag12].
The radiative contribution to energy losses for positrons and electrons was adopted so as to
be consistent with Bremsstrahlung data as well[SB86]. Differences between the positron and
electron are taken into account concerning both stopping power and Bremsstrahlung [Kim86].
The latter and electron pair production at high energy by heavy charged particles is described
through either a continuous or discrete energy loss regime.
zeL1 denotes the Barkas-Andersen effect (z3e) correction, which accounts for a stopping power
slightly smaller for negatively charged particles[Pit95]. L1 is defined as a parametric function
(Barkas effect)[BBS56, BDH63, Ash72]. It becomes relevant at E < 10 MeV/u and is imple-
mented in FLUKA as per [ICRU–49].
z2eL2 is the Bloch (z4e) correction, introduced by F. Bloch[Blo33a, Blo33b]. It is defined by [ICRU–37]
as
L2(y) = ψ(1)−<[ψ(1 + iy)], (2.32)
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with ψ being the digamma function (logarithmic derivative of the gamma function) and
y = zeα/β, where α is the fine structure constant and < denotes its real part. Its importance
increases at lower energies, being particularly relevant for distant collisions of ions within an
10 MeV/u < E < 1 GeV/u energy range. Alternatively, a simplified version of equation 2.32
is sometimes employed[BP82]:
L2(y) = −y2
[
1.20206− y2
(
1.042− 0.8549y2 + 0.343y4
)]
. (2.33)
RegardingM, it is a correction important for medium/heavy relativistic projectiles, related to
the electron–ion Mott [Mot29] cross–section (Mott correction to Rutherford scattering cross section)
introduced in FLUKA in 2010. This higher order correction is required whenever zeα/β  1 is
no longer satisfied, since the Bethe-Bloch equation does not account for electron–ion scattering
cross–sections beyond the 1st Born approximation [Bat16].
TheMott correction is applied as a parameterized factor in FLUKA based on offline calculations,
to yield the appropriate stopping power factor based on the relationship between Mott and Bethe
differential cross–section
(
dσM
dE and
dσB
dE , respectively
)
:
M =
∫ (
dσM
dE
− dσB
dE
)
EdE, (2.34)
where ε is the transferred energy. Secondary electron production and energy loss fluctuations
are corrected as well[LQZ95, JKE09]. Overall, straggling in FLUKA simulations, using the 1st order
Born approximation and Mott cross sections, was verified to be within the intervals of measured
variances for various combinations of relativistic ions and targets[Sch96].
Summarizing, these corrections result in the following equations, for spin 0 projectiles:(
dE
dx
)
e−
∣∣∣∣∣
0
= −4πNr2mc2ρZ
A
z2
β2
(L+M); (2.35)
and for spin 1/2,(
dE
dx
)
e−
∣∣∣∣∣
1
2
= −4πNr2mc2ρZ
A
z2
β2
(
L+ 1
8
∆Emax
(mc2 +Mc2)
+M
)
. (2.36)
Regarding the elastic interactions via the Coulomb force with atomic nuclei, and although these
energy losses are much less relevant than those with atomic electrons at therapeutic energy, they
are accounted for in FLUKA as non–ionizing energy losses. Also, displacements per atom (DPA),
can be also estimated in FLUKA[Fas11].
Energy loss fluctuations. As the Bragg Peak characteristics are notably affected by charged par-
ticles’ average ionization and its fluctuations, an accurate modeling of those effects is particularly
important. The Landau–Vavilov distribution is typically used to describe energy losses in thin ab-
sorbers but it is difficult to implement in MC, FLUKA uses instead an alternative implementation
exploiting statistical properties of cumulants of distributions applied to both heavy charged par-
ticles and e+/e−[Vav57, Fas97b]. This includes full compatibility for δ–ray emission as well as the
already mentioned effect of Mott corrections, matching the average restricted stopping power[Bat16].
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Multiple Coulomb Scattering. Transport of charged hadrons and muons in FLUKA is accomplished
with an original implementation of multiple scattering, based on the Molière theory of Multiple
Coulomb Scattering, improved by Bethe [Mol48, Mol55, Bet53]. This implementation of the model is
characterized by a “condensed history” approach, speeding up the calculation since it does not
sample all interactions individually. It accounts for correlations between the final step angular
distribution, lateral deflections (average/second moment) and path–length corrections. A rejection
technique is used to apply nuclear form factors and spin–relativistic corrections at the 1st or 2nd
Born approximation level[Fer92]. Additionally, it includes the Fano correction for heavy charged
particle multiple scattering[Fan54].
Optionally, the code can work in Single Scattering mode, an algorithm based on theMott formula
with a screening factor consistent with Molière theory implementation in FLUKA. It is also capable
of reproducing electron backscattering and energy deposition in very thin material layers where
Molière theory does not apply. It is not a default setting because it is penalyzing in terms of
CPU[Fas97a].
Overall, the transport and energy loss mechanisms implemented in FLUKA have been verified
to be well in agreement with data for heavy ions (carbon, oxygen and helium ions) and provided
experimental parameters (e.g. I) are consistent. Some benchmarking examples are provided in
literature for medical applications[Som07, Mai07, Man15]. The use of FLUKA for generation of input
data to the clinical TPS at HIT and its validation in terms of depth dose distributions in water,
yielding range agreement within 100 µm in range and absolute 1.5% in dose in ion therapy in
general exemplifies the accuracy the electromagnetic physics models but also of the nuclear models
capability in predicting non–elastic nuclear interactions[Bat16, Tes17].
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Chapter 3
Tools developed using FLUKA
“When you want to know how things really work, study them when they’re coming apart.”
— William Gibson, Zero History.
This chapter details the various tools conceived for:
1. Generation of SOBPs using FLUKA, according to preset parameters defined by the user and
checked against a research treatment planning system;
2. Enabling the simulation of PET acquisitions in in beam PET scenarios, using the newly
developed FLUKA PET tools.
3.1 Generating stable SOBP according to clinical irradiation parameters
In order to compare the dosimetric properties of different beams in clinical–like scenarios, SOBPs
with an uniform physical dose at the “plateau” were systematically generated for this work. A
plateau value of 1 Gy was considered optimal, since it was assumed to translate into 3 Gy (RBE),
which are values of biological dose prescribed, per fraction, for scanned carbon ion treatments
reported in clinical cases[Bau13, Bau14]. Moreover, [IAEA–TRS–461] stipulates a RBE value of
around 3 for carbon ion beams at the SOBP “plateau” center depending on the tissue and tumor
type, based on GSI and NIRS studies, further supporting the present work approach[KS00, Suz00].
However, one must recall that, even though dose intake can only be completely evaluated using the
notion of biological dose, the present study is limited to a physical dose evaluation.
Using FLUKA built–in estimators, absorbed dose was scored for dose delivery verification. This
value was normalized to [Gy ≡ J kg−1] (see equation 1.13). Water was used as target material for
optimization with TRiP TPS, which was developed at GSI and used at HIT for research purposes
only. The dose profile scored consisted of 12C and 16O ions SOBPs, with subsequent extrapolation
for RIβ+.
As the creation of these SOBPs requires inverse planning, some SOBP results optimized at
HIT in water with the research TPS for 12C and 16O ions, were provided for this work. The dose
optimization process consists of the automatic generation of pencil–like beams with modulated
intensities so as to achieve proper longitudinal and lateral prescribed doses[Bau14]. The research
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TPS data provided were not entirely based on the standard TRiP98 code developed and used for
clinical purposes at GSI[Krä00, Kra08], being instead upgraded with an older FLUKA version, hence
it will be referred simply as oldtps in this work. At HIT, an improved version of TRiP is used for
research purposes, further upgraded with a detailed model of the HIT beamline using a more recent
FLUKA version[KMP12, Bau14, Ian15]. FLUKA was also used for validation and generation of the
dosimetric TPS input, such as laterally integrated depth dose, double Gaussian parametrization
and fragment spectra, for each of 255 energy steps for protons, carbon and oxygen ions as already
mentioned in chapter 2. From here onward, whenever referring to this newer research TPS version,
or when both are mentioned, this latter version will be denominated explicitly newtps and the
older oldtps. Moreover, one should note that at HIT the Syngo PT Planning is employed for
clinical applications with carbon ions, but no data from this commercial TPS has been used in this
work.
For the comparisons hereby included in this work, oldtps data were provided by HIT. They
include the initial ion kinetic energy (tabulated) and number of ions per beam spot, as well as the
focus information, which is the beam lateral size in air at isocenter, for each of the isoenergetic
layers. An initial beam size in vacuum of 2.5 mm FWHM was considered in the simulations for all
the beams at each spot.
The data were used to check whether a valid SOBP in water could be obtained for an in silico
comparison. Six therapy plans were provided in total, their characteristics are depicted in table
3.1:
Table 3.1: Treatment plan details.
Beams SOBP length [cm] SOBP dose [Gy] Field area [cm2] Depth in water [cm]
12C 3 1 5×5 10
12C 3 1 5×5 15
12C 3 1 5×5 20
16O 3 1 5×5 10
16O 3 1 5×5 15
16O 3 1 5×5 20
The SOBP dose refers to the dose value at the SOBP “plateau”, whereas the field area consists
of the surface covered by the beam spots at each isoenergetic layer, later depicted in figure 3.4. The
SOBP length indicates the “plateau” longitudinal length. As for the SOBP depth, it refers to the
longitudinal isocenter of the “plateau”. Please note that the data were valid for water phantoms
only.
The geometry setup in FLUKA had to make use of minor approximations, as some of the el-
ements along the beam path were either far too complex to be implemented, or their information
was undisclosed due to confidentiality issues[Rin15, Tes16a]. Besides the geometry approximations,
the description of materials in terms of water equivalent thicknesses could amplify the inconsis-
tencies, particularly in the case of oxygen ion beams, due to a larger impact of nuclear reaction
effects[KMP12].
All beam line elements are manufactured by Siemens AG and consist of: vacuum window,
a beam and application monitoring system (BAMS) with two multiwire proportional chambers
(MWPCs), separated by three ionizing chambers (IC) for beam monitoring, and finally a Ripple
Filter (RiFi)[PMS13]. These elements are depicted in figure 3.1.
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In order to accomplish a simulation employing the TPS data, multiple beams had to be gener-
ated simultaneously from different spots over a squared grid, attaining the desired radiation field.
This procedure is illustrated in figure 3.4 (a). These data consisted of a total of 625 beam spots, each
created at different coordinates, evenly distributed and separated from the neighbouring spot by 2
mm, as depicted in figure 3.4 (b) in a simulation scoring only the beam particle fluence (BEAMPART).
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(a) Initial beam spots’ distribution in
the squared grid.
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(b) Transverse view of BEAMPART fluence (particle
cm−2) as the ions traverse the vacuum window.
Figure 3.4: BEAMPART scoring before (a) and at (b) vacuum window, using source.f for the grid–like field generation.
Due to the fact that every beam in such scheme has equal energy, and predefined number of
particles per spot, the overall structure is denominated as an isoenergetic layer. The latter is charac-
terized by an average range and intensity and, by combining different isoenergetic layers, a SOBP
is obtained[Pa12b, Tes16a]. Besides the particle type, energy, intensity and positional distribution
of beams in space, each beam spot in this work was set with momentum spread ∆p/p = 0.1%
(FWHM), its shape gaussian with a FWHM of 2.5 mm in vacuum, broadened after traversing air
and beam line elements[PMS13]. This value was implemented in source.f, in the appendix A.
3.1.1 SOBP creation method
The TRiP data from HIT consisted of 12C and 16O ion beams. In order to perform an inverse
optimization and create SOBPs for 11C and 15O, a set of scripts was developed that, for a particular
geometry:
1. Calculate the energies to produce pristine Bragg Peaks at the specific ranges desired in a
FLUKA simulation. A database bpgen.cpp comprising fitted energy vs range values, for
multiple ions, was created for the purpose.
2. After selecting the desired SOBP depth in water, one can simulate the desired number of
pristine Bragg Peaks according to the database energy parameters for the beam particle
chosen.
3. Once finished, the laterally integrated output, in the form of energy deposition E , is optimized
so that the weights (i.e. number of ions) for each of the pristine Bragg Peaks are calculated.
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This leads to a SOBP “plateau” dose level as defined by the user, upon unit conversion as
detailed in equation 3.3.
4. The subsequent SOBP is then automatically plotted, generating a table with the correspond-
ing number of ions for each field/peak. The number of ions calculated in this process will be
denoted as I.
The three last items are handled by a program supra.cpp which, as bpgen.cpp, can be found
in the appendix. The following scheme details the main steps to generate a SOBP:
Multiple (n) output files
FLUKA SimulationFit Energies
Output (big.dat)
Quad.dat matrix (E)
vec.dat vector (ℵ)
Pristine Bragg Peaks
Plot & Normalize Final SOBP
Solve
E × I = ℵ
Generates, from a fitted (En-
ergy vs Range) database
(bpgen.cpp), initial energies
for each simulation’s input
(with source.f).
Using [AWK], the multiple
.dat are arranged into a
“big.dat” file.
awk–generated: 1) squared matrix (quad.dat), consisting
of n lines comprising maximum dose values of big.dat.
2) n normalization vectors (ℵ) with prescribed dose.
A C++ code produces the
gnuplot script (importing
I values) to be applied over
big.dat, plotting the SOBP.
A scripted [R] code solves
the matrix calculation for
ival.dat, providing the I
values.
Figure 3.5: Schematic view of the SOBP creation process, the green–coloured entries are handled by supra.cpp
Considering a circular Gaussian shaped beam spot, the transverse beam profile is obtained as
I(x, y) =
I
2πσ2(x,y)
exp
[
− (x
2 + y2)
2σ2(x,y)
]
, (3.1)
with I(x, y) being the intensity at position (x, y) with respect to the isocenter and I the total
intensity, in particles per second[HL15].
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The partial energy deposition from a pencil ion beam with initial energy E (at the isocenter)
can be described as dose D in the following manner[Bor97, Krä00, Kra08]
D(E, r) [Gy] = 1.602× 10−10d(E, z)
[
MeV
g cm−2
] I
2πσ2
[
particles
cm2
]
exp
(
−1
2
r2
σ2
)
, (3.2)
with d(E, z) being the laterally integrated dose at depth z, r the lateral distance from the
central axis of the beam, σ the Gaussian beam profile standard deviation and I the ion number.
The constant factors ensure the proper numerical conversion from [MeV] to [J], as
[
Gy ≡ J kg−1
]
However, assuming an homogeneous, squared field dose delivered over an area A(x, y), as will
be the case in the present work, and adapting equation 3.2 to FLUKA estimators, one can rewrite
it instead as
D(E, x, y, z) [Gy] = κ
[
J
GeV
]
1
ρ
[
cm3
kg
]
E(z)
[
GeV
cm ppp
] I
A(x, y)
[
particles
cm2
]
, (3.3)
where E is the energy deposition. In FLUKA, as it is scored in a volume it is given in
units of
[
GeV cm−3 ppp−1
]
, with ppp referring to “per primary particle”. For the subsequent cal-
culations, this result comes integrated over the area A(x, y) of the estimator, with the result-
ing USRBIN-1D yielding then
[
GeV cm−1 ppp−1
]
as indicated in equation 3.3. Please note that
κ = 1.602× 10−10
[
JGeV−1
]
and ρ the density chosen according to the room temperature.
The notion of dose area product (DAP) will be sometimes introduced throughout this analysis
to highlight the area A(x, y) selected for the energy deposition calculation. DAP is given in units
of [Gy cm2]. The field dimensions used to score the data in the water phantom consisted of a
square with area of 4 × 4 cm2. This surface was smaller than the original 5 × 5 cm2 generated
before interaction with beam line elements [figure 3.4 (b)], so as to ensure that the dose delivery
was homogeneous over the surface chosen and not laterally degraded for the following calculation.
Three major weaknesses can be identified in the scripted procedure described in figure 3.5,
namely: reliance on a database which would have to be modified to calculate SOBPs in different
material or geometry; statistical requirements limiting its application in complex scenarios without
heavy CPU power; since the calculation is performed for a laterally integrated volume, it may fail
when applied to heterogeneous materials. Nevertheless, for the scope of this work the procedure
followed can be considered adequate.
Provided the database bpgen.cpp is properly set, supra.cpp will generate a table containing
all the simulation outputs from the multiple .dat files. Each column will correspond to the energy
deposition in depth of a pristine Bragg Peak, integrated laterally, the so called big.dat file.
For the present case, 16 isoenergetic layers and pristine Bragg Peak results, were used for the
sake of consistency according to the TRiP data provided. However, other valid combinations could
be attained with the present method, for different ranges, with different number of isoenergetic
layers and alternative SOBP plateau lengths. One should note that the database fits are only valid
within the considered ranges of 2–30 cm.
The last step of the calculation is accomplished by representing big.dat file into a squared
matrix (quad.dat), consisting of the lines that contain the maximum value of energy deposition
per individual beam. In this manner, the lines of the squared quad.dat matrix are to be regarded
as the unweighted isoenergetic layers contributions, whereas the columns correspond to pristine
Bragg Peaks values.
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The peak normalization values are then extracted, properly weighting the contributions from
all beams to the final SOBP result. Once in the form of a squared matrix n×n, or quad.dat, it can
then be described as E × I = ℵ:
quad.dat ival.dat vec.dat
E11 E12 E13 · · · E1n
E21 E22 E23 · · · E2n
E31 E32 E33 · · · E3n
...
...
...
. . .
...
En1 En2 En3 · · · Enn
 .

I1
I2
I3
...
In
 =

ℵ
ℵ
ℵ
...
ℵ

As for n, it is now strictly equal to the number of pristine Bragg Peaks simulated, this assuming
each has a unique maximum value. E(z) is the energy deposition value in depth, directly given by
FLUKA as output
[
GeV cm−1 ppp−1
]
, with the maximum of each beam diagonalized.
In the present case considered, the normalization constant ℵ = κ/ρA, is the factor required for
a single peak to reach a dose D, and obeys the following relationship extracted from equation 3.3
D [Gy] =
κ
ρAEI, (3.4)
where the simulation media density ρ and estimator area A are given by the user in supra.cpp.
A vector column of ℵ–value entries is then generated with as many elements as there are isoenergetic
layers (vec.dat). These act as a normalization factor, and ensure that the sum of peak values of
each pristine Bragg Peak of the SOBP will attain the prescribed dose. Hence, it sets the system as
E × I = ℵ automatically. Note that in this work D was set to 1 Gy, but the method is also valid
for other values, in which case the normalization factor would be rescaled accordingly.
In, on the other hand, is the number of ions required to achieve the prescribed dose value.
Obtaining the number of ions corresponding to each beam, and thus with a certain energy, can be
achieved solving for I: 
I1
I2
I3
...
In
 =

E11 E12 E13 · · · E1n
E21 E22 E23 · · · E2n
E31 E32 E33 · · · E3n
...
...
...
. . .
...
En1 En2 En3 · · · Enn

−1
.

ℵ
ℵ
ℵ
...
ℵ

The inverse of the squared matrix is obtained implicitly by solving the system E × I = ℵ, by
supra.cpp, retrieving I = E−1 × ℵ under the form of a .dat file, denominated ival.dat.
The values in big.dat are plotted in units of DAP [Gy cm2], using an expression of the form
used in equation
DAP [Gy cm2] = D×A′ = ℵEIA′, (3.5)
ultimately obtaining the DAP values at different positions in depth. Here, A′ is an area value
that behaves de facto as a normalization factor, to scale the dose according to the area chosen for
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the plot. The reason for using DAP is to explicitly convey the information of the lateral limits of
the isoenergetic layer for the plot. For a direct comparison with oldtps data provided, A′ was
set as a squared area with 4 cm length, yielding a maximum dose 1 Gy, thus the DAP value at
the SOBP corresponded to 16 [Gy cm2]. SOBP plots were directly obtained from the simulated E
result values, contained in big.dat, while applying ival.dat as I in equation 3.3, resulting in the
final SOBP.
Regarding the oldtps data provided in table 3.1, it contains the total number of particle for
obtaining a SOBP of 1 Gy at each of the 16 isoenergetic layers I ′n, where n = 1, 2, 3 . . . 16. However,
it has been observed by the TPS provider that when recalculated with FLUKA, the TRiP plan for
12C yielded 0.95 Gy and not 1 Gy at the SOBP “plateau”. This has consequences that will manifest
in chapter 5.
The number of particles, for each isoenergetic layer provided in the oldtps, is equally divided
among the 625 raster scan spots (ix,y) that compose the dose delivery cross section 5×5 cm2 surface
before interaction with the beam line elements. Then, each isoenergetic layer n is accounted for
with their respective i values, so that the total number of particles delivered in the plan IT to
accomplish a SOBP are given by:
IT =
16∑
n=1
I ′n =
16∑
n=1
(
25∑
x=1
25∑
y=1
in,x,y
)
. (3.6)
Note that the resulting dose distribution was seen to correspond to an homogeneous dose only
over a surface of 16 cm2 at the SOBP, even though the initial surface covered by the beam spots
was of 25 cm2, as displayed in figure 3.4.
3.2 Developments for the application of FLUKA PET tools to ion
beam range verification scenarios
FLUKA PET tools are one of the major medical themed features currently under development
in FLUKA, extending its functionalities in the medical imaging domain[Ort13, Ort14, Bat16, Au18a].
Using these tools, the first reconstruction of PET signals from a beam irradiation was accom-
plished, its results will be presented later in chapter 5. For consistency, the signals were collected
employing the same geometry setup described in section 3.1, but now featuring a PET scanner
model and patient geometry, in various acquisition modalities. Contrary to the previous section
procedure, customized estimators had to be used, such as user–routine defined lists of particle
events occurring in a PET–shaped geometry (USERDUMP) along with other PET tools specific
scoring elements.
With these tools, it is expected to confirm the imaging advantages of RIβ+ over stable ions
beams, generated in the form of SOBPs with the procedure described in section 3.1. For SOBPs with
equal dose, RIβ+ should boost the amount of annihilation events at rest, leading to considerable
improvements in the reconstructed PET signal. Presently, the FLUKA PET tools package
consists of[Ort15]:
PET geometry tools – Allows the construction of different PET scanners employing reproducible
geometrical elements (lattices) and their roto–translation. The user can either select from
some existing commercial models or define a customized model. Scanner construction takes
place in three stages, of increasing complexity: blocks → modules → rings (see appendix B).
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Scoring routines – All the simulation data relevant to the reconstruction (e.g. coincidence γ
hit coordinates) is collected by these routines and associated with the detector’s geometry,
in either binary or ascii file format. The user can activate flags for obtaining additional
information, at the expense of data size increase (e.g. parent isotope flags). Dead time and
energy window constraints are enforced through the FLUKA input parameters.
Post–processing routines – Consist of routines embedded in the FLUKA code and an external file
(postprocess.param) to parse detector information to the routines. The latter allows for the
processing of output files, creating both a coincidence list or sinogram representation, based
on the coincidence timing window. In both representations, scatter, random, true and total
coincidences are produced.
The sinogram is a set of projections obtained from different angles, as a linear transform
of the original image. Each projection will consist of parallel one–dimensional rays across
the two–dimensional target, yielding the integral of the object contrast along each ray to
a single projection pixel. In this representation, a single row describes the projected view
of the intensity throughout a single angle (Michelogram)[Def97]. For each pair of crystal
rings defined by the user, a sinogram storing either 2D or 3D images in a binary file will
be created[Fah02, Ort13]. For the Siemens Biograph mCT, 109 sinograms were created, in a
3D mode. In order to apply iterative reconstruction algorithms to 3D data and mitigate
the computational burden, the data is first rebinned into 2D sinograms employing Fourier
rebinning. This methodology results in relatively fast reconstructions, but may incur into
resolution losses. The characteristics and quality of these sinograms can be improved with
several post–processing parameters, such as: arc correction, maximum ring difference, number
of segments, span and mashing factor [Ort15]. The parameter options employed in this work
are shown in table C, in the appendix B
Imaging tools – The current version includes a fast 2D reconstruction filtered–back–projection
(FBP) algorithm, for fast sinogram reconstructions with limited quality. This version also
features an embedded iterative maximum-likelihood–estimation–method (MLEM) based re-
construction algorithm, to transform coincidence lists into images[Tou16]. The latter is capable
of producing better quality images than the FBP, but it also requires longer reconstruction
times. Moreover, it lacks attenuation corrections, which are currently under development.
External reconstruction algorithms can be applied to both the coincidence list or sinogram
produced as output. For the results that will be later presented in chapter 5, image recon-
struction algorithms optimized for the scanner model were employed[Gia14, Gia16].
With this package, mainly developed by P. G. Ortega et al., one can exploit the full predic-
tive power of FLUKA, to validate not only treatment scenarios (dosimetry), but also reproduce
PET/CT scanner response in R&D environment and perform diagnostics (imaging). However,
the PET response simulation was limited to predefined β+ emitter source scenarios. In order to
perform realistic in beam PET simulations with FLUKA PET tools, the following tasks were
accomplished:
1. Creation of a realistic PET device in the flair library similar to the scanner found at HIT,
using the Siemens Biograph mCT model online information[STP08].
2. Usage of a patient voxel phantom, instead of a water phantom, for a more realistic dose
distribution[Bat16].
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3. Integration of an approximate beam time structure and inclusion of the possibility of filtering
the events, according to the acquisition time, in the tools post–processing routines[Au18a].
The Siemens Biograph mCT PET/CT scanner (Siemens Molecular Imaging, Knoxville, USA)
is now available in the FLUKA PET tools scanner database in flair. The full extent of both
geometry and operational parameters, implemented in the TruePoint TrueV option (which extends
the FOV by 33%), can be found in table 2, annexed.
Regarding the overall scanner geometry, it was defined so as to be in line with the setup found
at HIT, depicted in figure 3.6, just next to the treatment room, for offline PET acquisitions. The
setup simulated in this work corresponded effectively to an in beam PET, in the sense that scanner
and beam line are coupled, while at HIT the scanner and the beam line are in different rooms,
as mentioned in chapter 1. As a consequence, the irradiation and acquisition scenarios hereby
presented for PET acquisition, namely: online (i.e. resulting from both in–spill and inter–spill), in
room and offline, were all simulated with the scanner and beam line coupled. This was intended as
the simplest way to evaluate all acquisitions without altering the simulations. This implementation
is illustrated in figure 3.7
Figure 3.6: Siemens PET mCT Biograph model version available at HIT[STP08].
The beam line elements employed were those delineated in figure 3.1, but with the scanner setup
positioned as in a fully operational in beam PET scenario. However, the PET/CT scanner was
neither shifted nor open as in typical in beam PET setups, so as to keep the system as simple as
possible for the performance evaluation of the different ion beams.
Even though this scanner model is currently applied in offline PET acquisitions, it has success-
fully passed tests to validate its performance in online mode[Sha11]. Please note that the present
work is not intended as a clinical or technical validation of any PET acquisition scenario, the pur-
pose is instead to set a proof of concept for the FLUKA PET tools with subsequent evaluation
of the different ion beams performance. Furthermore, one must note that the hereby proposed in
beam PET modality uses a full ring and thus the images obtained could have an increased quality
(e.g. more statistics, more efficient image reconstruction) than in previously reported in beam PET
setups[CSE06]. However, the aforementioned effect is common to all ion beam species studied.
In addition to the PET/CT setup, an antropomorphic head voxel geometry was also used
instead of a water phantom, as depicted in figure 3.7 (a). It was used for obtaining the PET
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Figure 3.8: FLUKA’s PET tools description, from simulation setup to the final image reconstruction: The
dashed lines correspond to optional features whereas the functions connected by solid lines are automatically handled
by the tools. USERDUMP corresponds to the built–in FLUKA estimator’s output (in ascii), to be used as input in the
post–processing stage and subsequent image reconstruction.
Due to the large amount of particles and inherent computational burden, it was decided to use
only a range of 10 cm as a representative irradiation scenario for both water and antropomorphic
head voxel geometries. For each input, the output results in an USERDUMP, whose general structure
and columns of interest are highlighted in table 3.2.
Table 3.2: USERDUMP structure, with the post–scripting elements highlighted and different abbreviations explained
in the text.
EV-NUM SOU-NUM PART-ID SOU-ID IRADL IANGL IRING SOU-X SOU-Y SOU-Z
SOU-T SOU-KinE HIT-X HIT-Y HIT-Z HIT-T DEP-E WEIGHT N-CMPT N-RAYL
EV-NUM (red) is an unique number identifying the event detected, in every simulation. The
yellow entries HITX,Y,Z are the coordinates on the lattice at which the energy is deposited, SOUX,Y,Z
are the origin coordinates of the particles leading to the aforementioned hit. As for the orange
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entries (-T), they denote the time (in ns) of these respective events, for each simulation.
For the ensuing irradiation scenarios, the above mentioned USERDUMP file can be subsequently
postprocessed to obtain the sinogram and a list of coincidences reflecting the beam–time and PET
acquisition effect. The advantage of doing this retrospectively is that one can test as many plausi-
ble irradiation scenarios as desired. In order to have a final image, obtained only with coincidence
events acquired during those pre–determined periods, one needs to manipulate the “time” informa-
tion dumped, highlighted in orange in table 3.2. This is presently a constraint of in beam PET
simulations with FLUKA PET tools, in view of the missing ability to reflect the IRRPROFI card
information, which includes the irradiation time and intensity, in the USERDUMP output. Further-
more, since various simulations were required for the different isoenergetic layers of every SOBP, a
code was devised, acting in the following manner:
1. During the simulation, as the particles are transported, they will hit (HITX,Y,Z) and deposit
energy (DEP-E) on the lattice elements constituting the PET detector. If within a certain en-
ergy window, a line is printed in the USERDUMP, containing the source (SOUX,Y,Z,ID) information
that originated the hit (see table 3.2).
2. The reconstruction is then applied considering the time window (using HIT-T) information,
and the hit coordinates’ values. If these criteria are properly space/time–correlated, they are
later reconstructed as coincidence events. Moreover, it is also distinguished between types
of coincidences: scattering, random or true coincidences. This is done automatically while
processing the output.
3. The SOU-T (source time in ns), refers always to the time at which the source particle (e.g. 11C,
neutron) produced the particle originating the hit (e.g. photons, electrons) in time HIT-T.
Therefore, to re–structure the dataset, both SOU-T and HIT-T values in the same line must be
equally shifted in time, otherwise the particle’s flight travel would not be physically consistent.
For instance, considering a 11C beam simulation, in the USERDUMP#2 resulting from INPUT#2
and hence the 2nd energy layer of the SOBP:
(a) Let one assume that the USERDUMP obtained from an isoenergetic layer used ∼5.977E6
primary beam ions, with the subsequent detection registered. One of its events was
chosen, corresponding to a 11C decay, originally at SOU-T=100.000 ns and a photon
hitting the PET structure at HIT-T=101.612 ns.
(b) According to the beam time structure, and since it corresponds to the second energy
layer, the transport should occur between the beginning and the end of the second spill.
In this example, it will be considered that the spill occurs between the 9th and 10th
second, in terms of absolute time in the overall irradiation.
(c) Naturally, a “shift” of the decay time of the 11C is required, extended to the resulting
photon hit time by the same factor +T, for the sake of consistency. This factor +T
being, in this particular case, a pseudo random value between 9 and 10 seconds. The
decision to use such procedure to generate the +T value in fixed time intervals ensures
the reproduction of the collective performance of the 625 beam structure in the grid,
while adding to it a realistic time structure.
(d) Completing the example, assuming the shift +Tn is of 9.6 seconds, where n identifies
the irradiation interval, SOU-T will then become SOU-T+9.6 s and HIT-T will be also
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incremented by 9.6 s in that USERDUMP line. When applied to all beams it results as
depicted in figure 3.9.
Beam Time
+Tn for USERDUMP
T1 T2 T3 T4 T5 T6 T7 T8 T9 T10 T11 T12 T13 T14 T15 T16
Figure 3.9: Schematic view of the time structure ordering in the USERDUMP .
where each +Tn value is randomly placed only within the boundary conditions of the corre-
sponding spill. This method automatically ensures that every line in the output will reflect
the beam time effect.
4. For consistency, the EV-NUM entries (red, in table 3.2) in each of the n USERDUMPs will have to
be changed accordingly, to avoid repetition during post–processing.
Merging all the USERDUMPs will gather the full dataset, now properly time structured as illus-
trated in figure 3.10:
USERDUMP-3USERDUMP-2USERDUMP-1 USERDUMP-16
Beam Time 1 Beam Time 2 Beam Time 3 Beam Time 16
USERDUMP-1’ USERDUMP-2’ USERDUMP-3’ USERDUMP-16’
Time Structured USERDUMP
. . .
. . .
. . .
Figure 3.10: Flow diagram illustrating the merging of the results scored for different beam times in a single
USERDUMP for subsequent post–processing.
Once the beam time structure is correctly enforced, and all events ordered, the acquisition time
may be accounted for. As the current output contains events from the first particle that hits the
detector (e.g. a prompt γ) to the last (e.g. resulting from the decay of some long–lived isotope), to
account only for the events in the time window(s) desired, a filtering based on the HIT-T column
must be employed. The final USERDUMP thus obtained will be ready to be processed with the
standard tools.
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The standard tools will produce coincidence list–mode data or sinograms, but now properly
ordered and containing only the events acquired at the respective acquisition time windows. The
resulting images will be shown in chapter 5, along with the coincidence details of these acquisitions.
Chapter 4
Basic dosimetry and imaging studies of ion
beams using FLUKA
“Es ist nicht das Ziel der Wissenschaft, der unendlichen Weisheit eine Tür zu öffnen, sondern eine
Grenze zu setzen dem unendlichen Irrtum.”
— Bertold Brecht, Leben des Galilei (1939)
In this chapter, the dosimetric and imaging properties of different ions were assessed by means of
FLUKA simulations of irradiation in water, using the beam species listed in table 4.1. Particularly,
their fragmentation products were studied by decomposing the various contributions to the final
Bragg Peak curves.
Table 4.1: Ion species evaluated in this work and relevant properties[Som07])
Ion Half–life (t1/2) Decay emission β+ endpoint energy [MeV]
12C Stable — —
11C 20.38 min β+ 0.96
10C 19.31 s β+ 1.91
9C 136.50 ms β+ (60%) 15.47
16O Stable — —
15O 2.03 min β+ 1.73
Regarding 12C, it was chosen due to its established use in ion therapy[Kam15]. As for 16O, it is
being considered a next candidate for therapy at HIT, and it is deemed particularly relevant due to
its higher efficacy against radioresistant tumors, less lateral scattering and higher LET[KMP12]. In
addition to that, they are the stable counterparts of 11C and 15O, which are ion species of relevance in
the framework of advanced studies at HIMAC, as mentioned in chapter 1. The produced intensities
of 11C and 15O may soon match therapy needs and 11C LET is almost equivalent to 12C[Tom03].
Regarding 15O, it is also an interesting species for treatment of hypoxic tumors[Kit06, Moh16]. At
HIMAC, 10C, 11C and 15O were employed as probes in range verification. Even though of limited use
as a probe, since probes should have half–lives no longer than a couple of minutes to be effective,
11C is potentially interesting to verify dose delivery in range a posteriori, either in offline or in
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room PET modalities. Moreover, 11C, 15O and 10C are also of potential imaging interest in view
of their half–lives in in beam PET [Ina08]. In this work’s fragmentation study, 10C and 9C were only
partially evaluated, in order to compare their trend with other heavier carbon ion beams. Even
though 10C has been used as a probe by NIRS, its study is far less advanced than 11C, whereas 9C
has too short a half–life for direct clinical application and its use is restricted to cellular damage
evaluation[Ise04, Kit06]. In addition to the aforementioned species, 8B, 13N and 17F beams were
occasionally simulated, for testing purposes, during the generation of different SOBPs detailed in
chapter 3 and shown in the appendix A.
The β+ originating from 11C decay has a rather low endpoint energy with respect to 10C and
15O (table 4.1). While the maximum range for β+ from 11C is about 4.2 mm, for 15O and 10C it
can reach 8.4 and 9.2 mm in water, respectively[Ise04, CE16]. The blurring due to this β+ range for
11C is thus smaller than the resolution of commercial PET scanners. Note that the PET imaging
spatial resolution is ultimately limited by the β+ range and non–collinearity in addition to the
detector granularity[Der79, Bai05]. Conversely, 13O, 12N and 9C have all endpoint energies above 15
MeV and half–lives much below 1 s, rendering them less suitable for PET applications[Som07]. Since
the mean kinetic energy of emitted β+ is approximately one third of the endpoint energy value, the
distribution of β+ emitted by 13O, 12N and 9C was estimated with FLUKA to be higher by factors
of ∼ 1.5, 2.5 and 2 with respect to 11C, resulting in a stronger blurring effect.
Several built–in estimators in FLUKA were used to acquire (i.e. “score”) the simulation data
in various geometries. Particularly, physical absorbed dose and annihilation events at rest were
scored in 3D geometries (USERBIN) and employed in dosimetric and imaging studies, respectively.
The annihilation event at rest (ANNIHRST) is a newly developed estimator, its output consists of
“Annihilation events at rest per primary particle”. As a quantity directly associated with decay, it
must be coupled with the DCYSCORE card either for a certain decay time or in semi-analogue mode,
to be retrieved in the form of a rate or in absolute value, respectively. The imaging potential was
evaluated by quantifying the annihilation events at rest arising from the use of different beam types
in the simulations.
Unless explicitly said otherwise, the simulation plots will assume that all radioactive species
produced decay, with the result being therefore “time integrated” and with the radiation emitted
accounted for.
4.1 Dosimetric evaluation of pristine Bragg Peaks for different ion beams
As the primary ion beam traverses a medium, it loses energy in an ever–increasing manner, cul-
minating at the Bragg Peak region. Being heavy projectiles, many types of ionizing radiation will
be produced as secondaries. A portion of this radiation will consist of lighter secondary nuclei,
which will form the fragmentation tail[Har17]. Although not analyzed in this work, such fragments
may have a different RBE value than the primary particle, hence requiring their impact to be well
assessed for clinical applications.
The experimental “mapping” of those secondary particles is nowadays a topic of great interest,
as it can provide better insight on the nuclear reactions taking place, particularly due to the fact
that the projectile and most of its fragments are “lost” inside the body in hadrontherapy. However,
comparison with experimental data is still not optimal, as data for carbon and other ions are
scarce[Pri12, Rob13, Har17]. Given the reliance of TP on MC engines for basic data calculations
in ion beam therapy, validation of various secondary production and distribution could not only
demonstrate the adequacy of the models implemented in the MC codes, but it could also prove
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itself most useful in the prediction of dose delivery and also imaging[Som06, Böh10, Mai10, Rob13].
The latter is chiefly due to the relationship between fragmentation and subsequent signal output
for example through β+ emitter nuclei production[Sal16].
In figure 4.1 it is illustrated a Bragg Peak dose delivery profile with various species, calculated
with FLUKA in a water phantom. The event generators rMQD–2.4 and BME, mentioned in chapter
2 were activated, along with EVAPORATion and COALESCEnce physics cards. Among the fragments
by–products, there will be species decaying through the β+ mechanism which are centerpiece in this
work. These can be an imaging asset due to their occurence exactly at the Bragg Peak, for RIβ+,
or in its vicinity for stable beams’ irradiation scenarios. However, the mixed field of secondary
radiation (e.g. p, γ, n etc. . . ) is definitely going to contribute to the dose both in the direct beam
path as well as in its proximity, depending on the type and energy of the radiation. Low energy
neutron transport in FLUKA, below 20 MeV and down to thermal energies, was activated using
the LOW-NEUT card. As for the energy transport thresholds, they were set at 100 keV for charged
hadrons, 80 keV for electrons and positrons and 10 keV for photons.
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Figure 4.1: Simulation of Bragg Peak curves for the four major ion species studied in this work, with two additional
carbon RIβ+, for equal range in water. On the left, a logarithmic scale is used whereas on the right the result is
plotted using linear scale and a shorter range margin. The peak dose is normalized to 1 Gy in both cases.
The importance of the mixed field surpasses the prediction of patient dose intake, it also leads
to a more accurate imaging potential estimation. Nonetheless, the dosimetric study should remain
prioritary with respect to any subsequent imaging potential assessment.
Fragmentation is present throughout the three zones depicted in figure 4.1, but its effect becomes
more visible in the fragmentation tail, beyond the Bragg Peak. This effect becomes a limiting factor
in the selection of heavy charged particles in hadrontherapy, especially for the treatment of deep
seated tumors or near OAR.
As discussed in chapter 1, 12C ions are regarded as optimal in view of their high peak–to–
entrance RBE differential effect and therefore it is important to understand how RIβ+ perform
with respect to it. In fact, it remains to be seen whether the radioactive species considered in this
work, despite their expected imaging potential, would display a comparable dosimetric performance
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for equivalent–in–range Bragg Peaks dose profiles. On the other hand, if it is demonstrated that
fragmentation tail doses, or the overall mixed fields, for RIβ+ are comparable or more advantageous
than those of their stable counterpart (e.g.11C vs 12C ions), their enhanced imaging properties would
make them an asset in clinical practice.
Indicatively, in preliminary simulations no significant surplus of dose has been identified using
RIβ+ in the fragmentation zone, as seen in figure 4.1[Aug16]. It has also been observed that the
peak–to–entrance dose was equivalent in all beams included in the analysis.
The dose ratio between 11C and 12C yields an approximately ∼ 20% reduction in dose imme-
diately after the peak (figure 4.1). The trend beyond the Bragg Peaks has been investigated for
irradiations of different ranges in water, resulting in the figure 4.2.
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Figure 4.2: 1 Gy Bragg Peak, 12C/11C dose ratio at 5, 8, 10, 15 and 20 cm ranges in water. The turquoise
vertical lines denote the Bragg Peak position.
The fragmentation dose tail ratio attains 15% for Bragg Peaks at 5 cm depth and surpasses
20% for Bragg Peaks at 20 cm. Even more advantageous ratios were observed for either 10C and
9C with respect to 12C, although not quantified here since studies for medical applications of these
ions are far from advanced. Regarding 15O, no major advantage with respect to 16O is observed.
This fragmentation dose tail ratio effect is also visible in the more realistic SOBPs, which will be
presented later in the section 4.1.2.
Throughout the projectile interaction with water, many types of nuclear reactions will occur
and each component of the resulting mixed field of radiation will deposit energy of its own at
different ranges, depending on their energy, production angle and particle type. Regarding the
angle, fragments were seen to be essentially forward projected[Böh10, Rob13]. The fluence evolution
can be visualized by means of a reduction of primary ions and thus an increase in secondary particles’
fluence (see figure 4.3).
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Figure 4.3: Comparison of physical dose (right side) and fluence of different particles in depth (left side), obtained
with FLUKA. The fluence is normalized to the primary ion value at the entrance of the water phantom (0 cm),
whereas the dose values are normalized to 1 Gy, according to the total dose value at the Bragg Peak.
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Depending on the primary ion, some resulting secondary particles may travel considerable
lengths as visible in figure 4.3, including light and/or neutral particles but also projectile frag-
ments. This is the rationale of the studies of protons and gammas as an indicator for Bragg Peak
position mentioned in chapter 1, provided adequate detectors are available to counteract the neu-
tron background (figure 4.3)[Ag12b]. For the RIβ+ irradiations studied, and compared to their
stable counterparts, the value of electron fluence is substantially increased (figure 4.3), particularly
at the Bragg Peak, by a factor of ∼ 20 and ∼ 12 for carbon and oxygen ions, respectively. Note
that the electron fluence includes also positrons (E+&E- estimator) as well as δ–rays. The latter
production was explicitly set using the DELTARAY transport card to an energy threshold of 300 keV,
this value was quite high and consequently it results in an artificially abrupt decrease in electron
fluence at approximately half–way to the Bragg Peak position, as δ–rays cease to be produced below
that threshold. However, in this way one can better identify the sharp raise in electron fluence near
the Bragg Peak due to the contribution from the β+ emitters coming at rest. As for the gamma
fluence, it increases at the Bragg Peak for oxygen ions by 60% and for carbon ions over a factor of
∼ 2.5. Neutron fluences are found to be rather comparable between radioactive and stable beams
in figure 4.3.
On the other hand, energy deposition as a result of gammas and neutrons is not relevant in
the Bragg Peak region, due to their neutrality and longer range. Despite the high electron fluence
seen in figure 4.3, the energy deposited by electrons is very low. In fact, and as expected, energy
deposition is mostly dominated by the primary and other secondary ion’s ionization effect.
Regarding the aforementioned ∼ 20% gain in 11C over 12C at the fragmentation dose tail,
observed in figure 4.1, it appears to be chiefly influenced by an interplay between α particles
and heavier ion contribution, as seen in figure 4.3. The validity of these results requires however
experimental verification.
Gamma and neutron particle fluences might increment the dose elsewhere depending on their
energy. If for the former the biological impact is relatively low, the latter can be as relevant as
ions, depending on their energy. Also, they are characterized by a wider spatial distribution with
respect to ions for instance.
The information in figure 4.3 is insufficient to fully characterize the radiation produced by the
different beams, for it conveys no indication on the energy of particles exiting the Bragg Peak region,
nor does it provide full spatial information. To characterize the energy spectra of this radiation,
FLUKA USRBDX estimators were used to score the differential fluence, as a function of energy,
integrated over solid angle, traversing an one cm diameter detector sphere centered at the Bragg
Peak position and in the outward direction only. These plots are seen in figure 4.4.
Gamma coincidences, originating from the annihilation events (i.e. 511 keV), differ by more
than an order of magnitude in favor of RIβ+ irradiation in figure 4.4. This is in line with the
gamma fluence simulation trend in figure 4.3.
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out by whether they proceed directly from Coulombic energy losses or nuclear reactions (prompt),
or were instead created through radioactive decay mechanism (decay). Additionally, the energy
deposition ascribed to the primary beam particle only was also scored. Radioactive decays were
evaluated by means of user routines comscw.f and stuprf.f, annexed. FLUKA was thus used in
Semianalogue mode applying DCYSCORE cards coupled with the various USRBINs estimators.
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Figure 4.5: Evaluation of prompt, decay and primary ion contributions to the total dose for the different ion
species Bragg Peaks in water, using FLUKA. The plots are normalized to 1 Gy at the total dose peak value.
Clearly the decay component in figure 4.5 (b) is almost three orders of magnitude lower at the
peak value compared to the prompt energy deposition, which is dominated by the primary particle
up to the Bragg Peak. In fact, the combined (prompt) effect of primary ion and heavy ions produced
is definitely responsible for the vast majority of energy delivered in the vicinity of the Bragg Peak
region.
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4.1.1 Influence of nuclear models on fragments contribution to the Bragg peak
A modified version of both stuprf.f and comscw.f user–routines was prepared for a more in–
depth analysis of the fragmentation dose tail composition (the appendix A), accompanied with 9C
and 10C results (figure A, also annexed). As mentioned in chapter 2, FLUKA uses its rQMD–
2.4 implementation down to ∼ 125 MeV/u energy range, at which point 12C and 16O ions are
typically still able to travel few cm in water[Som09]. The BME model in FLUKA becomes then
the sole responsible for handling ion interactions at energies below 100 MeV/u. Since these models
are entirely different entities, it was important to verify their performance around the 125 MeV/u
frontier.
Additionally, a previous work featuring an earlier BME implementation displayed discontinuities
on the activity profiles resulting from 12C and 16O irradiations, at the boundary between the two
models[Som09]. These discontinuities were ascribed to the production of 11C and 15O, having been
overcome since then. In fact, this improvement has a positive effect in the present work, as the
transition between the above referred models in figures 4.6 and 4.7 was verified to be both gradual
and without discontinuity. For the secondary ions, the rQMD component in all plots is going down
as the Bragg Peak starts to build–up, typically around 7–8 cm in range for the considered energy,
depending on the particle type. At those ranges, some of the projectile energy drops below the 125
MeV/u threshold while some fragments are produced at various energies, including below the 125
MeV/u level and thence their interactions start to be handled by BME[Cer06]. In the latter case,
energy deposition profile typically peaks at the Bragg Peak. As for the rQMD model, it contains
certainly mostly projectile fragments and thus their range varies in some cases by more than 1
cm. The formation of the double peaked shapes in the BME plots, for ions with higher Z than the
projectile’s, is due to the complete and incomplete fusion model (not present for rQMD), although
the peak importance appears to be overestimated at the higher energy component (the initial peak).
Among all secondary ions energy deposition scored in figure 4.6 at the Bragg Peak, the most
important inelastic collision energy contribution is from carbon isotopes (2 − 3% at the peak),
particularly by BME. At that range in water, boron isotopes and α particles only attain 1% of
the total energy. The fragment energy distribution peak shapes are broadened considerably by the
influence of BME interactions, notably involving carbon and boron isotopes. The fragmentation
dose tail is mostly “fed”, immediately after the peak in 12C, by boron ions and to a less degree α
particles, although the latter contribution dominates beyond the ∼ 11 cm depth, after the peak of
boron isotopes. More than 50% of the fragmentation dose tail is, in fact, ascribed to α particles
at 14 cm in depth (see annexed figure A). For 11C, α particles contribution clearly dominates.
Furthermore, it can also be concluded from figure 4.6 that the previously observed effect in figure
4.2 does not derive from a single fragment type dominance, it results instead from a combination
of various fragments.
With respect to oxygen irradiations in figure 4.7, the main isotopes contributing to the inelastic
interactions at the Bragg Peak are nitrogen and carbon. At the aforementioned range, the contri-
bution from oxygen isotopes inelastic collisions differs by more than a factor 2, between 16O and
15O, and becomes irrelevant after the peak. This aforementioned effect can be attributed chiefly
to the rQMD component. In both 15O and 16O, the fragmentation dose tail is essentially formed
by contributions of boron and carbon ion isotopes interactions via rQMD. Contrarily to the carbon
irradiations in figure 4.6, α particles only dominate 2–3 cm after the Bragg Peak, consistent with
the observation in figure’s 4.3 energy distribution in range beyond the Bragg Peak, where heavy
ions were seen to be of major relevance to oxygen compared to α particles.
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Figure 4.6: Absorbed dose by carbon ion beam fragments in inelastic collisions for a 10 cm deep Bragg Peak in
water, normalized to 1 Gy at its total dose maximum, and filtered by Z and intervening model.
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Figure 4.7: Absorbed dose by oxygen ion beam fragments in inelastic collisions for a 10 cm deep Bragg Peak in
water, normalized to 1 Gy at its total dose maximum, and filtered by Z and intervening model.
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Regarding 9C and 10C results (annexed figure A), the importance of secondary ions decreases.
In fact, the major contributions via inelastic collisions to the energy deposition at the Bragg Peak
attain no more than 1% for boron (9C) and for carbon (10C). In the latter case, α particle contri-
bution dominates entirely after the Bragg Peak. The remaining major isotopes contributing to the
fragmentation dose tail 1 cm after the peak are beryllium fragments and 3He.
4.1.2 Simulating SOBPs for radioactive ion beams
The method described in the previous chapter, and detailed in the appendix A, was employed to
obtain both the beam kinetic energies and number of particles calculated with the present work
systematics (IS) corresponding to 1 Gy SOBPs of 12C and 16O, or alternatively 16 Gy cm2 DAP,
with the desired characteristics in water of TPS data detailed in table 3.1. The procedure was then
extended to RIβ+. The disentangled (DT) pristine Bragg Peak ion numbers at each isoenergetic
layer for 11C and 15O are shown in figure 4.8, compared with 12C and 16O, for a SOBP with center
at 15 cm in water.
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Figure 4.8: SOBPs centered at 15 cm in water, with the individual contributions at each isoenergetic layer
disentangled.
An attempt to validate this work’s methodology with FLUKA recalculations based on the TPS
data will be presented in chapter 5. However, from figure 4.8, it appears that the developed method
does not show considerable variations in the number of primary ions, at each of the different
isoenergetic layers, for the various ion beams employed. A more detailed dataset is provided in
table A, annexed, for various SOBPs of RIβ+ at different depths in water. The 11C, 12C, 15O and
16O SOBPs generated are shown in figure 4.9, for a qualitative assessment of their dose distribution
when centered at different depths (10 and 20 cm) in water.
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Figure 4.9: Dose maps for 1 Gy SOBPs centered at different depths in water (10 and 20 cm), for the various ion
beams.
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The fragmentation tail ratio trend reported in figure 4.1 for pristine Bragg Peaks is still visible
in figure 4.10, in spite of the interplay between different isoenergetic layers and the effect of multiple
projectile fragments in range, which could mitigate the advantageous effect highlighted in figure
4.2. On the other hand, a difference of ∼ 3% is observed at the entrance dose, in favor of the stable
ion species. Even though this difference is rather low, the dose levels at that range are much higher
than in the fragmentation tail zone.
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Figure 4.10: SOBP for different ion beams, centered at 20 cm depth in water, using the number of ions (IS)
calculated to attain an equivalent SOBP dose. On the left a logarithmic scale is employed whereas on the right side
a linear scale is used instead.
For oxygen beams, and in line with the observations in figure 4.1 for mono energetic beams, the
simulations did not show a considerable difference in fragmentation tail dose, although it appears
that 15O leads to slightly higher doses both at the fragmentation tail and entrance zones.
4.2 Imaging potential of radioactive ion beams
The verification of the imaging potential of RIβ+ requires a direct PET imaging comparison, ideally
within the framework of a patient irradiation scenario, with equivalent irradiation and acquisition
parameters (i.e. comparable acquisition time, PET model, dose delivered). However, given the
unavailability of patient data for RIβ+ irradiation scenarios, simulated stable ion beam irradiations
were used as a basis for extrapolations of RIβ+ with the same dose delivery characteristics. This
work methodology was further extended to voxelized phantoms, but only considering physical
dose, without accounting for the RBE effect in the different irradiations.
Once comparable SOBP doses are attained, one can estimate the imaging potential of RIβ+
via:
1. Direct calculation of the annihilation events at rest produced, evaluating their spatial distri-
bution and time evolution, considering also the isotope of origin.
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2. Usage of FLUKA PET tools to obtain a reconstructed image from comparable in beam
PET irradiation with acquisition scenarios of clinical relevance, using an anthropomorphic
voxel phantom, an in silico version of PET scanner model used at HIT and an approximate
description of its beam line elements using a RiFi and water equivalent approximations.
The second point is considerably more complex, as it requires scoring and processing data
using external tools developed in the previous chapter, its results will be shown in chapter 5, after
comparison of the SOBPs produced in this chapter. Note that although annihilation events at rest
maps can be useful to assess photon emission origin, and therefore the events’ distribution, they do
not replace PET reconstruction images acquired during irradiation, which are more realistic.
4.2.1 Assessment of radioactive ions potential in PET imaging for SOBPs
In hadrontherapy, the distribution of β+ emitters, either introduced with a biologically active
molecule or produced by an ion beam, is an important information. Apart from the biological
washout, the distribution is dynamic in both time and space due to the irradiation profile and
subsequent decay. When employing PET techniques to visualize irradiation induced activity, the
reconstructed image can be used to monitor the beam range. The following results assess the
intrinsic imaging potential prior to image reconstruction by estimating the increment of annihilation
events at rest using RIβ+, and their spatial distribution for the in beam PET scenarios studied.
In order to be consistent with the SOBP data, the scored annihilation events at rest must account
for the weights applied to each of the pristine Bragg Peaks composing the SOBP generated using the
tools described in the last chapter. This was accomplished using ival.dat as normalization factor,
an example is found in the annex, in program ultra.cpp. In this way, the annihilation events at
rest distribution in space and their total yield integrated over time can be assessed for SOBPs of
equivalent dose. Since the time information of each isoenergetic layer, and their respective decay,
is not yet considered, the following results are to be regarded as “integrated over time”, or as an
infinitely long acquisition time to score all annihilation events at rest produced.
The annihilation event at rest distribution resulting from each 1 Gy SOBP, time integrated for
three different depths in water, can be seen in 1D and 2D in figures 4.11 and 4.12, respectively.
Additionally, table 4.2 quantifies the simulated results, with annihilation events at rest abbreviated
to Æverest for simplicity.
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Table 4.2: Analysis of the annihilation events at rest, integrated over time, with respect to the SOBP dose profiles,
in water.
Æverest value [1× 106 Events] at: Distance between Æverest
Scenario Beam proximal edge distal edge maximum peak and SOBP distal edge [mm]
11C 1.28 13.00 14.60 0.8
SOBP 12C 0.26 0.27 0.52 5.0
10 cm 15O 0.68 6.00 7.10 1.0
16O 0.19 0.32 0.44 4.0
11C 1.7 13.00 13.50 0.4
SOBP 12C 0.36 0.30 0.57 10.0
15 cm 15O 0.91 6.80 6.80 0.2
16O 0.26 0.35 0.51 6.8
11C 1.50 10.00 13.00 1.3
SOBP 12C 0.47 0.32 0.64 14.5
20 cm 15O 1.08 6.13 6.37 0.8
16O 0.33 0.41 0.56 8.8
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Figure 4.11: Total annihilation events at rest, laterally integrated, from different SOBPs with the same physical
dose in water. The dose profile is superimposed in arbitrary units for visualization purposes.
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Considering the dose distribution of pristine Bragg Peaks composing the SOBP previously high-
lighted in figure 4.8 and the distributions plotted in figure 4.11:
1. The annihilation events at rest resulting from stable ion beam irradiations do not evidence a
clear peak, and their maximum do not coincide with the range of the distal edge of the SOBP.
Note that SOBP dose distal edges are observed at 11.5, 16.5 and 21.5 cm in range, and these
positions correspond exactly to the dominant Bragg Peaks, where the highest number of ions
is delivered as observed in figure 4.8. In fact, for 12C, the maximum of annihilation events
at rest occurs at 11.0, 15.5 and 20.1 cm in depth. For 16O, the deviation to the SOBP dose
distal edge is smaller, but still the maximum of annihilation values correspond to 11.1, 15.8
and 20.6 cm in depth. Conversely, the maximum for RIβ+ are all within 1.3 mm from the
distal edge of the SOBP. Also for the latter species, the distal dose fall–off, consisting of the
distance corresponding to the distal curve decreasing from 90 to 10% of the SOBP edge value,
coincides with the annihilation events at rest distribution distal fall–off.
2. Most notably, the annihilation events at rest resulting from irradiations with RIβ+ lead to a
considerable gain in magnitude of annihilation events throughout the SOBP. Comparing the
carbon ion distributions, this gain is of a factor 4.9, 4.7 and 3.2 for the proximal rise edge of
the SOBP, at 8.5, 13.5 and 18.5 cm respectively. As for the distal edges at 11.5, 16.5 and 21.5
cm, the gain reaches over a factor 30. With respect to oxygen ions, the gains are overall lower
but still considerable: for the proximal edge the gains are 3.6, 3.5 and 3.3, approximately,
whereas for the distal edge the gain corresponds to a factor 15–20.
It is noteworthy to point out that the extremely favorable distal distribution of annihilation
events at rest hereby seen is ascribed to the last isoenergetic layer having an higher weight, as seen
in figure 4.8. Should the dose delivery being altered in terms of this layer weight, or sequence, this
would reflect in the distribution of annihilation events. However, the overall gain with RIβ+ would
be of course not altered, provided the total number of particles used is maintained. A reverted
dose delivery in layer weight is often used when accounting for the RBE effect and consequently to
quantify the biological dose.
In figure 4.12, one can appreciate qualitatively the lateral distribution of annihilation events
at rest, which was integrated in figure 4.11. It varies approximately from 4 to 5 cm between the
proximal and distal edges for 11C and from 4.0 to 4.7 for 15O due to the smaller lateral scattering.
Comparing with the dose maps shown in figure 4.9, it is possible to see a clear correspondence
between the higher dose zones and the higher annihilation events at rest distributions, both in
range (Z) and laterally (X). In fact, the dose distribution is laterally homogeneous between the
proximal and distal edge, at least within a 4 cm lateral interval. Therefore, the annihilation events
at rest gain observed with RIβ+ over stable ion beam irradiations can be also useful to highlight
the shape of the dose distribution.
Annihilation events at rest can provide an estimate of the ideal imaging potential, but the results
shown so far did not account for its evolution in time. In a PET clinical scenario, the distribution
of β+ emitter activity observed for a specific radionuclide depends on the total number of primary
ions employed, beam time structure and time of PET acquisition[Bau13]
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Figure 4.12: Annihilation events at rest 2D maps, integrated over time, proceeding from the various 1 Gy SOBPs
of different ranges in water.
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Assuming an offline PET acquisition, once the beam delivery is finished, decay mechanisms will
be the sole responsibles for the production of β+ emitter isotopes. This in contrast to β+ emitter
production taking place during irradiation, where decay and inelastic nuclear reactions compete.
This competition becomes more complex to evaluate if one has to account for multiple β+ emitters,
decaying during beam time. Decay dynamics is considered to be affected ultimately by the β+
emitters’ rate of production and decay according to the Radioactive Decay Law in expression 4.1.
The spontaneous decay products will, in time, contribute to the imaging signal according to their
activity[SF02, Pri12]
A(t) ≡ −dN(t)
dt
= λN(t) = λN0e
−λt = A0e
−λt [Bq], (4.1)
where λ is the decay constant and N the radionuclide number, λ is given by
λ ≡ lim
∆t−→0
(∆N/N)
∆t
[s−1],
and is specific of each radionuclide. If only one type of β+ emitter is contributing or if there
is a predominant contribution from a specific species over all others, the activity can be calculated
easily. However, multiple concentrations of β+ emitters are typically produced by the primary beam
interactions with the target.
The decay evolution in an online scenario at time t, where production and decay compete, is
described analytically by the differential equation[SF02]
dN(t)
dt
= Q(t)− λN(t), (4.2)
where Q(t) is the production rate of the specific radionuclide in [nuclei s−1], its solution can be
obtained in the form of
N(t) = N0e
−λt +
∫ t
0
Q(t′)e−λ(t−t′)dt′, (4.3)
where N0 stands for the initial number of radionuclides[SF02]. If Q(t) is constant, then
N(t) = N0e
−λt +
Q
λ
(
1− e−λt
)
. (4.4)
In a more complex scenario, described in a previous work[PBH08] for a synchrotron with spills
of a certain duration (ts) and respective pauses (tp), the activity evolution of a certain β+ emitter
can be described for the first spill as
A(t) = Q
(
1− e−λt
)
0 < t < ts, (4.5)
with the decay ensuing during the subsequent pause being described as
A(t) = Q
(
1− e−λts
)
e−λ(t−ts) ts < t < ts + tp. (4.6)
Consequently, the number of decays of a β+ emitter, in an acquisition time ∆t, is given by
N(t,∆t) =
∫ t+∆t
t
A(t′)dt′, (4.7)
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provided that a 100% β+–decay branching ratio applies. For an in beam PET acquisition, the
two contributions pertaining in–spill and inter–spill PET acquisitions, for S spills, can be identified
as detailed in the above mentioned work[PBH08]. The number of radionuclides of a certain type
decayed during spill (Ns) and respective pauses (Np) being as:
In–spill:
Ns = S
[
Qts −
Q
λ
(
1− e−λts
)]
+
Q
λ
(
1− e−λts
)2
e−λtp
S−1∑
i=1
(S − i) e−(i−1)λ(ts+tp), (4.8)
Inter–spill:
Np =
Q
λ
(1− e−λts)(1− e−λtp)
S−1∑
i=1
(S − i)e−(i−1)λ(ts+tp) (4.9)
The online PET acquisition scenario described in this work would result therefore from the
sum of equations 4.9 and 4.8. Extending the PET acquisition after beam delivery by a time text, a
situation which was excluded in section 5.1 but which was considered in section 5.2, the number of
decays Next of a certain radionuclide is obtained via[PBH08]
Next =
Q
λ
(
1− e−λts
) (
1− e−λtext
) S−1∑
i=0
e−iλ(ts+tp). (4.10)
Finally, for both an offline/in–room PET acquisition[PBH08], spanning from t1 to t2 = t1 + ∆t, the
amount of decays Noff of a certain species is calculated with:
Noff =
Q
λ
(1− e−λts)e−λt1(1− e−λt2)
S−1∑
i=0
e−iλ(ts+tp). (4.11)
The scenarios depicted above can be also converted for a cyclotron, by employing a single spill
of time ts without tp and S = 1 in equations 4.8, 4.10 and 4.11[PBH08].
It is expected that the higher signal emission from RIβ+ could lead to PET detection im-
provements within the acquisition time interval ∆t. The average radioactivity Aa available for an
acquisition can be estimated with
Aa =
A0
λ∆t
(
1− e−λ∆t
)
, (4.12)
with the caveat that, depending on the PET sensitivity, the expected count rates actually
acquired by the setup may vary. Furthermore, assessing the evolution of the β+ emitters distribution
with respect to a set of possible time acquisition windows, enables understanding which ion beams
are actually more adequate in the PET acquisition modalities considered (e.g. online and offline
PET ).
This information complements the aforementioned discussed data on the magnitude of annihila-
tion events at rest for the various SOBPs, enabling a deeper understanding of the reaction channels
involved. In order to find which isotopes are “parenting” the β+ emission, evaluating their individ-
ual impact on the annihilation events at rest mapped throughout the different acquisition times, it
was necessary to implement:
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1. An irradiation with a suitable beam time structure profile;
2. Acquisition times compatible with clinical applications;
3. Simulations that were no longer time integrated, scoring the rates of annihilation events at
rest, at different time stamps.
This required implementing additional settings such as RADDECAY, DCYTIMES and IRRPROFI in
the FLUKA simulation, to reproduce the appropriate irradiation and acquisition pattern. The
chosen time structure and acquisition settings for SOBPs of 11C, 12C, 15O and 16O in water is
shown in table 4.3, consisting of the intensities, in 106 ions/s and the spill spawn time, in seconds.
Table 4.3: Intensities [106 ions s−1] for each of the 16 isoenergetic layers to attain a SOBP of 1 Gy, at 10 cm
in water, including the respective intervals ∆t, in seconds, as implemented in IRRPROFI card in FLUKA.
Layer ∆t 11C ∆t 12C ∆t 15O ∆t 16O
1 5 5.8042 5 5.5668 4 4.7645 4 4.5303
– 4 0 4 0 4 0 4 0
2 1 5.977 1 5.8649 1 4.367 1 4.0035
– 4 0 4 0 4 0 4 0
3 5 5.2526 5 4.9536 4 4.2475 4 4.1038
– 4 0 4 0 4 0 4 0
4 2 5.536 2 5.5325 2 3.858 2 3.4704
– 4 0 4 0 4 0 4 0
5 5 5.1996 5 4.7266 4 4.1393 4 3.9848
– 4 0 4 0 4 0 4 0
6 3 5.191 3 5.173 2 5.258 2 4.9076
– 4 0 4 0 4 0 4 0
7 5 5.3716 5 4.951 4 4.2688 4 4.1258
– 4 0 4 0 4 0 4 0
8 4 5.119 4 4.9088 3 4.5593 3 4.243
– 4 0 4 0 4 0 4 0
9 5 5.8864 5 5.4756 4 4.6988 4 4.5053
– 4 0 4 0 4 0 4 0
10 5 5.2884 5 5.0324 4 4.3215 4 4.0828
– 4 0 4 0 4 0 4 0
11 5 6.9016 5 6.4454 5 4.405 5 4.1482
– 4 0 4 0 4 0 4 0
12 5 7.0152 5 6.8298 5 4.6532 5 4.355
– 4 0 4 0 4 0 4 0
13 5 9.1966 5 8.5708 6 4.8248 6 4.5332
– 4 0 4 0 4 0 4 0
14 5 10.943 5 10.639 7 5.0116 7 4.8343
– 4 0 4 0 4 0 4 0
15 5 15.01 5 14.908 7 7.1324 7 6.8716
– 4 0 4 0 4 0 4 0
16 5 39.736 5 37.566 8 15.039 8 14.919
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An irradiation time of ∼130 s was considered in every irradiation scenario. The irradiation
length and intervals chosen for this work was based on values found in literature for synchroton–
like beam time structure with 12C ions, which reported 5 s long spills with few seconds of interval
in between them[Mar11]. In this work the beam pauses were of 4 s and the spill time was not fixed,
but varied typically around the 5 s value for carbon ions. Such extended spill time intervals are still
technically feasible but can affect the PET imaging quality, due to the combination of background
and biological washout contributions.
Furthermore, in this work, the spill distribution varied slightly between carbon and oxygen ion
species as shown in table 4.3, even though the overall beam time of 130 s was kept unchanged. It
was decided to keep the beam delivery profile of oxygen ions consistent with that of carbon ions
in most layers, preserving at least a minimum of ∼ 4× 106 ions/s spill intensity and thus reducing
the spill time in some of the initial layers. Since the pause times were kept constantly at 4 s, the
last layers’ spill times were consequently extended considerably with respect to carbon ions. The
carbon ion intensities chosen varied within ∼ 5× 106 − 4× 107 ions/s and were similar to those in
the experiment previously reported, namely ∼ 5×106−8×107 ions/s[Mar11]. As for the sequence of
irradiation, it took place from the lowest isoenergetic layer to the highest, following the procedure
done at GSI and also initially undertaken at HIT.
Furthermore, even though there were 625 beam spots disposed in a squared grid for each of the
16 isoenergetic layers, the time structure “within spill”, for any given energy layer, was neglected.
Note that for very short–lived beams and/or a more realistic online acquisition evaluation the fully
detailed time structure should be accounted for. Therefore, to reproduce the beam time structure,
only 16 major intervals of irradiation, or spills, and 15 pauses were considered in the IRRPROFI
card. Note that the values presented in table 4.3 result from the number of particles delivered (IS)
for each isoenergetic layer, directly from ival.dat file, corresponding to 1 Gy SOBP.
With the time structure properly defined, some intervals–of–interest to score the rates of anni-
hilation events at rest were selected, for their relevance in clinical context.
Beam Time Structure
FLUKA DCYTIMES 1 2 3 4 5 6
Figure 4.13: DCYTIMES and DCYSCORE are time values, in seconds, relative to the end of beam (EOB), which is
denoted as DCYTIMES #3. This latter value can be considered the origin (0) in the beam time structure.
The time stamp values, in seconds and with respect to the origin of the beam time structure
(DCYTIMES #3), considered in figure 4.13 are listed below:
1 -125 (for carbon ions) or -126 (oxygen ions); End of first layer.
2 -63 (for carbon ions) or -70 (for oxygen ions); End of 9th layer.
3 0 (EOB)
4 60
5 300
6 600
The choice of decay time stamps, including values during irradiation time up to 10 minutes
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afterwards, ensured the inclusion of most fragments of interest in this analysis, even short lived β+
emitters. An illustration of how decay will affect the annihilation events rate, in time, is shown in
figure 4.14.
EOB
On
Time
Ev
en
ts
/s
Figure 4.14: Scheme illustrating how decay during beam time can affect the event rates seen during acquisitions
both before and after EOB. The green line denotes the annihilation event rate [Events/s] trend observed for a single
β+ emitter, whereas the blue line denotes the beam time structure, with “On” meaning that a spill is being delivered.
This depiction is not numerically accurate.
An example of a qualitative assessment of rate of the annihilation events at rest 2D distribution,
obtained at 5 minutes after EOB, is shown in figure 4.15. This example is relevant for it corresponds
to the decay time at which rates of annihilation events at rest resulting from 11C and 15O are
equivalent.
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Figure 4.15: Rates of annihilation events at rest for the different SOBPs, at 5 minutes after EOB.
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In figure 4.16 the distribution of annihilation events at rest is obtained in time–integrated
mode, hence with the FLUKA card RADDECAY set to semi–analogue, to include all events in time
and provide a broader overview of the species contributing to the total signal acquired.
The subsequent figures 4.17 and 4.18 depict the rates of annihilation events at rest [events
s−1] at the decay times studied, discriminated by parent isotope. The accounting of the different
contributions was accomplished in FLUKA by filtering out the parent isotope information using
comscw.f with the code given in the appendix A.
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Figure 4.16: Total annihilation at rest events of different primary beams, stable (on the right) and radioactive (on
the left), integrated over time and filtered according to parent isotope, for SOBPs of 1 Gy at 10 cm in water. The
dose profile of the SOBP is superimposed, in arbitrary units.
4.2 Imaging potential of radioactive ion beams 101
E
ve
nt
s/
s
 1
 10
 100
 1000
 10000
 100000
0 5 8.5 11.5 15 20
E
v
e
n
ts
 p
e
r 
s
e
c
o
n
d
Depth in water (cm)
Total
C-11
C-10
C-9
B-8
N-12
N-13
O-13
O-15
O-14
Ne-19
Ne-18
1
st
 peak
(a) 11C
 1
 10
 100
 1000
 10000
 100000
0 5 8.5 11.5 15 20
E
v
e
n
ts
 p
e
r 
s
e
c
o
n
d
Depth in water (cm)
Total
C-11
C-10
C-9
B-8
N-12
N-13
O-13
O-15
O-14
Ne-19
Ne-18
Ne-17
F-17
SOBP (9)
(b) 11C
 1
 10
 100
 1000
 10000
 100000
0 5 8.5 11.5 15 20
E
v
e
n
ts
 p
e
r 
s
e
c
o
n
d
Depth in water (cm)
Total
C-11
C-10
C-9
B-8
N-12
N-13
O-13
O-15
O-14
Ne-19
Ne-18
Ne-17
F-17
SOBP
(c) 11C
E
ve
nt
s/
s
 1
 10
 100
 1000
 10000
 100000
0 5 8.5 11.5 15 20
E
v
e
n
ts
 p
e
r 
s
e
c
o
n
d
Depth in water (cm)
Total
C-11
C-10
C-9
B-8
N-12
O-15
O-13
O-14
Ne-19
Ne-18
F-17
1
st
 peak
(d) 12C
 1
 10
 100
 1000
 10000
 100000
0 5 8.5 11.5 15 20
E
v
e
n
ts
 p
e
r 
s
e
c
o
n
d
Depth in water (cm)
Total
C-11
C-10
C-9
B-8
N-12
N-13
O-13
O-15
O-14
Ne-19
Ne-18
F-17
SOBP (9)
(e) 12C
 1
 10
 100
 1000
 10000
 100000
0 5 8.5 11.5 15 20
E
v
e
n
ts
 p
e
r 
s
e
c
o
n
d
Depth in water (cm)
Total
C-11
C-10
C-9
B-8
N-12
N-13
O-13
O-15
O-14
Ne-19
Ne-18
Ne-17
F-17
SOBP
(f) 12C
E
ve
nt
s/
s
 1
 10
 100
 1000
 10000
 100000
0 5 8.5 11.5 15 20
E
v
e
n
ts
 p
e
r 
s
e
c
o
n
d
Depth in water (cm)
Total
C-11
C-10
C-9
B-8
N-12
N-13
O-15
O-13
Ne-18
1
st
 peak
(g) 15O
 1
 10
 100
 1000
 10000
 100000
0 5 8.5 11.5 15 20
E
v
e
n
ts
 p
e
r 
s
e
c
o
n
d
Depth in water (cm)
Total
C-11
C-10
C-9
B-8
N-12
N-13
O-13
O-15
O-14
Ne-19
Ne-18
F-17
SOBP (9)
(h) 15O
 1
 10
 100
 1000
 10000
 100000
0 5 8.5 11.5 15 20
E
v
e
n
ts
 p
e
r 
s
e
c
o
n
d
Depth in water (cm)
Total
C-11
C-10
C-9
B-8
N-12
N-13
O-15
O-14
O-13
Ne-19
Ne-18
Ne-17
F-17
SOBP
(i) 15O
E
ve
nt
s/
s
 1
 10
 100
 1000
 10000
 100000
0 5 8.5 11.5 15 20
E
v
e
n
ts
 p
e
r 
s
e
c
o
n
d
Depth in water (cm)
Total
C-11
C-10
C-9
B-8
N-12
N-13
O-13
O-15
O-14
Ne-18
1
st
 peak
(j) 16O
 1
 10
 100
 1000
 10000
 100000
0 5 8.5 11.5 15 20
E
v
e
n
ts
 p
e
r 
s
e
c
o
n
d
Depth in water (cm)
Total
C-11
C-10
C-9
B-8
N-12
N-13
O-13
O-15
O-14
Ne-19
Ne-18
F-17
SOBP (9)
(k) 16O
 1
 10
 100
 1000
 10000
 100000
0 5 8.5 11.5 15 20
E
v
e
n
ts
 p
e
r 
s
e
c
o
n
d
Depth in water (cm)
Total
C-11
C-10
C-9
B-8
N-12
N-13
O-13
O-15
O-14
Ne-19
Ne-18
Ne-17
F-17
SOBP
(l) 16O
Figure 4.17: Instantaneous annihilation events at rest rate [Events/s], filtered by parent isotope for SOBPs of 1
Gy at 10 cm in water, at the time corresponding to the end of first energy layer (1st column), end of ninth energy
layer (2nd column) and EOB (3rd column). The SOBP dose profile is superimposed (arbitrary units).
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Figure 4.18: Annihilation at rest event rate in events/s, for SOBPs of 1 Gy at 10 cm in water, according to parent
isotope, at 5 minutes (a–d) and 10 minutes after EOB (e–h). The SOBP profile is superimposed (arbitrary units).
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As illustrated in figure 4.16, one can observe that indeed the major contributors to the overall
annihilation events at rest are 11C and 15O. In particular, for irradiations with radioactive beams,
the aforementioned radioactive species contribute with over 95% of the time integrated annihilation
event, at the peak value. The contribution of 15O is seen to lead to a major background effect, over
70% of the total production, out of the SOBP target region, in all irradiation scenarios. This is
mainly due to the 15O target fragmentation production which is dominant in the considered water
target. Regarding 12C irradiation, the observed abundances of 11C and 10C are in line with cross
section data collected for 250 MeV/u 12C ions in water, corresponding to approximately 56± 4 and
5 ± 0.8 mbarn, respectively[Fie11]. For 16O irradiations at 290 MeV/u in water, the cross sections
of 15O, 11C, 13N and 10C correspond to approximately 28, 16, 6 and 1.7 mbarn[Fie11], with these
proportions being approximately in line with the abundances verified in the simulation as well.
Through the irradiation, multiple species contribute to the total rate of annihilation events at
rest (figure 4.17). For the 11C ion irradiation, 10C and 11C each account for almost ∼ 45% of the
events observed at SOBP target region, with less than 10% being ascribed to 8B and other species.
In the 12C ion SOBP target region, during irradiation, the rate of annihilation events at rest is
mainly composed of 10C (∼ 50%) and to a less degree 8B, with the 11C contribution building up
later on. In SOBPs of 15O and 16O, during irradiation, the contribution of 15O predominates over
all others. For the 15O ion SOBP, one observes that its advantageous distribution at the distal zone
of the annihilation event at rest rate is already present at EOB time, whereas for the 11C ion SOBP
this is not the case, due to the longer half–life of 11C compared to 15O. At EOB, in figure 4.17,
the peak value for RIβ+ annihilation rates is at least one order of magnitude higher than in stable
ion beam irradiations, and its range coincides with the distal edge of the SOBP dose profile. For
15O it peaks at ∼ 40 000 events/s while for 11C it surpasses slightly the 10 000 events/s threshold.
At 5 min after EOB, as depicted in figures 4.18 and 4.15, the annihilation event rate distribution
is comparable for both RIβ+ irradiation cases (∼ 6 000 events/s) and is here seen to be strongly
dominated by the primary ion species, a trend that is observed also later at 10 min after EOB. For
the RIβ+ irradiations, both the rates of annihilation events at rest and the SOBP dose profiles are
seen to coincide at their respective distal–fall off.
At 10 min after EOB, as seen in figure 4.18, 11C annihilation rate at the peak region is only
slightly below 6 000 events/s, but it is almost a factor 6 higher than 15O, which in the meanwhile
underwent a strong decay. Nevertheless, the rates of annihilation events at rest resulting from
RIβ+ irradiations are at least one order of magnitude higher than the rates resulting from stable
ion beams, at the peak value.
As previously mentioned, the gain is more evident distally, in view of the irradiation sequence.
The last energy layer, and leading dose peak, is the least affected by the ongoing decay as it is
generated only at the end of the irradiation and has consequently less time to decay.
From these simulation results, one can estimate that the annihilation events at rest gain with
RIβ+ is more than an order of magnitude compared to stable ion beams. Moreover, this higher
annihilation rate magnitude is seen to be more advantageously localized within the SOBP target
region throughout the time stamps under analysis. The annihilation rate observed for SOBPs of
15O ions outperforms that of 11C ion SOBPs until up to 5 minutes after EOB, underperforming
from then onwards as consequence of 15O decay. The general decay trend is in line with the half–life
of the respective primary beam ions for RIβ+, since their effect dominates after the EOB.
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Chapter 5
Computational and experimental assessment
of radioactive ion beams for PET imaging
“(...) Leben Sie jetzt die Fragen. Vielleicht leben Sie dann allmählich, ohne es zu merken, eines fernen
Tages in die Antwort hinein.”
— Rainer Maria Rilke, Briefe an einen jungen Dichter (1908)
5.1 Dosimetric and imaging results using a synchrotron–like TP
5.1.1 Verification of Bragg Peaks of 12C and 16O ion beams
A demonstration that the Bragg Peak energy deposition results using an established TPS (see
section 3.1) could be compared directly with those produced in this study was performed, ensuring
the latter validity. The SOBPs simulated with FLUKA in this work are based on calculations in
water for the geometry defined in figure 3.1, using approximate elements of the HIT beam line. The
initial kinetic energy and number of particles employed to generate each Bragg Peak (ES, IS) were
obtained using the procedure described in chapter 3 and detailed in the appendix A.
These results were compared with 12C SOBPs at 10 cm in water, recalculated using FLUKA
based on data from HIT’s oldtps, and can be seen in figure 5.1. As previously stated in chapter
3, oldtps stands for an earlier version of the research TPS, meanwhile outdated. The parameters
used in the recalculation with FLUKA to generate the SOBP consisted of the isoenergetic layer
energy value and number of particles, ET, IT, respectively.
Additionally, data from the newer version of the research TPS (newtps) were provided for this
test purpose only, already in SOBP form as a FLUKA simulation result[Tes16a]. This aforementioned
SOBP data was therefore optimized using updated beam line elements, hence being denoted as
“calibrated” (i.e. cross–checked). The isoenergetic beam layer energy and ion number employed
were not disclosed but, in the normalization for its plotting in figure 5.1, the overall number of
particles delivered was assumed to be equal to IT.
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Figure 5.1: Comparison of the 12C SOBP centered at 10 cm depth in water calculated in this work with oldtps
research TPS data, recalculated with FLUKA. The newtps result (courtesy of T. Tessonnier) is also plotted.
All the SOBP considered in figure 5.1 were laterally integrated over a surface of 20 × 20 cm2
and plotted in range in intervals of 1 mm. To compare the lateral profile, newtps and this works’s
SOBP FLUKA simulation were plotted directly in figure 5.2, integrating over their respective
SOBP plateau. The oldtps data was not included in figure 5.2 since its recalculation was laterally
integrated over a single binning unit.
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Figure 5.2: Comparison of the 12C SOBP lateral profile calculated in this work with newtps research TPS
version (this latter gently provided by T. Tessonnier). Both results are integrated over the SOBP plateau.
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Nevertheless, an 0.4 mm shift lies within the 0.5 mm tolerance and is within the fluctuations that
can be observed when repeating measurements in subsequent days.
Table 5.1 summarizes the benchmarked SOBP and pristine Bragg Peak characteristics in figures
5.1, 5.2 and 5.3. The peak to entrance ratio (per) is defined as the ratio between the dose value
at the proximal edge, in case of a SOBP, with respect to the dose value at the water phantom
entrance (see chapter 4 figure 4.10). For a pristine Bragg Peak, the peak value is used instead. The
value ∆W50% is the length, in range, between the half proximal edge value and the half dose value
at the distal edge. As for the distal fall–off value, it consists of the distance in range between its
decreasing from 90 to 10% of the distal edge value (again as depicted in chapter 4 figure 4.10). The
FWHM value was calculated considering the lateral profiles obtained in figure 5.2.
Table 5.1: Quantitative evaluation of the SOBPs and Pristine Bragg Peaks characteristics.
SOBP Pristine Peak
Characteristic oldtps newtps This work newtps This work
per 1.754 1.791 1.754 6.168 6.294
∆W50% [cm] 4.2± 0.1 4.0± 0.1 4.3± 0.1 0.35± 0.01 0.35± 0.01
Distal fall–off [mm] 2.0± 0.1 1.5± 0.1 2.1± 0.1 0.97± 0.01 1.06± 0.01
FWHM [cm] — 5.0± 0.1 5.0± 0.1 — —
Ions delivered 6.00× 108 (IT) ≡ IT 6.07× 108 (IS) — —
Since the oldtps data used in the FLUKA recalculation was based on the TRiPs code, which
in turn relied on an older FLUKA (2006) version for its basic input data and was optimized for
older beam line elements, one should expect to observe intrinsic differences with respect to the
newtps data based on a more recent version of the FLUKA code (e.g. beam deflection, nuclear
reactions). Moreover, differences ascribed to the beam line elements description, particularly for
the RiFi, lead to inconsistencies in between the E and I values used from the research TPS (T) and
from this work (S), which can be appreciated in table 5.2. The impact of range shifts was mitigated
by employing ES data fitted from a database, generated by SOBPGen.cpp, so as to match oldtps
ET range, within 100–300 µm accuracy. On the other hand, the intensity modulation discrepances
were more difficult to address. The research TPS recalculation, laterally integrated over a relatively
large surface (20×20 cm2), rendered satisfatory results as seen in figure 5.1 and table 5.1. However,
while extending this calculation for smaller integration volumes with lateral areas of 4× 4 cm2, it
was found that the recalculated number of ions delivered for each of the Pristine Bragg Peaks, or
the Supra.cpp IS values for each isoenergetic layer, did not match oldtps data IT values.
The main reason for this discrepance is that the recalculated oldtps plan was found to homo-
geneously yield 0.95 Gy in a 4 × 4 cm2 surface at the SOBP region, instead of 1 Gy for 12C in
water at 10 cm in range, hence translating into ∼ 15.2 [Gy cm2]. Consequently, the energy depo-
sition results obtained in the reduced volume differed systematically whenever directly compared.
Increasing the volume would lead to a better agreement, but the dose homogeneity in this work
was seen to deteriorate steeply beyond the 4× 4 cm2 surface, as one can see in figure 5.2 where the
dose falls by approximately two orders of magnitude between 2 and 2.5 cm from the isocenter, a
trend that is indeed confirmed by newtps data.
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Table 5.2: This works’ simulated (S) and oldtps research TPS TRiP parameters (T) for stable beams. The
comparison is done directly for each of the 16 isoenergetic layers and the three different SOBP depths, namely 10
cm (top), 15 cm (middle) and 20 cm (bottom) in water; E – initial kinetic energy (MeV/u), I – number of ions
(×106 ions), ea and er – absolute and relative error, respectively. Each of the error values for a given isoenergetic
layer pertain either IS and ES and use respectively IT and ET as reference.
layer 12C 16O
# ES IS ET IT er(E)[%] ea(I) ES IS ET IT er(E)[%] ea(I)
1 205.26 26.509 206.91 20.585 0.80 –5.92 243.33 17.363 244.15 12.539 0.34 –4.82
2 207.88 6.324 209.53 12.676 0.79 +6.35 246.48 4.622 247.26 8.914 0.32 +4.29
3 210.48 23.957 212.12 18.284 0.77 –5.67 249.61 15.295 250.36 11.219 0.30 –4.08
4 213.06 11.197 214.70 16.344 0.76 +5.15 252.72 8.073 253.54 11.546 0.32 +3.47
5 215.62 23.346 217.25 18.941 0.75 –4.41 255.80 14.609 256.59 11.530 0.31 –3.08
6 218.16 15.543 219.79 19.060 0.74 +3.52 258.87 10.804 259.55 12.231 0.26 +1.43
7 220.68 24.037 222.31 20.724 0.73 –3.31 261.91 15.264 262.65 13.792 0.28 –1.47
8 223.18 19.845 224.81 22.084 0.73 +2.24 264.93 13.530 265.66 14.025 0.28 +0.50
9 225.67 26.465 227.29 24.207 0.71 –2.26 267.94 17.006 268.64 15.428 0.26 –1.58
10 228.14 25.163 229.76 26.382 0.71 +1.22 270.92 16.853 271.59 16.644 0.25 –0.21
11 230.60 31.119 232.20 30.051 0.69 –1.07 273.89 20.233 274.51 18.281 0.23 –1.95
12 233.04 33.640 234.64 36.096 0.68 +2.46 276.84 21.771 277.41 20.998 0.21 –0.77
13 235.46 42.035 237.05 42.972 0.67 +0.94 279.77 27.037 280.29 25.179 0.19 –1.86
14 237.87 52.132 239.45 67.295 0.66 +15.16 282.69 33.596 283.19 33.319 0.18 –0.28
15 240.27 73.419 241.84 18.694 0.65 –54.73 285.59 47.362 286.05 38.701 0.16 –8.66
16 242.65 186.63 243.03 205.22 0.16 +18.59 288.47 118.29 288.92 130.79 0.16 +12.50
Total – 621.36 – 599.62 – –21.74 – 401.71 – 395.14 – –6.57
1 265.79 29.860 267.20 24.624 0.53 –5.24 316.48 20.849 316.67 16.624 0.06 –4.23
2 268.04 7.922 269.43 13.357 0.52 +5.44 319.21 4.915 319.29 7.848 0.03 +2.93
3 270.28 26.538 271.66 20.574 0.51 –5.96 321.92 18.663 321.97 14.182 0.02 –4.48
4 272.51 13.427 273.88 18.028 0.50 +4.60 324.62 8.943 324.64 11.733 0.01 +2.79
5 274.73 25.396 276.09 20.263 0.49 –5.13 327.31 17.435 327.31 16.593 0.00 –0.84
6 276.94 18.615 278.29 20.934 0.49 +2.32 329.99 12.358 331.25 20.455 0.38 +8.10
7 279.14 26.208 280.48 22.574 0.48 –3.63 332.65 17.730 333.91 12.452 0.38 –5.28
8 281.33 23.058 282.67 24.275 0.47 +1.22 335.31 15.686 336.58 18.191 0.38 +2.51
9 283.51 29.448 284.84 27.115 0.47 –2.33 337.95 19.135 339.22 17.054 0.37 –2.08
10 285.69 29.304 287.02 30.630 0.46 +1.33 340.58 19.235 341.84 20.205 0.37 +0.97
11 287.85 35.808 289.18 34.873 0.46 –0.94 343.20 22.990 344.44 22.094 0.36 –0.90
12 290.00 39.481 291.34 42.451 0.46 +2.97 345.81 25.195 347.03 28.124 0.35 +2.93
13 292.15 49.573 293.50 50.017 0.46 +0.44 348.41 31.645 349.64 22.839 0.35 –8.81
14 294.29 60.601 295.65 79.946 0.46 +19.35 350.99 39.334 350.95 28.601 0.01 –10.73
15 296.41 82.440 297.79 17.966 0.46 –64.47 353.57 54.510 353.56 50.580 0.00 –3.93
16 298.53 236.24 298.87 248.27 0.11 +12.03 356.14 150.10 356.20 155.57 0.02 +5.47
Total – 733.92 – 695.90 – –38.02 – 478.72 – 463.15 – –15.57
1 319.28 34.357 320.07 27.612 0.25 –6.75 381.33 24.603 381.74 19.301 0.11 –5.30
2 321.31 7.981 322.17 15.364 0.27 +7.38 383.80 5.745 384.27 10.516 0.12 +4.77
3 323.33 30.650 324.26 22.908 0.29 –7.74 386.27 21.822 386.77 15.812 0.13 –6.01
4 325.35 14.808 326.34 20.582 0.30 +5.77 388.73 10.020 389.28 14.906 0.14 +4.89
5 327.36 29.049 328.41 23.052 0.32 –6.00 391.18 20.979 391.82 16.446 0.16 –4.53
6 329.36 20.064 330.48 26.491 0.34 +6.43 393.63 13.406 394.31 14.000 0.17 +0.59
7 331.36 30.754 332.98 31.939 0.49 +1.19 396.07 21.061 396.17 18.093 0.03 –2.97
8 333.35 26.193 334.94 24.304 0.48 –1.89 398.50 17.186 399.77 26.634 0.32 +9.45
9 335.33 34.031 336.89 33.610 0.46 –0.42 400.92 22.612 402.13 14.553 0.30 –8.06
10 337.31 34.818 338.83 36.182 0.45 +1.36 403.34 22.015 404.50 24.957 0.29 +2.94
11 339.28 42.495 340.77 25.282 0.44 –17.21 405.76 27.484 406.83 24.209 0.26 –3.28
12 341.24 46.215 341.73 52.850 0.14 +6.64 408.17 29.923 408.92 20.655 0.18 –9.27
13 343.20 58.298 344.94 102.29 0.50 +43.99 410.57 38.354 410.71 42.047 0.03 +3.69
14 345.15 73.221 346.42 15.468 0.37 –57.75 412.96 47.097 414.33 77.468 0.33 +30.37
15 347.10 89.093 347.90 84.105 0.23 -4.99 415.35 65.060 – – – –65.06
16 349.04 299.82 349.37 270.40 0.10 -29.42 417.74 187.60 417.90 206.77 0.04 +19.17
Total – 871.85 – 812.44 – –59.41 – 574.97 – 546.37 – –28.60
The stable ion beam SOBPs calculated in this work for 10, 15 and 20 cm depths in water at the
SOBP center are shown in figures 5.4 and 5.5, modulated in number of ions at each isoenergetic
layer according to IS and IT, laterally integrated over a 4 × 4 cm2 surface. For the reasons
already mentioned, the oldtps parameter IT does not match this works’ results for the number
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of ions, IS. In addition, it is also shown on the right side of figures 5.4 and 5.5 the individual
peak disentanglement from the respective SOBP (DT), so as to verify whether the number of
ions calculated at each isoenergetic layer was adequate. This verification was necessary, since
considerable deviations between the calculated and TPS number of particles delivered could denote
an inconsistency with the methodology adopted to generate the IS values. Moreover, the number
of ions delivered in time and at each spill, and hence energy layer, would affect the PET acquisition
simulation results. This is particularly true for online PET acquisitions, but to a lesser degree also
for in room and offline PET acquisitions.
In the figures 5.4 and 5.5, only the last SOBP in range is shown disentangled, this had to do
with the fact that, from the data presented in table 5.2, it was found that these SOBPs have highest
discrepance between IT and IS. Hence they represent a worst case scenario, more interesting for
the present work analysis. Indeed, both in 12C and 16O SOBPs, and even in the worst case scenario
detailed, it appears that the deviations are almost entirely ascribed to the systematic deviation with
respect to the oldtps ion number, with the relative weight of each pristine Bragg Peak seemingly
adequate.
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Figure 5.4: (a) 12C SOBPs as obtained by this work’s FLUKA simulations (IS), and using TRiP’s plan infor-
mation (IT ) in the FLUKA recalculation, at different ranges in water. (b) 12C SOBP’s individual peaks’ disentan-
glement detailed at 20 cm range.
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Figure 5.5: (a) 16O SOBPs as obtained by this work’s FLUKA simulations (IS), and using TRiP’s plan infor-
mation (IT ) in the FLUKA recalculation, at different ranges in water. (b) 16O SOBP’s individual peaks’ disentan-
glement detailed at 20 cm range.
Summarizing, it has been found that:
• The tools devised in this work led to a good agreement with the data laterally integrated in
the water phantom, as in table 5.1. The energy parameters employed, based on the oldtps
research TPS version and employing beam line approximations, matched the newtps data in
range within 0.4 mm, provided the RiFi was removed for the comparison and some relevant
simulation parameters were adapted (water density and ionization potential).
• For volumes with smaller lateral width, namely 4 × 4 cm2, the intensity modulation result
agreement with oldtps deteriorated, although the lateral profile was inline with the newtps
values, as displayed in figure 5.2. The oldtps data provided, integrated over a 4 × 4 cm2
surface, was found by HIT colleagues to attain 95% of the expected dose[Tes16b] and this has
been also reflected in the total number of ion values calculated and the deviations in table
5.2, which ranged between ∼ 1 and 7 % for 16O SOBPs at 10 cm and 12C at 20 cm range,
respectively.
• Regarding the individual Bragg Peaks composing the SOBP, both the number of ions calcu-
lated in this work’s models and recalculated from the oldtps are not completely in line, even
if a 5% factor is accounted for in table 5.2. Nevertheless, the SOBP shape and the individual
Bragg Peaks trend observed in the right side of figures 5.4 and 5.5 indicates major similarities
in the way that both SOBPs are constructed. This is also supported by observations when
comparing IS and IT values in table 5.2.
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• Irrespective of the inconsistencies mentioned, no range discrepance above 300 µm was observed
in between the SOBPs predicted ranges’ for 12C and 16O. The methodology employed to
generate IS was seen to render nominal values of 16 [Gy cm2] for all scenarios simulated and
was seen to be in line with the 12C newtps data provided by HIT.
5.1.2 Extrapolation for radioactive ion beam SOBPs in a water phantom and in a
voxelized patient’s head geometry
In spite of the fact that the SOBPs produced differed from the recalculated oldtps TRiP data,
they match well newtps 12C data as previously mentioned. Therefore it will be assumed that
the methodology employed can be extended to RIβ+, in view of the arguments discussed in the
previous section.
The method was seen to be able to use FLUKA simulation data to obtain beam kinetic energy
and number of ions for each isoenergetic layers (ES, IS) to generate SOBPs of 12C and 16O within the
range intervals and at the nominal dose levels required, namely 1 Gy or 16 Gy cm2. An extrapolation
was performed for radioactive ion beams of 11C and 15O, in order to obtain comparable SOBPs,
these results are shown in figure 5.6:
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Figure 5.6: Radioactive ion beams’ SOBPs at different ranges in water, as obtained by FLUKA (IS) in water.
The next step included a patient head voxel scenario, instead of water, with comparable SOBPs
of both stable and RIβ+ being obtained at equivalent ranges in the voxelized geometry[Bat16]. The
full process of SOBP creation was accomplished in steps, the complete procedure is detailed in the
appendix A: “Auxiliary programs”.
Additionally, the Siemens Biograph mCT (TrueV) PET setup created in chapter 3 and shown
in figure 3.7, was adapted to the present geometry, as depicted in figure 5.7. This enabled the
generation of reconstructed images while accounting for the beam time structure and PET acqui-
sition intervals in an in beam PET mode, diverging effectively from HIT’s offline PET procedure.
Finally, it allowed the testing of the FLUKA PET tools’ in its first application to an in beam
PET scenario[Au18a].
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The reconstructed images were then evaluated in order to assess the four ions’ performance in
different therapy modalities. These PET acquisition modalities, time and intensity parameters,
were (arbitrary) variations of feasible scenarios at GSI/HIT reported in earlier works[PBH08, Sha11].
The offline and in room PET acquisition modalities spawned considerable minutes in time,
whereas the online PET acquisitions were rather short, with 130 s only. An attempt was made
to be consistent with a previous study, which reported that with 180 s online PET acquisition,
with random suppression techniques, one could obtain a (tenfold) advantage in signal acquisition
compared to a 30 minute offline PET acquisition[PBH08].
This work is not aimed at assessing the merit of any of these PET acquisition modalities or
compare the results with literature, since the present work is only a simulation and a rather simple
one. Instead, it will be attempted to highlight the merit of the different beam species for imaging
with comparable dose delivery.
As the voxel phantom contained an heterogeneous material/density distribution, the previous
methodology to calculate the total number of ions delivered in chapter’s 3 equation 3.3 was re-
placed with a more complex, differential evolution iterative optimization method gently provided
by W.S. Kozłowska, yielding the values displayed in table 5.3[KV17]:
Table 5.3: Parameters for SOBPs of 1 Gy, centered at 10 cm depth in an anthropomorphic voxel phantom; E –
initial beam kinetic energy (MeV/u), I – number of ions (×106 ions).
Layer 11C 12C 15O 16O
# E I E I E I E I
1 229.13 52.650 217.82 46.714 268.37 24.665 258.43 32.601
2 231.95 5.529 220.49 7.226 271.70 13.299 261.64 0.049
3 234.75 0.025 223.15 7.694 275.01 9.642 264.84 8.531
4 237.54 42.360 225.79 23.886 278.30 4.071 268.01 19.414
5 240.30 3.169 228.40 22.015 281.58 12.239 271.16 4.885
6 243.05 25.547 231.00 3.554 284.83 29.029 274.30 17.635
7 245.77 28.181 233.58 43.937 288.06 0.088 277.41 7.786
8 248.48 13.934 236.15 15.128 291.28 23.517 280.51 26.980
9 251.17 33.514 238.70 9.189 294.48 9.740 283.58 5.336
10 253.84 22.433 241.23 41.199 297.66 20.618 286.64 12.963
11 256.49 42.132 243.74 29.842 300.82 30.285 289.68 33.360
12 259.12 27.124 246.23 37.074 303.97 14.100 292.70 26.884
13 261.73 54.307 248.71 30.128 307.10 31.405 295.70 1.099
14 264.33 35.066 251.17 42.233 310.21 27.286 298.68 49.301
15 266.91 88.235 253.61 89.073 313.31 57.370 301.64 43.972
16 269.47 218.81 256.04 212.74 316.39 136.58 304.58 140.37
Total – 693.01 – 661.63 – 443.93 – 431.16
The distributions of both dose and annihilation events at rest on the voxel, using the afore-
mentioned ion numbers and energy parameters for 15O can be, respectively, seen in figure 5.8
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The resulting Annihilation events at rest obtained during each PET acquisition time’s modality
can be seen in figure 5.10
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Figure 5.10: Annihilation Events at Rest obtained only during the considered acquisition scenarios. The SOBP
dose profile is superimposed in the plot as golden points.
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For the four SOBPs studied, while using the PET Biograph mCT in silico model and an HIT–
based approximated beam line, the reconstructed PET images were obtained throughout the various
acquisition modalities, and can be seen throughout figures 5.11–5.16. The beam time structures
were kept consistent with those stated in table 4.3, while the number of ions delivered followed
table’s 5.3 parameters.
Moreover, the number of decays observed and the subsequent coincidences detected are consis-
tent, in proportion, with previous studies reported in the literature for 12C for head irradiations at
HIT[PBH08]. Namely, an availability of physical decays for imaging estimated at ∼ 3× 106 during
spill (∼ 7 × 106 in this work), a similar value in between spills and ∼ 1.2 × 107 offline (∼ 2 × 107
in this work). The irradiation schemes and acquisition times naturally differed from those followed
in the current work and hence a direct comparison is not possible but, nevertheless, it is relevant
to mention that this work’s simulation yields are not entirely detached from reported calculations.
The offline PET acquisition is the current procedure adopted at HIT, and the sole acquisition
modality among those studied in this work which could be compared with operational data. How-
ever, the signal will be affected by the biological washout and therefore a direct comparison was
impossible. In addition, one must consider that the scanner in HIT is in a different room, thus
being less subject to activation and noise disruption, whereas in the present scenario the scanner
and beam line system is integrated as in an in beam PET scenario, even for the offline, and in room
PET acquisitions. Still, in this work the only noise background levels arise from the 130 seconds
irradiation (without accounting for the LSO radioactivity), whereas a non–negligible background
would be certain to occur after several irradiations and consequent activation of some beam line
elements. Possibly the configuration hereby employed could eventually become ineffective as the
LSO crystals become activated, lowering the true coincidences’ acquisition count rates.
Ion beam therapy PET acquisitions have lower true counts with respect to typical nuclear
medicine imaging, the amount of coincidence counts obtained in the current work is in line with the
offline 12C irradiation number of registered coincidences reported in other works[Sha11] (∼ 105−6).
Moreover, it is found generally within the typical limits of advanced image reconstruction methods’
applicability (80 000), reported in previous a work[Kur13].
In view of the prompt generated noise and typical low true count rates, which could decrease
the quality of the images beyond acceptable levels, the reconstructions were obtained using two
distinct methods:
• A version of the MLEM method, implemented in the FLUKA PET tools as a standard
by Y. Toufique, reading directly from the coincidence list file[Tou16].
• Biograph mCT FOV–optimizedMLEMmethod with Fourier rebinning and intra–reconstruction
smoothing, devised by C. Gianoli et al. and employed to the sinogram file[Gia16, Gia14].
The latter method would ensure that reconstructions were done with a more appropriate method-
ology considered, since the former was missing any noise reduction–techniques options and was not
optimized for the PET scanner model.
Both images were seen to be somewhat equivalent in contrast, differing only in generation time
and quality depending on the iteration number, as well as other parameters (e.g. corrective methods
applied such as ToF). The contrast recovery is performed in steps, converging iteratively to the
stable value. However, the noise will increase consistently with each iteration.
In the following figures 5.11–5.16, one can appreciate the results of both reconstruction methods
employed for the total coincidence events, in list mode and sinograms, respectively. In the standard
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mode the contrast is presented with a relative scale, to highlight the overall distribution of signal
emitters in all beam irradiations. On the other hand, in the optimized mode an absolute scale is
provided for each scenario to assess the difference between RIβ+ and stable ion beams resulting
contrast.
On the top left of the figures 5.11–5.16, the number of ions employed in the irradiation for each
beam species are presented in blue. For the time comprising each acquisition, it is also shown the
number of photons effectively hitting the scanner (violet) and the actual coincidence events detected
(red), in order to understand the scale of events involved in the reconstructions for each beam specie
and acquisition time. Regarding in–spill and inter–spill PET acquisitions, in figure 5.15 and 5.16
the number of ions employed in each spill is provided as taller bars while the information on the
photons hitting the scanner will be given in smaller bars. The top right panel of figures 5.11–
5.16 provides the number of coincidence events for each ion beam species in the acquisition time
considered, as well as the proportion of true, scatter and random events among the total value.
For oxygen ion beams, the highest amount of coincidence events is acquired online, attaining
∼ 106 with an 15O beam, of which two thirds are true coincidences, most definitely due to the
contribution of short lived 15O as main source of β+ emitters. For the same acquisition mode, but
irradiating with 16O, the coincidence events decrease to 60%, of which only slightly more than half
are trues. In the acquisitions after EOB one observes a steadily decrease in true coincidence events
compared with online using stable oxygen ion beams already in an in–room PET acquisition, with
a decrease of almost a factor 2 of the online “trues” count. On the other hand, the same number
of events is observed offline, albeit with a longer acquisition time. The 15O beam, on the contrary,
maintains the same level of true coincidence events during the in room PET acquisition time
compared to the online, but in the offline acquisition it halves.
Regarding carbon ion beams, the maximum number of coincidence events is acquired offline with
the 11C beam in view of the high levels of 11C produced, with slightly over 106 true coincidence
events. Using 12C beams, the number of coincidences observed decreases by sevenfold in the same
acquisition period. In an in room PET acquisition modality the difference is only a factor four,
favouring the radioactive ion beam, whose overall coincidence events decrease to about a third of
what observed during the offline PET acquisition. In the online acquisition modality, the perfor-
mance of stable ion beams is comparable in terms of true coincidence events (∼ 3× 105) while for
radioactive ion beams, 11C underperforms comparing to 15O by ∼ 25%.
When analyzing the online acquisition submodalities, namely inter–spill and in–spill, it is ob-
served that the amount of coincidence events in the latter is generally much higher than in the
former. In acquisitions during spill, the total coincidence event count varies from ∼ 5 × 105 for
16O ions to almost ∼ 8 × 105 for the radioactive oxygen ion beam, with the proportion of true
coincidence events varying from half to two thirds, respectively. As for carbon ion irradiations, the
amount of true coincidences obtained by using the radioactive ion beam (∼ 3.6×105) is only about
20% higher with respect to its stable counterpart.
While the non true coincidence events in offline modalities were only scatters, during spill the
random coincidences dominate, particularly for the stable ion irradiations were they account for
almost half of the total value.
In between spills, the difference between radioactive and stable ion irradiations is more consid-
erable. Using 15O ions, the true count increases by a factor 6, from ∼ 1.9 × 104 to 1.3 × 105. For
carbon ion irradiations, this difference is slightly less than a factor 4. Moreover, the true coinci-
dence counts acquired with radioactive oxygen ion beams are more than twice those observed in
11C irradiations.
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Therefore, there is clearly a positive impact in using radioactive ion beams, in all acquisitions,
as summarized in table 5.4.
Table 5.4: Ratio between true coincidence events acquired using radioactive and stable ion beams.
Species compared Offline in room online in–spill inter–spill
11C/12C 7.27 3.77 1.41 1.27 3.64
15O/16O 2.97 5.99 2.11 1.76 6.58
For the irradiations studied, the total coincidence count evolution in time, and their parent
isotopes are depicted in figure 5.17 and table 5.5, respectively.
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Figure 5.17: Total coincidence event counts throughout the acquisition time considered with the different beam
species, the points denote the counts without neutron background.
Table 5.5: Coincidence events filtered by parent isotope in the various acquisition modalities.
Acquisition Ion beam 8B 9C 10C 11C 12N 13N 13O 14O 15O
11C 34297 8408 102906 75156 3210 1008 485 1629 34199
Online 12C 19785 3293 16989 7937 4223 970 378 1480 31741
15O 22308 5851 22956 4856 8327 4473 2860 20748 424736
16O 15898 2917 13475 4362 3895 1599 743 3061 54472
11C 0 0 8678 360777 0 5238 0 1982 81881
In room 12C 0 0 1511 42413 0 4916 0 1922 76948
15O 0 0 1462 23025 0 17865 0 21374 747125
16O 0 0 856 20925 0 6716 0 3443 108563
11C 0 0 2 1420043 0 12904 0 225 28399
Offline 12C 0 0 0 166794 0 12364 0 227 26260
15O 0 0 1 91584 0 46198 0 2206 257537
16O 0 0 1 82399 0 17332 0 352 37564
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However, besides the qualitative enhancements in imaging and the quantified higher level of
coincidence events observed for radioactive ion beams, one must assess how these coincidences
reflect a better definition of the Bragg Peak for range monitoring. This problem is addressed in
table 5.6 and continued in table 5.7:
Table 5.6: Characterization of annihilation events at rest, coincidence event counts and the SOBP dose profile in
different acquisition scenarios for all beams considered.
Dataset Characteristic 11C 12C 15O 16O
Ions delivered 6.93× 108 6.61× 108 4.44× 108 4.31× 108
Dose SOBP Proximal edge [cm] 8.71± 0.1 8.72± 0.1 8.70± 0.1 8.80± 0.1
Distal edge [cm] 11.63± 0.1 11.63± 0.1 11.64± 0.1 11.63± 0.1
Online
max. value 47220 9487 111200 13600
Annihilation max. position [cm] 9.99± 0.01 9.60± 0.01 9.19± 0.01 9.99± 0.01
events at ∆W90% [cm] 1.67± 0.01 0.84± 0.01 2.14± 0.01 0.72± 0.01
rest ∆W50% [cm] 3.07± 0.01 5.49± 0.01 3.17± 0.01 3.87± 0.01
Distal fall–off [mm] 10.4± 0.1 45.9± 0.1 8.2± 0.1 39.4± 0.1
max. value 20407 16301† 26823 14492†
Coincidence max. position [cm] 10.3± 0.1 20.7± 0.1† 10.3± 0.1 20.7± 0.1†
event counts ∆W90% [cm] 2.3± 0.1 — 2.3± 0.1 —
(PET) ∆W50% [cm] 16.3± 0.1 — 4.1± 0.1 —
Distal fall–off [mm] 97± 1 — 91± 1 —
In–spill
max. value 28250 6991 67330 9707
Annihilation max. position [cm] 10.19± 0.01 9.99± 0.01 11.19± 0.01 10.59± 0.01
events at ∆W90% [cm] 1.34± 0.01 0.03± 0.01 1.31± 0.1 0.04± 0.01
rest ∆W50% [cm] 3.24± 0.01 5.80± 0.01 3.32± 0.1 3.48± 0.01
Distal fall–off [mm] 12.1± 0.1 45.8± 0.1 8.8± 0.1 38.2± 0.1
max. value 17786 16271† 21136 14460†
Coincidence max. position [cm] 10.3± 0.1 20.7± 0.1† 11.4± 0.1 20.7± 0.1†
event counts ∆W90% [cm] 0.9± 0.1 — 0.8± 0.1 —
(PET) ∆W50% [cm] 18.3± 0.1 — 5.0± 0.1 —
Distal fall–off [mm] 92± 1 — 87± 1 —
Inter–spill
max. value 20090 3088 51460 5152
Annihilation max. position [cm] 9.19± 0.01 8.77± 0.01 9.19± 0.01 9.34± 0.01
events at ∆W90% [cm] 0.39± 0.01 0.12± 0.01 0.71± 0.01 0.05± 0.01
rest ∆W50% [cm] 2.82± 0.01 3.66± 0.01 2.89± 0.01 2.42± 0.01
Distal fall–off [mm] 10.9± 0.1 29.6± 0.1 13.4± 0.1 23.3± 0.1
max. value 2754 433 6424 644
Coincidence max. position [cm] 9.8± 0.1 8.7± 0.1 9.5± 0.1 9.6± 0.1
event counts ∆W90% [cm] 1.5± 0.1 0.4± 0.1 1.5± 0.1 1.2± 0.1
(PET) ∆W50% [cm] 2.8± 0.1 3.9± 0.1 2.9± 0.1 3.3± 0.1
Distal fall–off [mm] 10± 1 40± 1 13± 1 19± 1
† Inconclusive due to the high background level.
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Table 5.7: (Continuation of the previous table).
Dataset Characteristic 11C 12C 15O 16O
In room
max. value 209100 16260 481600 32470
Annihilation max. position [cm] 11.89± 0.01 11.32± 0.01 11.99± 0.01 11.58± 0.01
events at ∆W90% [cm] 0.30± 0.01 0.25± 0.01 0.27± 0.1 0.38± 0.01
rest ∆W50% [cm] 0.81± 0.01 4.04± 0.01 0.84± 0.01 1.57± 0.01
Distal fall–off [mm] 3.3± 0.1 19.6± 0.1 3.5± 0.1 6.9± 0.1
max. value 22831 2045 49269 3612
Coincidence max. position [cm] 11.6± 0.1 10.8± 0.1 11.7± 0.1 11.2± 0.1
event counts ∆W90% [cm] 0.4± 0.1 1.1± 0.1 0.4± 0.1 0.6± 0.1
(PET) ∆W50% [cm] 1.1± 0.1 4.2± 0.1 1.1± 0.1 2.2± 0.01
Distal fall–off [mm] 4± 1 28± 1 3± 1 10± 1
Offline
max. value 786600 42680 184100 22900
Annihilation max. position [cm] 11.93± 0.01 11.34± 0.01 11.99± 0.01 11.84± 0.01
events at ∆W90% [cm] 0.29± 0.01 0.60± 0.01 0.32± 0.01 0.44± 0.01
rest ∆W50% [cm] 0.79± 0.01 2.30± 0.01 0.91± 0.1 2.49± 0.01
Distal fall–off [mm] 3.3± 0.1 5.5± 0.1 4.1± 0.1 24.6± 0.1
max. value 87274 5127 19163 2588
Coincidence max. position [cm] 11.7± 0.1 11.0± 0.1 11.7± 0.1 11.4± 0.1
event counts ∆W90% [cm] 0.4± 0.1 1.0± 0.1 0.5± 0.1 1.0± 0.1
(PET) ∆W50% [cm] 1.1± 0.1 2.8± 0.1 1.1± 0.1 3.4± 0.1
Distal fall–off [mm] 4± 1 6± 1 5± 1 27± 1
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Figure 5.18: Points: coincidence event counts obtained with PET tools in depth, with the SOBP dose profile
superimposed, in golden points (Gy). The total annihilation events at rest simulated are shown in arbitrary units.
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The results from table 5.4 quantify the relative increase in true coincidence events, observed
in the figures 5.11–5.16 and attained by using 15O and 11C. In particular, it is observed a gain of
over a factor 7 in offline acquisition using 11C, while the greatest gain employing 15O is verified at
inter–spill, with over a factor 6, and in–room with almost a factor 6.
As for tables 5.6 and 5.7, they include the SOBP region limits in depth, along with an evaluation
of both the annihilations events and the PET coincidence counts profile, also in depth. The distal
fall–off corresponds here to the longitudinal distance required to have the distributions’ curve de-
scending from 80% to 20% of its maximum value, in mm. The ∆W% values denote the longitudinal
distance in between the proximal rise and distal fall–offs at 90% and 50% of the maximum value.
These quantities are meant to illustrate the favourable correlation between coincidence counts and
annihilation events distributions with respect to the distal edge of the SOBP dose profile. In the
simulation results presented, this advantage is only evident for the offline modalities. The reason
for this lies in the beam delivery time structure, for it goes from the lowest to the highest energy
layer. Consequently, during the 130 s of online acquisition, the contribution from the higher energy
layers, and particularly the last which alone amounts to ∼ 30% of all particles delivered to the
SOBP (see table 4.3) is not fully accounted for. Should the beam delivery sequence be reverted,
the online acquisition would be improved, as demonstrated in the appendix C with the coincidence
event counts distributions resulting in sharper peaks for 11C and particularly 15O, with maxima
within 1 mm of the SOBP distal edge. Conversely, the offline acquisition modalities benefit from
both the extended acquisition time (240 s for in–room, 25 minutes for offline) and the fact that the
last layer delivered corresponds to the distal edge of the SOBP. An online and offline acquisition
is illustrated in figure 5.18. In the offline acquisition modalities, in table 5.7, more coincidence
counts are verified for RIβ+ with respect to the stable ions, by a factor of 8–9, this increase is
also corroborated by the annihilation events at rest results. Contrarily to the stable ion beams, the
RIβ+ coincidence/annihilation peaks are better defined in shape and their peak position tends to
be nearer to the distal peak of the SOBP.
As for the inter–spill acquisition modality, in table 5.6, one can appreciate a more notable
difference between the signal gain from 11C and 15O beams, with respect to their stable counterparts,
of a factor ∼ 7 and almost 10, respectively. This is due to the shorter half life of the 15O ions
contributing to the signal acquisition, during a relatively short time. The correlation with the
distal edge of the SOBP is not as advantageous as in the other offline modalities in table 5.7,
because of the lack of the contribution from the last spill (the last acquisition interval in inter–spill
is between the 15th and the 16th spills) and its relevance to the overall amount of ions delivered.
Concerning in–spill acquisitions in table 5.6, the (mostly) neutron and prompt gamma background
has a great impact on the quality of the coincidence event signal obtained, preventing treatment of
data from stable ion beams. Moreover, it affects the gain observed with RIβ+ compared to stable
ion beams. This gain is a factor ∼ 4 for carbon and ∼ 7 for oxygens ions if annihilation events
at rest are considered, but almost inexistent for the coincidence event counts due to the noise.
The background effect can be better understood in figure 5.18–a. Nevertheless, one can observe a
stronger signal (∼ 20%) with 15O rather than 11C, due to the interplay between the effects of 14O
and 15O of oxygen ion beams with respect to 10C and 11C from carbon ion beams (see table 5.5).
The correlation between the position of annihilation and coincidence event distributions with
the SOBP dose profile is, for the reasons already discussed, very difficult to disentangle from the
online data acquisition simulated with the present work’s methodology, unless the SOBP is reversed.
However, it is very satisfactory in the offline acquisition modalities simulated. Overall, RIβ+ attain
a consistently better performance with respect to stable ion beams.
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rigidity (i.e. employing the first bending magnet and first horizontal slit), resulting in fragment
production according to its z/A ratio.
Behind the slit, an achromatic wedge shaped energy degrader may be applied to reduce the
fragments’ energy and energy spread, an holder moves within 20 cm vertically to select among four
possible degraders (figure 5.19). Applying the energy loss difference, an horizontal, second slit at
F2 selects the particles and the final beam (figure 5.19). Using a second bending magnet before F2,
the fragmented beam can still be further charge separated since fragment charge and energy loss in
the degrader are correlated.
The purity of the extracted beam will vary according to the slit width parameters. In fact,
low–purities and intensities are considered the major factors limiting RIB clinical usage. Therefore,
the contaminant species should be well identified (e.g. 11C beams are known to be prone to have
contamination of 12C and 7Be, 10B)[Kan98, Tom03]. An attempt to characterize impurities is included
in the appendix D, via the magnetic rigidity in the scenarios simulated. However, it can only be
applied if the relevant inter–target geometry is known, which was not the case.
Contaminant particle identification is performed using a system consisting of a ToF counter
and a silicon semiconductor detector ∆E–ToF counter at the third slit. The ToF measurement is
performed exploiting the 10.466 m long flight–path between F1 and F2, which are equipped with
start & stop counters, and 0.5–mm–thick plastic scintillators at F2 (energy degrader and third slit
in figure 5.19)[Kou98, Tom03]. MWPCs at F1, F2, and F3 are used to assess the positions and sizes
of the beam with cross monitors. Hence, with the ToF and ∆E information, the particles can be
identified and the purity of the selected particle in the separator is found[Kan04]. Production yields
are then extracted from the ratio between the number of identified particles and the primary beam
intensity, calibrated with a secondary emission monitor within a 10% error margin.
Below, two examples of a production scheme applied for both 11C and 15O, are given. Further
below, the general characteristics of primary/secondary beams experimentally obtained are shown
in table 5.8.
12C [290 MeV/u] + Be [4.2 cm] −→ 11C [210 MeV/u] + fragments
16O [430 MeV/u] + Be [6.0 cm + Al] −→ 15O [254.4 MeV/u] + fragments
At NIRS, the primary beam kinetic energy can attain a maximum of 430 MeV/u, yielding
ranges of 30 and 22 cm with 12C and 16O beams in water, respectively[Nod11]. As the energies of
the secondary beams will be lower, their ranges will be therefore lower as well.
Table 5.8: General irradiation experimental parameters[Kan98, Moh16].
Beam 11C 12C 15O 16O
Energy (MeV/u) 210.0 290.0 254.4 430.0
Momentum acceptance (FWHM) ±2.5% ±0.1% ±2.5% ±0.1%
Angular acceptance (mrad) 26 26 26 26
Production rate ∼ 0.4% — ∼ 0.45% —
Purity 90± 5% — 97± 5% —
FWHM (mm) 19.5 9.0 19.5 9.0
The intermediate target material is chiefly selected according to its physical properties (e.g.
cross section), and thus fragment–of–interest production as an outcome of nuclear reactions. Its
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Table 5.9: Beam profile analysis for the Bragg Peaks simulated. The data pertaining to measurements is found
enclosed in parentheses.
Dataset Beam per Penumbra Penumbra Peak Range ∆W50%
90–10% [mm] 80–20% [mm] [mm] [mm] [mm]
X
11C 2.56 (2.49) 6.8 (9.0) 4.3 (4.8) 67.4 (68.1) 70.2 (71.1) 22.4 (24.0)
12C 4.96 (5.04) 1.2 (1.3) 0.7 (0.7) 157.7 (158.0) 158.3 (158.6) 4.1 (3.9)
15O 2.68 (2.65) 8.5 (7.3) 4.7 (3.8) 86.5 (87.6) 89.2 (90.1) 23.5 (22.8)
16O 3.42 (3.43) 6.2 (9.7) 1.0 (1.3) 227.7 (228.1) 228.4 (228.7) 6.1 (5.4)
Y
11C 2.56 (2.62) 6.9 (7.8) 4.3 (6.3) 67.4 (66.6) 69.5 (69.6) 20.3 (18.3)
12C 4.97 (5.06) 1.2 (1.3) 0.7 (0.6) 157.7 (158.1) 158.3 (158.6) 4.4 (4.0)
15O 2.68 (2.84) 8.3 (7.8) 4.7 (4.3) 86.3 (86.1) 89.2 (88.6) 23.6 (21.3)
16O 3.42 (3.72) 6.3 (7.7) 1.0 (0.9) 227.9 (228.1) 228.4 (228.7) 6.0 (5.4)
Regarding the dose results, it was observed that the fragmentation dose tail of 11C was slightly
underestimated by FLUKA, as visible in figure 5.22, which could be at least partially ascribed to the
beam impurities. This discrepancy between the data and simulation occurs chiefly beyond the 10%
distal fall–off (see table 5.9) and could have an impact not only in 11C therapeutic performance with
respect to 12C, but also highlights a possible discrepancy in the fragmentation channel modeling in
FLUKA. Regarding 15O, the code’s predictions matched well the experimental data, which could
indicate that the discrepancy observed for 11C could be attributed to its higher impurity level (table
5.8), with respect to 15O. In order to assess the contribution from the fragmentation in the Bragg
Peak one would need to characterize the beams’ impurity content, so as to include this information
in the simulated framework and then proceed with the re–calculation, afterwards checking if a better
agreement with the data is verified. However, since such information was difficult to integrate and
validate via simulation, this course of action was not pursued in this work.
Concerning 15O, when applying the normalization the experimental data evidenced an offset in
the horizontal part of the cross ionization chamber while the vertical data subset appears to be in
line with the predictions, this could be caused by a small misalignment of the phantom or the beam
before the irradiation, as the setup is fully symmetric.
Also, the simulation results put into evidence a disagreement between the simulated and mea-
sured 16O peak value for the vertical dataset acquisiton. A small vertical misalignment seems to
be the most plausible explanation, given that the per value in table 5.9’s horizontal dataset is
confirmed by the data.
Overall, there was a good agreement of the simulation values with the experimental data in most
of the range indicators of table 5.9. In fact, for the Range values the agreement was verified to be
within 0.3 mm for stable and up to 1 mm for radioactive ion beams. Peak positions differed slightly
more, but still less than 0.4 mm for stable and up to 1.1 mm for radioactive ion beams. It was also
possible to notice deviations in the ∆W50% values especially for RIβ+, with discrepancies up to
0.7 mm for stable beams and 2.3 mm for radioactive ion beams. These effects are also reflected in
the Penumbra (90− 10%) values, which can differ by up to 3.5 mm.
Some of those variations can be attributed to the reproduction of the secondary beam port in
the simulation, since not all its settings are known. The momentum acceptance of RIβ+ shown
in table 5.8, ±2.5% was relatively high. Even though the optimal momentum spread values used
in the simulations (±1.5 and ±1.25%, for 11C and 15O, respectively) were found to be within the
margins defined in table 5.8, the resulting Bragg Peak curves are more difficult to analyze than
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The full extent of the irradiation and acquisition information is given in table 5.10.
Table 5.10: Carbon and oxygen ion irradiation details.
Beam Inter–target Bragg Peak [cm] Spills tscan [s] Energy [MeV/u]
11C Be [5.1 cm] 5.7 3 1380 190
12C — 13.6 5 1380 290
15O Al+Be [6.0 cm] 7.6 2 780 254.4
16O — 19.7 5 1380 430
Inter–target corresponds to intermediate targets, simple blocks of variable shape, thickness and
material, used to obtain secondary beams with the desired characteristics[Moh16]. As for tscan it
refers to the scanning time.
Multiple range–shifters can be applied to achieve the selected secondary beam range, as it is
generally more practical than modifying the primary beam energy. The range–shifter thickness is
decided a priori according to calculated factors for water and PMMA stopping powers. For the
acquisitions in table 5.10, no range shifters were employed.
Simulation. Having previously characterized the beam range and momentum spread in water
against experimental data, these results were extended to PMMA, as this was the target ma-
terial used for imaging acquisition. For the PMMA blocks inclusion in the simulation, a density
value of 1.186 [g cm−3] was recommended by NIRS Imaging Physics Team. Using tables 5.10 data
as range reference, IPMMA value in FLUKA was set at 74.0 eV, as it was found that it matched the
Bragg Peak position predicted by the NIRS colleagues (this value was also used in other validation
work[Rob13]), leading to the following results reported in figure 5.24.
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Figure 5.24: Simulated results in PMMA, for all the beams previously benchmarked in water, with the scanner
FOV center marked on the plot with vertical dashed lines.
A small shift in the Bragg Peak position in depth was observed for the RIB only, and will be
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later quantified in table 5.13. Nonetheless, by using a stopping power ratio between PMMA and
water of circa 1.160–1.165[KKO13], one can verify that the simulated results lie within the expected
depth interval.
Fragmentation simulations. Among the many fragments relevant to this study, and before discrim-
inating between different light ions species, it was important to observe how the primary beam
attenuation and fragment production (see figure 5.25) evolves in depth in PMMA for the irradia-
tions considered.
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Figure 5.25: Relative fluence of different particles in the PMMA block, normalized with respect to the maximum
(initial) fluence of the primary beam.
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Regarding the energy deposition results, but discerning among ions with Z > 2 (figure 5.26), for
an easier evaluation of their contribution to the overall energy deposition, one obtains the plots of
figure 5.26:
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Figure 5.26: Relative energy deposition of different ions (from 2 ≤ Z ≤ 10) in the PMMA block, normalized to the
maximum peak energy. The total energy deposition is also plotted in black.
The results depicted in figures 5.25 and 5.26, are solely qualitative and are meant to provide the
reader some visual guidance on a few relevant effects, namely: the fragmentation dose tail which,
as seen in chapter 4, is formed essentially by projectile fragments travelling farther than the Bragg
Peak position; the position at which some ions come at rest can have a considerable shift (∼ 1 cm
for Z=6 and Z=8 in figures 5.26-a and –d, respectively) with respect to the Bragg Peak ; for RIβ+
this shift is not as pronounced and thus the β+ emitting fragments position, and thence their signal,
will more accurately coincide with the Bragg Peak.
This simulated data cannot be properly benchmarked since there was no fragment identification
in the experiment. However, these results can support some of the following conclusions via imaging.
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Imaging simulations. Following the characterization of the major ion species’ behavior at the Bragg
Peak depth in the PMMA block, the study of the annihilation events at rest produced by the
different isotopes ensued. These isotopes will be the source of signal detected by the openPET
scanner apparatus.
In figure 5.27, dose distribution and the total annihilation events at rest can be seen, in depth and
integrated over time. In addition to the total yield of annihilation events at rest, the contributions
according to the isotope (β+ emitters) of origin were also distinguished.
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Figure 5.27: Total annihilation events at rest, per single primary particle, according to isotope of origin. The
result is scored in the PMMA block, with the dose distribution shown in arbitrary units.
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From figure 5.27, one can observe that RIβ+ yield of annihilation events at rest, integrated
in time and per primary particle, is more than one order of magnitude above that of the stable
beams, at its maximum. Moreover, it is possible to observe, qualitatively, that the distributions of
the annihilation events at rest resulting from 11C and 15O irradiations are much better correlated
with the distal fall–off of the respective Bragg Peaks. The main isotope contributing to the 12C
irradiation’s total annihilation events at rest distribution, at the maximum, is essentially 11C (albeit
10C and 15O distort its peaked shape). For 16O irradiations, 11C and 15O broaden the Bragg Peak
shape in depth. Concerning RIβ+ annihilation event at rest distributions, for 11C irradiations the
peak is mostly formed by 11C ions, with only ∼ 2% of 10C at the peak. As for 15O, the annihilation
event at rest peak is also mostly formed by the beam particle, with contributions from 14O, 11C
and 13N amounting to a few per cent each.
Despite providing general information on the relative amount of annihilation events at rest,
their location and provenience, the simulation results discussed in this section so far lack time
information. Since the different isotopes decay contribution is dynamic in time, according to each
specie’s half–life, the signal time acquisition interval and the beam time structure need also to be
accounted for.
Considering the time structure depicted below in the schematic in figure 5.28 and in table
5.11, for stable and RIβ+, the annihilation events were estimated at any point of the openPET
acquisition time up to the end of the scanning time.
Beam time structure for the different beams
1.2 Radioactive ion beam results from HIMAC 27
Despite providing general information on the relative amount of annihilation events at rest, their
location and provenience, these results lack time information. Since the different isotopes’ decay
contribution is dynamic in time (depending of the species’ half life) the signal time acquisition
interval needs also to be accounted for.
Considering the ti e structure depicted below in table 4.5, for stable and RIBs, the annihilation
events was estimated at any point of the open-PET acquisi ion time up to the end of the scanning
time. For all the beams evaluated the open-PET easurement time accounted for 1380 s, except
15O which lasted only 780 s. Essentially, the open-PET measurement time consisted of three
major stages: Delay time (d), Beam On and acquisition time. The latter taking place not
only after the last spill, but also in between spills.
Beam time structure for the different beams
Beam Time Structure
Spill 1 Spill 2 Spill 3
11C — (1380s) — d1 Total Acquisition time = 1354.5 (s)
Beam Time Structure
Spill 1 Spill 2 Spill 3 Spill 4 Spill 5
12C — (1380s) — d2 Total Acquisition time = 1355.7 (s)
Beam Time Structure
Spill 1 Spill 2
15O — (780s) — d3 Total Acquisition time = 757.4 (s)
Beam Time Structure
Spill 1 Spill 2 Spill 3 Spill 4 Spill 5
16O — (1380s) — d4 Total Acquisition time = 1352.9 (s)
Delay times (d): d1 = 19.8, d2 = 14.8, d3 = 18.8 and d4 = 17.6 (s).
To complement the beam time structure data, the intensities’ effect were also included. This
way, it would be possible to account for all the interactions and quantify accurately the annihilation
events at rest at any point in time, both during and after irradiation.
Figure 5.28: openPET beam time structure details, for the Delay time (d) please refer to table 5.11.
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For all the beams evaluated, the openPET measurement time accounted for 1380 s, except 15O
which lasted only 780 s. Essentially, the openPET scanning time consisted of three major stages:
Delay time (d), Beam On and acquisition time, with the latter taking place not only after
the last spill, but also in between spills (lilac colored in the schematic). The Beam On periods are
represented by the upward rectangular function, where no acquisition occurs. The Delay time
corresponded to a variable time in each scan before the 1st spill.
To complement the beam time structure data, the number of particles delivered was also in-
cluded, these values are provided in table 5.11 and were used to normalize the simulation results.
Table 5.11: In beam PET irradiation data.
Beam Ions per spill Intensity Total ions delivered Delay
[106 ions spill−1] [106 ions s−1] [106 ions] time [s]
11C (190 MeV/u) 18.0 9.5 54.0 19.8
12C (290 MeV/u) 18.0 9.5 90.0 14.8
15O (254.5 MeV/u) 12.2 6.4 24.4 18.8
16O (430 MeV/u) 11.6 6.1 58.0 17.6
This way, it would be possible to reproduce all the beam interactions and quantify the annihi-
lation events at rest at any point in time, both during and after irradiation. An example of the
annihilation events at rest rates [events s−1] evolution in time, scored in the PMMA phantom, is
provided in table 5.12. These values take into account the different irradiation profiles depicted in
the schematic in figure 5.28, as well as the values in table 5.11.
Table 5.12: Annihilation events at rest rate [Events s−1] calculated in the PMMA phantom with FLUKA at
different scanning times: EOB – End of Beam; 5 minutes after EOB and at the end of the PET scanning time.
Beam EOB 5 minutes EOB At scan’s end
11C 109 822 19 303 10 253
12C 103 261 9 801 3 579
15O 147 139 16 820 3 833
16O 131 722 12 758 3 517
The annihilation event at rest results were then integrated in time, but over the specific acqui-
sition intervals only. This was done in an attempt to correlate the results with the image acquired
by the scanner, since ultimately the annihilations would be the chief source of signal detected by
the openPET scanner. These results can be seen plotted in figure 5.29, for a qualitative compari-
son. In the referred figure, the simulation results were normalized to the number of beam particles
delivered. However, please note that the reconstructed results did not correspond quantitatively
to β+ activity and therefore, since the quantities compared are different, the simulation and the
experimental data do not match under the same color scale. Subsequently, figure’s 5.24 simulated
Bragg Peak position, along with the FOV center values, were respectively compared with the an-
nihilation events at rest peak position and the peak position of the experimental data counts from
figure 5.29.
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Figure 5.29: Annihilation events at rest simulated in PMMA throughout the acquisition time (left column) and
openPET signal reconstruction experimentally acquired in relative counts (right column, in arbitrary units).
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This comparison was performed in depth, with the lateral components integrated, to investigate
the agreement between simulated and measured data. These results are presented in table 5.13,
with annihilation events at rest being abbreviated as Æverest.
Table 5.13: Comparison between simulated Bragg Peak position and position of the maximum of both simulated
annihilation events (S) and experimental (E) signal acquired. The values ∆S and ∆E correspond to |S2 − S1| and
|E2 − E1|, respectively.
Beam Bragg Peak (S1) FOV center† (E1) Æverest peak (S2) Experimental data (E2) ∆S [mm]
position [mm] position [mm] position [mm] max position [mm] (∆E) [mm]
11C 58.5 57 61.5 60.0 3.0 (3.0)
12C 136.1 136 136.5 135.0 0.4 (1.0)
15O 74.8 76 78.0 75.0 3.2 (1.0)
16O 196.8 197 195.0 196.3 1.8 (0.7)
† OpenPET’s FOV position along the axis, corresponding to the expected Bragg Peak position.
The acquired signal depicted on the right side column of figure 5.29 was reconstructed using an
in–house implementation of anOSEM algorithm (8 subsets and 10 iterations), with a normalization
and scattering correction being performed for 3D image reconstruction[Moh16]. This method is
similar to MLEM, but handles instead the data into subsets of projections throughout the volume
for faster convergence[Zan04]. However, no detector calibration has been performed, thus the result
reconstructed can be regarded as “relative counts”, instead of absolute ones. Regarding the dataset
volume, it consisted of a 340 × 340 × 500 voxelized matrix, being each voxel a cube of 1.5 mm
length. For the FLUKA simulation (left side column of figure 5.29), the binning size was selected
so as to coincide with the data pixel size, allowing for a straightforward comparison.
ImageJ software was employed to extract the reconstructed data and plot it into a 2D matrix
form, integrating laterally over the phantom geometry, for comparison with the FLUKA simulation
plot. Subsequently, it was plotted using only an arbitrary normalization factor, matching the
FLUKA result, which was directly given per primary particle. Following this procedure, both
results were then equally normalized by the number of beam particles delivered.
Since the experimental data are not calibrated for obtaining activity, they do not compare di-
rectly with the simulated annihilation events at rest distribution, quantitatively. As a consequence,
no normalization factor could be employed to extrapolate quantitative parameters (e.g. scanner
efficiency factor) and the comparison with simulated data was performed by evaluating the distri-
butions’ relative profiles, as well as their shape and position.
Taking the integrated result in the vicinity of the Bragg peak zones the results obtained for the
different beams are compared in more detail in figure 5.30, with a substantially reduced volume
mesh of 6×6×6 cm3. This volume will be, from now onwards, denominated as the region of interest
(ROI). In order to obtain a more meaningful comparison between simulation and experimental data,
background reduction techniques were applied. These techniques consisted of the subtraction of a
constant value in the ROI voxels of each of the experimental data sets provided which was found
to correspond to the background.
One–dimensional profile plots (figure 5.31) were created integrating both the simulation and
experimental data in either their radial or axial components throughout the ROI. This allowed for
a clearer assessment of the comparison performed, particularly nearer the Bragg Peak zone.
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Figure 5.30: Detail of the distribution of annihilation events at rest in PMMA, for the different irradiations
obtained with FLUKA throughout the acquisition time, in the ROI (left). Detail over the same region, but plotting the
openPET signal reconstructions (right) experimentally acquired and treated with background reduction techniques.
The experimental data, given in relative counts, were normalized to the simulation’s results integrated in the ROI
for a more direct comparison of both distributions.
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Figure 5.31: Radial (left) and axial (right) comparison between integrated annihilation events at rest simulated
and the reconstructed data acquired in PMMA. The reconstructed results were treated with background reduction and
normalized to the respective simulations’ maxima, for visualization purposes.
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For the data acquisition with openPET and the following reconstruction in table 5.13, the Bragg
Peak positions obtained with FLUKA were found to differ slightly from the openPET scanner FOV
centered position (figure 5.24) in the situations pertaining to RIβ+ irradiation only, by 1.5 mm for
11C and 1.2 mm for 15O.
An evaluation of the shape and relative annihilation events at rest peak magnitude was then
performed for the different distributions, its results are detailed in tables 5.14 and 5.15.
Table 5.14: Comparison between the distribution shape and profile resulting from different irradiations for both
simulated and experimental data (the latter is presented in parentheses).
Beam FWHM ∆W50% ROI value Maximum value Peak section
[mm] [mm] [%] of total [%] of ROI [%] of ROI
11C 21.0 (22.5) 7.5 (9.0) 95.4 (79.1) 1.45 (1.20) 21.18 (15.95)
12C 12.0 (12.0) 13.5 (16.5) 41.1 (42.7) 0.90 (0.83) 7.37 (7.21)
15O 21.0 (19.5) 7.5 (7.5) 94.7 (79.0) 1.35 (1.30) 19.49 (17.07)
16O 12.0 (15.0) 15.0 (16.5) 36.9 (39.3) 0.74 (0.66) 6.24 (6.12)
In order to characterize the shape, the lateral distribution’s FWHM was obtained for both the
simulated and experimental results, the latter enclosed in parentheses. Regarding the longitudinal
shape, it was characterized using the previously defined ∆W50% parameter. In addition to that,
the figure of merit of RIβ+ usage was estimated by evaluating the percentage of events obtained in
the ROI with respect to the total. This allows for a more representative comparison between the
annihilation events at rest simulated and signal actually reconstructed by the apparatus, since for
11C and 15O, the vast majority of signal is contained in the ROI (see table 5.14)
Moreover, it was calculated (1) the maximum value in a single voxel unit (1.5–mm–length cube)
and (2) the “peak section”, which is here defined as the laterally integrated volume at the range
corresponding to the aforementioned voxel unit (i.e. 1.5 mm in longitudinal length and the lateral
dimensions coinciding with that of the ROI). Both the values (1) and (2) were presented in table
5.14 as percentage of the integrated signal at the ROI, for a more direct assessment of the higher
density of localized events at the respective peak position.
Regarding the evaluation of the relative signal magnitude in table 5.15, the distributions re-
sulting from the different beam irradiations were again compared using both the ROI value, the
maximum value in a voxel unit and the peak section. However, instead of presenting the results
as percentage of the ROI total it was decided, for the sake of clarity, to compare it directly with
the 12C value instead. In table 5.15, the simulated values of annihilation events at rest were com-
pared directly to the 12C value, considering also their yield per primary beam particle, at the ROI,
maximal voxel unit value and peak section.
On the other hand, the relationship between experimental data β+ emitter signal maximum
position in depth observed was seen to be rather in line with the peak of FLUKA’s annihilation
events at rest calculated (table 5.13), except for 15O, where the variation was slightly higher (2.2
mm). Some of these deviations could be attributed to experimental calibration factors. Neverthe-
less, both the range and shape of β+ emitters signal experimentally obtained were considered to be
in fairly good agreement with the simulated distribution of annihilation events at rest throughout
the acquisition time, as displayed in figure 5.29 and, more in detail, in figures 5.30 and finally 5.31.
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Table 5.15: Different distributions’ values relative magnitude for both simulated and experimental (exp.) data,
with respect to 12C, which is normalized to the unity (12C ≡ 1).
Beam Æverest Æverest peak Æverest Exp. data Exp. data Exp. data
max. value section ROI volume max. value peak section ROI volume
11C 12.53 22.27 5.24 12.08 16.75 6.41
12C 1 1 1 1 1 1
15O 18.27 32.07 6.20 13.16 17.83 6.22
16O 1.45 1.49 1.20 1.02 1.00 1.14
Although the peaks of annihilation events at rest simulated for RIβ+ are characterized by a
better correlation with the Bragg Peak position (figure 5.28), this was not verified experimentally
as the beam properties of RIβ+ differed greatly from the stable ion beams used, particularly in
momentum spread, as verified in the FWHM comparison (table 5.14). A more direct evaluation
would ideally require equivalent beam properties to be more accurate. In spite of that, one can
appreciate a major gain in both Bragg Peak and annihilation events at rest localization by com-
paring table 5.14’s ∆W50% values, for RIβ+ (FLUKA’s annihilation events at rest, corroborated
by experimental data). Namely, it reports approximately a factor 2 decrease in ∆W50%, for RIβ+,
despite the fact that their dose ∆W50% (table 5.9) was almost 4–5 times higher than for stable
beams, due to the aforementioned differences in momentum spread values. These findings are clear
indicators of steeper signal peaks in range (also visible in figure 5.31).
In fact, the higher concentration of signal resulting from RIβ+ irradiations, in the ROI and more
particularly at its maximum values and peak section, is a characteristic observed visually in figure
5.29 and (quantitatively) corroborated by table 5.14 data. However, one should note that the use
of a ROI does not avoid all possible imaging artifacts, since the reconstructed shapes have some
irregularity while the simulations are symmetric and therefore the comparisons tend to worsen for
smaller partitions of the ROI (table 5.15). It was also verified via FLUKA simulations that the
rate of annihilation events at rest immediately after the irradiation’s end was rather comparable
in between the carbon and oxygen beams species (see table 5.12). This despite the much higher
amount of particles delivered in the stable ion irradiations (table 5.11, almost a factor 2) which is in
line with the observations for inter–spill PET acquisitions in the previous section of this chapter.
Besides the aforementioned RIβ+’s advantage in localizing the Bragg Peak in range, with respect
to stable beams, one also observes a much higher overall signal magnitude. This latter property is
observed in figure 5.30, for the ROI, and using the same scale for the annihilation events at rest
calculated with FLUKA (its distribution compared with relative counts), and confirmed by table
5.15 data. Using RIβ+ and per comparison to their stable counterparts, it was reported in the
aforementioned table at least an order of magnitude in signal increase in some zones of interest of
the ROI, and a factor of ∼ 6 in the ROI itself.
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5. Computational and experimental assessment of radioactive ion beams for PET
imaging
Chapter 6
Conclusions
6.1 General Discussion
The FLUKA simulations performed in chapter 4 supported the feasibility of using radioactive ion
beams in hadrontherapy, as the dose distributions obtained were found to be either comparable
in terms of peak–to–entrance ratios or even beneficial as in the case of 11C ions fragmentation
dose tail, evidencing a ∼ 20% lower dose. Other ion species simulated, such as 10C ions, also
evidenced a promising fragmentation dose tail behavior, but a further analysis was not pursued in
view of their lack of clinical relevance. As for 15O, the simulations did not report any dosimetric
disadvantage with respect to 16O. The investigations with FLUKA have characterized the different
nuclear fragments contributing to the dose distribution up to, and beyond the Bragg Peak, with the
fragmentation dose tail formation.
The radioactive ion beams decay products were verified to have a considerably small impact,
circa three orders of magnitude lower in fact, on the overall dose delivered. Therefore, RIβ+
enhanced decay products and thence imaging signal do not significantly impact treatment effective-
ness.
In general, the simulation work benefited from the development and benchmarking of models
involved in fragment production at therapeutic energies, as well as the models for charged particle
transport and positron emission. Although the application of the FLUKA code with stable ion
beams in the hadrontherapy context is well established, the present work details its first systematic
application to radioactive ion beams. It was verified that the transition between the models gov-
erning fragmentation, and particularly at the frontier between rQMD and BME modules (∼ 125
MeV/u), was smooth and artifact free (see chapter 4 for more details). Moreover, the peak position
trends for the different fragmented species were seen to be in line with the A/z2 ratio and their
nature as either projectile or target fragments.
The use of water equivalent thickness degraders as approximations for the beam line elements
from HIT, a realistic RiFi model and the FLUKA recalculations of SOBP treatment plans based on
the methodology described in chapter 3 allowed for the systematic creation of customized SOBPs
for both stable and RIβ+, in a synchrotron–like irradiation scenario. Although a systematic shift in
number of ions was verified in the comparisons, this has been attributed to the intrinsic differences
between the research TPS versions, which led to dose values of 0.95 Gy at the SOBP region instead
of 1 Gy. Also, when FLUKA recalculations were compared with the newer version of the research
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TPS employed at HIT, without RiFi, the results were adequate and deemed consistent for the
subsequent imaging potential assessment in between the different SOBPs of 1 Gy in water.
Regarding imaging evaluation, it was estimated based on annihilation events at rest induced
by the irradiation and FLUKA PET tools image reconstruction, both features currently under
development in FLUKA. The latter allowed for the extraction of elements of interest for a posteriori
physical analysis, besides the image reconstruction result from the signals collected in a simulated
treatment with an in silico version of the same PET scanner model used at HIT. It consisted of
the first use of these tools in in beam PET scenarios and its description can be found in chapter 3.
Annihilation events at rest simulated for the various 1 Gy SOBPs were found in chapter 4 to
lead to about one order of magnitude higher number of annihilation events, for 11C and 15O, over
their respective stable counterparts. This effect is even higher (25 and 15, respectively) considering
the gain at the distal edge of the SOBPs, which is the last isoenergetic layer delivered in range, and
by far the one with the highest number of ions for the considered flat SOBPs. Overall, it was found
that the annihilation events’ distributions maximum for the RIβ+ coincided within 1.5 mm with
the distal dose peak, whereas the annihilation event at rest distribution resulting from stable ion
irradiations has a much less prominent peak, and deviated in range from the distal edge of the SOBP
by more than 1 cm in some cases. When analyzing the evolution in time of the annihilation events
rate, considering SOBPs of 1 Gy in water delivered in spills in a synchrotron–like manner, it was
found that 11C ion irradiations had an higher imaging potential than 15O starting from 5 minutes
after EOB, therefore being more suitable for offline PET acquisitions. Before that period, which
is often associated with online and in–room PET acquisitions, 15O is indeed more advantageous.
This is due to the latter shorter half–life and the role of the primary ions as main contributors to
the annihilation event rate after EOB.
Coupling to the previously defined HIT beam line elements approximations integrating an an-
thropomorphic phantom and virtual Siemens Biograph mCT PET scanner, and employing FLUKA
PET tools in various acquisition modalities, the 1 Gy SOBPs irradiations with 11C, 12C, 15O and
16O were followed by image reconstructions and quantitative assessment of the signals collected
in in beam PET scenarios in chapter 5. In order to obtain more realistic results, the simulations
were fully integrated, so that the PET response will reflect also the effect of secondary particles
produced. The previous estimates with annihilation events at rest were essentially confirmed, now
in the form of true coincidence events, for the offline PET acquisition modalities. However, given
the neutron generated background, the quality of the imaging acquisitions during spill time were
seen to suffer from a considerable distortion. With 11C, the offline PET acquisition gain in true
coincidence counts was estimated a factor 7 over that of 12C. For 15O the gain was ∼ 6 for in room
and inter–spill PET acquisitions. During spill, the true coincidence events acquired with RIβ+
did not surpass by a factor 2 those of stable ions, mostly due to the background effect. However,
the reconstructed signal distribution was more favorable, peaking closer to the distal edge of the
SOBP distribution (especially 15O), and the proximal to distal region almost coincides with that
of the SOBP. Furthermore, it can be concluded that RIβ+ can be an asset for range monitoring in
circumstances where background hinders stable ion beams usage, this was verified to be particularly
true in the alternate scenario annexed in which a reverted SOBP is employed. Nonetheless, it must
be noted that the acquisitions exempting spill time signal were able to highlight the distal peak
more effectively than the in spill PET scenarios, with proximal to distal regions consistently better
defined than those of stable beams. In addition to that, the distal fall–off coincided almost exactly
with the distal edge of the SOBP, which confirmed the remarkable potential of RIβ+ in treatment
verification and range monitoring.
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Regarding the results obtained at HIMAC and detailed in chapter 5, the experimental Bragg
Peak curves obtained in water were seen to be within ∼ 1 mm agreement in range with the FLUKA
simulated results. The Bragg Peak distributions were broader for the radioactive ion beams due to
their production via the projectile fragmentation method. Possibly, the effect of impurities and the
high momentum spread of the secondary beams, which had to be estimated for the simulations,
further deteriorated the comparison consistency particularly by altering the descending trend of the
curves after the Bragg Peak. On the other hand, some of the dosimetric deviations in water can also
be attributed to experimental misalignments, as in the case of 15O, in which the readings from the
horizontal and vertical sections of the cross ionization chambers were not symmetric. A discrepancy
of almost 10% in the peak–to–entrance ratio is also seen for the vertical reading of the cross ion
chamber for 16O irradiation, but this was not confirmed by the horizontal data. Clearly, there was a
systematically lower value in the simulation with respect to experimental data for the fragmentation
dose tail of 11C, which could be explained by a FLUKA underestimation of the fragments produced
in 11C interactions with PMMA or the presence of impurities. However, without reproducing the
impurity content of HIMAC’s 11C beam, none of the aforementioned possibilities can be confirmed.
The openPET image reconstructions confirmed that 15O and 11C outperform stable ions in the
magnitude of signal acquired in all in beam PET scenarios evaluated (by a factor of ∼ 13 and ∼ 12
at the peak, respectively), even with a factor of two lower amount of ions delivered. Unfortunately,
it was not possible to compare directly the imaging results with the simulations of annihilation
events at rest, as the data provided was not corrected for quantitative activity, comprising only
“raw data” in relative counts. Thus, all comparisons with these distributions were performed in a
relative form and by analyzing their shape, and not quantitatively, as ideally envisaged. Also, it
was not possible to verify in HIMAC’s results the agreement previously observed in chapter 4, while
correlating the positions of FLUKA simulated Bragg Peak with annihilation events at rest maxima
positions. The signal reconstruction maximum did not correlate favorably with the predicted Bragg
Peak position for radioactive ion beams, which could be ascribed to the influence of many factors
such as impurities’ effect, large momentum spread of RIβ+ and the fact that the Bragg Peaks of
different ion beams were being evaluated at different ranges.
Nevertheless, in the imaging reconstructions of HIMAC’s results in chapter 5, it was possible to
identify that both the lateral shape and the region between proximal and distal edges of the acquired
distributions were considerably better defined for RIβ+. This is because the beam shape FWHM
is initially more than a factor of two higher for RIβ+, whereas in the reconstructed distribution
the FWHM is instead lower than a factor of two, and becomes almost comparable for oxygen ions
in the experimental data. Regarding the β+ signal longitudinal peak sharpness, those originating
from RIβ+ are halved, hence leading to more well defined distributions. As for the dose peak
sharpness verified in water, these were a factor of 4–5 higher for RIβ+. Therefore, even though
with a fairly less optimal initial beam shape, the signal obtained with RIβ+ clearly outperforms
stable ions signal in range verification scenarios. Moreover, this trend was also verified by the
FLUKA simulations as well, despite the fact that only the annihilation events at rest obtained
in the PMMA were being considered. Both experimental and simulation data reported at least a
factor of ∼ 6 increase in signal with RIβ+, compared to their stable counterparts, and this effect
surpassed one order of magnitude in some localized estimators of the ROI.
Overall, one can conclude that RIβ+ can enhance the imaging signal output available for beam
range verification and treatment monitoring with respect to stable ion beams in hadrontherapy,
while maintaining comparable dose performance.
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6.2 Future Work
In view of the promising results obtained, future work will include:
I Full validation of FLUKA PET tools using National Electrical Manufacturers Association
(NEMA) protocols. To this end, some elements described in this work will become standard-
ized in the workflow of in beam PET simulations with FLUKA PET tools. Currently,
attenuation and scattering corrections are still missing in order to proceed with further vali-
dation;
II Inclusion of a biological dose assessment (via i.e. RBE estimations based on available biolog-
ical models) to investigate whether the performance levels reported with physical dose will
still be valid attending to the RIβ+ different fragments’ biological impact;
III Better assessment of the background effects (e.g. in routine clinical application activation
should not be neglected) along with the use a more realistic in beam PET geometry setup
(i.e. either opened/shifted). If possible, effects of biological washout should be modeled in
the reconstructions, and the effects of alternative sequence orders in the formation of the
SOBP should be more thoroughly assessed. All these factors will allow for the reproduction
of imaging reconstruction artifacts in in beam PET scenarios and lead to an improvement of
the image quality;
IV Attempt to compare a real patient case scenario with 12C against a simulated 11C treat-
ment. Thereafter, the present work methodology would be applied to simulate an equivalent
treatment with 11C, so as to obtain subsequently PET reconstructed images for a more re-
alistic comparison with a clinical scenario per contrast with the here presented evaluation
for an anthropomorphic phantom. This course of action can only be followed once I-III are
addressed;
V Improvement of the comparison using results from HIMAC, overcoming the limitation of this
work to an indirect comparison between simulation and experiment. This problem could
be approached in the future with either an activity calibrated result of the reconstructed
experimental data, to be provided for the comparison against FLUKA calculated β+ activity
or instead, the replication of the openPET scanner in FLUKA PET tools for a complete
simulation and fully–equivalent comparison (this latter, more complex option could not be
followed in this work due to lack of time);
VI Study of the momentum spread unknown parameters and impurities for the accessible beams
at HIMAC. This way, their effect could be inserted in the FLUKA simulation so as to obtain
a directly equivalent beam exiting the beam–line as in HIMAC. This would allow for a more
accurate reproduction of the RIβ+ impurities’ effect on the β+ activity reconstruction, as
well as a more reliable distribution shape.
Finally, given the expected upcoming availability of facilities able to directly acceleration of
radioactive beams, the results of this work and its envisioned continuation should enable a more
thorough assessment of RIβ+ for potential future use in medical applications.
Appendix A
FLUKA routines
comscw.f and stuprf.f — Excerpts:
*−−−−−−−−−−−−Comscw−−−−−−−−−−−−*
*FOR ENERGY DEPOSITION
IF (ISCRNG.EQ.1) THEN
*SELECT USRBIN#1
IF (JSCRNG.EQ.1) THEN
*PROMPT SCORING, AND OTHERWISE NOTHING
IF (IPRODC.EQ.1) THEN
COMSCW = ONEONE
ELSE
COMSCW = ZERZER
LSCZER = .TRUE.
ENDIF
*SELECT USRBIN#2
ELSE IF (JSCRNG.EQ.2) THEN
*DECAY SCORING, AND OTHERWISE NOTHING
IF (IPRODC.EQ.2) THEN
COMSCW = ONEONE
ELSE
COMSCW = ZERZER
LSCZER = .TRUE.
ENDIF
*SELECT USRBIN#3
ELSE IF (JSCRNG.EQ.3) THEN
*SCORE TOTAL ENERGY DEPOSITION
COMSCW = ONEONE
ELSE
COMSCW = ZERZER
LSCZER = .TRUE.
ENDIF
*OTHERWISE, AND TERMINATION...
ELSE
LSCZER = .TRUE.
ENDIF
RETURN
*=== End of function Comscw ===*
END
*−−−−−−−−−−−−Stuprf−−−−−−−−−−−−*
*(...)
*
INCLUDE ’(EVTFLG)’
INCLUDE ’(FLKSTK)’
INCLUDE ’(TRACKR)’
INCLUDE ’(GENSTK)’
INCLUDE ’(PAPROP)’ !properties of secondaries
created in a hadronic event
INCLUDE ’(FHEAVY)’ !intrinsic particle properties
(mass, charge, half live...)
INCLUDE ’(EVTFLG)’ !special stack for nuclear
fragments
*(...)
* FLAGS FOR IDENTIFYING INTERACTION
IF (LELEVT) THEN !Elastic interaction
ISPARK(1,NPFLKA) = 1
ELSE IF (LINEVT) THEN !Inelastic interaction
ISPARK(1,NPFLKA) = 2
ELSE IF (LDECAY) THEN !Particle decay
ISPARK(1,NPFLKA) = 3
ELSE IF (LDLTRY) THEN !Delta ray production
ISPARK(1,NPFLKA) = 4
ELSE IF (LPAIRP) THEN !Pair production
ISPARK(1,NPFLKA) = 5
*(...)
IF (LDECAY) THEN
WRITE(61,*)
XX,YY,ZZ,IJ,KPART(NPSECN),ISPARK(1,NPFLKA)
ENDIF
ENDIF
RETURN
*=== End of function Stuprf ===*
END
The comscw.f user routine is employed to weight the energy distribution obtained via the
USRBIN card, and it was modified to filter energy contributions from different origins using “decay”,
“prompt” and “total” flags. As for the stuprf.f user–routine, it is employed to provide additional
details on the decay elements scored (e.g. type, position).
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Source — Beam geometry parameters are fixed a priori for every field, thus being embedded
in source.f directly. Changeable parameters are either passed by the input (e.g. beam type)
or read from an external file with 625 entries corresponding to the raster scan beam spots for an
isoenergetic layer.
*−−−−−−−−−−Source−−−−−−−−−−−−−−*
PARAMETER(NLINES = 625)
DIMENSION XBP (NLINES), XSB (NLINES), YBP (NLINES), YSB (NLINES),
&EGY (NLINES)
SAVE LFIRST, KOUNT
DATA LFIRST / .TRUE. /
*(...)
* User initialization
WRITE(LUNOUT,*)’Modified source.f for Hitlike beams’
OPEN(UNIT=88,
& FILE=’’/path1’’
& ,STATUS=’’OLD’’)
OPEN(UNIT=89,
& FILE=’’/path2’’
& ,STATUS=’’UNKNOWN’’)
DO I = 1, NLINES
READ(88,*) EGY (I), XBP (I), YBP (I), XSB (I), YSB (I)
END DO
KOUNT = 0
ENDIF
* 88 is the external data file, 89 is a test sample
*Sample creation with 50 entries:
KOUNT = KOUNT+1
XI = FLRNDM(DUMMY)
LINE = INT(XI * DBLE(NLINES)) + 1
IF(KOUNT .LE. 50) THEN
WRITE(89,*) LINE, EGY (LINE), XBP (LINE), YBP (LINE),
& XSB (LINE), YSB(LINE)
ENDIF
*(...)
*Kinetic energy of the particle in GeV
TKEFLK (NPFLKA) = EGY (LINE)
* Translating kinetic energy into momentum
PMOFLK (NPFLKA) = SQRT (TKEFLK (NPFLKA)*(TKEFLK (NPFLKA)
& + TWOTWO * AM (IONID) ) )
* Polarization cosines:
TXPOL (NPFLKA) = −TWOTWO
TYPOL (NPFLKA) = +ZERZER
TZPOL (NPFLKA) = +ZERZER
* Particle coordinates, Z origin
XFLK (NPFLKA) = XBP (LINE)
YFLK (NPFLKA) = YBP (LINE)
ZFLK (NPFLKA) = −575.D3
*−−−−−−−−−−−−−−−−−Momentum Spread Implementation−−−−−−−−−−−−−−−*
* Getting energies as kinetic energy
TKEFLK (NPFLKA) = EGY (LINE)
* Translate kinetic energy into momentum
PMOFLK(NPFLKA) = SQRT ( TKEFLK (NPFLKA)*(TKEFLK (NPFLKA)
& + TWOTWO*AM (IONID)))
* Apply momentum spread (TT suggestion)
CALL FLNRRN (RGAUS0)
PMOFLK(NPFLKA)=PMOFLK(NPFLKA)+1.5E−3*PMOFLK(NPFLKA)*
& RGAUS0/S2FWHM
* Give each beam the appropriate FWHM (2.5 mm according to data)
CALL FLNRR2 (RGAUS1,RGAUS2)
XFLK(NPFLKA) = RGAUS1*0.1062D0
YFLK(NPFLKA) = RGAUS2*0.1062D0
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Fragmentation. The modified excerpts of comscw.f and stuprf.f routines to study fragmentation
are shown below, LTRACK (Generation Number) and JTRACK (Particle Identity) are associated explic-
itly to the inelastic nuclear reaction flags. The identification of the models responsible for fragment
transport, namely the BME or rQMD, is done according to the energy deposition boundary con-
dition using stuprf.f. As for comscw.f, it passes the filtered information into USRBIN estimators.
*−−−−−−−−−−−−Comscw−−−−−−−−−−−−*
*ENERGY DEPOSITION
IF (ISCRNG.EQ.1) THEN
*Carbon example
*SELECT USRBIN#21
ELSE IF (JSCRNG .EQ. 21) THEN
*ENFORCING CONDITIONS (C & BME)
IF (ISPUSR(3) .EQ. 11 .AND.
ISPUSR(2) .EQ. 2) THEN
COMSCW = ONEONE
ELSE
COMSCW = ZERZER
LSCZER = .TRUE.
ENDIF
*SELECT USRBIN#22
ELSE IF (JSCRNG .EQ. 22) THEN
*ENFORCING CONDITIONS (C & RQMD)
IF (ISPUSR(3) .EQ. 11 .AND.
ISPUSR(2) .EQ. 1) THEN
COMSCW = ONEONE
ELSE
COMSCW = ZERZER
LSCZER = .TRUE.
ENDIF
comscw.f — Filtering annihilation events
at rest of 11C ions:
*−−−−−−−−Condition enforcement−−−−−*
*Aniquilacao
IF (ISCRNG.EQ.9) THEN
*1 segundo
*Seleccionar USRBIN#1
IF (JSCRNG.EQ.1) THEN
*Aplicar aos seguintes isotopos (C−11)
IF (IAZTRK .EQ. 6011) THEN
COMSCW = ONEONE
ELSE
COMSCW = ZERZER
LSCZER = .TRUE.
ENDIF
*−−−−−−−−−−−−Stuprf−−−−−−−−−−−−*
*Particle ID (secondary)
!Individual flags
IF(LINEVT .AND. JTRACK .EQ. −2 .AND. LTRACK
.EQ. 1) THEN ! Inelastic nuclear reaction
IF (ILOFLK(NPFLKA) .EQ. 1) THEN
ISPARK(3,NPFLKA) = 1 ! Proton flag
ELSE IF (ILOFLK(NPFLKA) .EQ. −6) THEN
ISPARK(3,NPFLKA) = 2 ! Alfa flag
*(...)
!Group flags I
ELSE IF (ILOFLK(NPFLKA) .EQ. −2) THEN
*carbon example − part 1
IF (ICHRGE(−2) .EQ. 6) THEN
ISPARK(3,NPFLKA) = 11 !C flag
ENDIF
!Group flags II
ELSE IF ((ABS(ILOFLK(NPFLKA))) >=
10000) THEN
IZ = (ABS(ILOFLK(NPFLKA))/100000)
*carbon example − part 2
ELSE IF (IZ .EQ. 6) THEN
ISPARK(3,NPFLKA) = 11 !C flag
ENDIF
!Group flags III
ELSE IF (((ILOFLK(NPFLKA)) .LT. −6)
.AND.
& ((ILOFLK(NPFLKA)) .GT. −10000)) THEN
*carbon example − part 3
ELSE IF (ICHEAV(−ILOFLK(NPFLKA))
.EQ. 6) THEN
ISPARK(3,NPFLKA) = 11 !C flag
ENDIF
*(...)
*−Energy boundary RQMD/BME*
IF ((ETRACK−AM(−2))/DBLE(IBARCH(−2))>=
0.125D+00) THEN
ISPARCK(2,NPFLKA) = 1
ELSE IF ((ETRACK−AM(−2))/DBLE(IBARCH(−2))<
0.125D+00) THEN
ISPARCK(2,NPFLKA) = 2
ENDIF
ENDIF
*(...)
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A more detailed view of fragments contribution (by Z) to the Bragg Peak is shown below in
figure A, for carbon ions only. It already includes the summed up fractions from both BME and
rQMD.
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Figure A: Carbon irradiations and respective Z–filtered dose contribution, for an 1 Gy Bragg Peak at 10 cm depth.
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Auxilliary programs
bpgen.cpp: database with energy and Bragg Peak positions to produce SOBP
1 //Bragg Peak ’ s E vs Pz code , vers ion 3.0 ( Jul2016 )
2 #include<std i o . h>
3 #include<s t d l i b . h>
4 #include<math . h>
5 #include<iostream>
6 #include<iomanip>
7 #include<str ing >
8 #include<fstream>
9 using namespace std ;
10 int main ( ) {
11 std : : o fstream o u t f i l e ;
12 o u t f i l e . open ( "Energy . dat" , std : : ios_base : : app ) ;
13 int a , y , i , n ;
14 char sce , ion ;
15 double x , z , p , p2 , p3 , p4 ,E, p5 , p6 ;
16 cout << "RSA−Jul2016_3.0−SOBPgen\n" << endl ;
17 cout << "Choose the l e t t e r corresponding to the de s i r ed i r r a d i a t i o n environment ; "<< endl ;
18 cout << "Basic − FLUKA Cal cu l a t i on s with Beam on Water Phantom (B) "<< endl ;
19 cout << "HIT − Incremented accord ing to Heide lberg ’ s setup (H) "<< endl ;
20 cout << "VOXEL − Voxel in s t ead o f water phantom with Heide lberg ’ s setup (V) "<< endl ;
21 cout << "Customized − For pe r s ona l i z ed geometr i e s (P) "<< endl ;
22 c in >> sce ;
23 // Previous f i t data app l i e s here
24 i f ( sce==’B ’ ) {
25 cout << "Please int roduce the Atomic Mass (8<A<17) o f the ion : "<< endl ;
26 c in >> a ;
27 //Flag for ions not yet implemented
28 i f (a<8 or a>17){ cout << "Patience i s a v i r tu e " << endl ; return 0 ;}
29 cout << "Def ine the plateau length (cm) : " << endl ;
30 c in >> x ;
31 cout << "Centered at which depth? (cm) : " << endl ;
32 c in >> z ;
33 cout << "Total number o f peaks to be generated : " << endl ;
34 c in >> y ;
35 cout << "\n\n" << endl ;
36 //Generating t a b l e
37 i f ( a==8){ ion=’B ’ ; }
38 i f ( a==9){ ion=’C ’ ; }
39 i f ( a==10){ ion=’C ’ ; }
40 i f ( a==11){ ion=’C ’ ; }
41 i f ( a==12){ ion=’C ’ ; }
42 i f ( a==13){ ion=’N ’ ; }
43 i f ( a==14){ ion=’O’ ; }
44 i f ( a==15){ ion=’O’ ; }
45 i f ( a==16){ ion=’O’ ; }
46 i f ( a==17){ ion=’F ’ ; }
47 cout << " _____________________"<<ion<<"−"<<a<<"__________________________ " << endl ;
48 cout << " |__Field___|_____Energy_(MeV/u)___|___Peak_Z_(cm)___| " << endl ;
49 //Mighty powers used in our f i t
50 for ( i =0; i<=y−1; i++){p = z − (x/2) +i ∗(x/(y−1) ) ;
51 p2 = p∗p ;
52 p3 = p∗p∗p ;
53 p4 = p∗p∗p∗p ;
54 p5 = p∗p∗p∗p∗p ;
55 p6 = p∗p∗p∗p∗p∗p ;
56 //Database of August 2016
57 i f ( a==8){
58 E = −0.0000008657∗p6 + 0.0000986864∗p5 −0.0046372990∗p4 + 0.1178606612∗p3 −1.8451014685∗p2 +
28.7175754188∗p + 38.8987935615 ;
59 cout << " | ( "<< s e t p r e c i s i o n (10) <<i<<" ) | "<<E<<" | "<< p <<" | " << endl ;
60 o u t f i l e << s e t p r e c i s i o n (12) << E << endl ; }
61 else i f ( a==9){
62 E = −0.0000018268∗p6 + 0.0001813354∗p5 −0.0074918738∗p4 + 0.1692761372∗p3 −2.3847886850∗p2 +
34.2141873721∗p + 42.6552189447 ;
63 cout << " | ( "<< s e t p r e c i s i o n (10) <<i<<" ) | "<<E<<" | "<< p <<" | " << endl ;
64 o u t f i l e << s e t p r e c i s i o n (12) << E << endl ; }
65 else i f ( a==10){
66 E = −0.0000012791∗p6 + 0.0001366633∗p5 −0.0060407346∗p4 + 0.1449100813∗p3 −2.1470493289∗p2 +
31.8644522456∗p + 40.7708279408 ;
67 cout << " | ( "<< s e t p r e c i s i o n (10) <<i<<" ) | "<<E<<" | "<< p <<" | " << endl ;
68 o u t f i l e << s e t p r e c i s i o n (12) << E << endl ; }
69 else i f ( a==11){
70 E = −0.0000007885∗p6 + 0.0000912957∗p5 −0.0043704710∗p4 + 0.1134971616∗p3 −1.8199914643∗p2 +
29.1918996333∗p + 40.4020030546 ;
71 cout << " | ( "<< s e t p r e c i s i o n (10) <<i<<" ) | "<<E<<" | "<< p <<" | " << endl ;
72 o u t f i l e << s e t p r e c i s i o n (12) << E << endl ; }
73 else i f ( a==12){
74 E = −0.0000007794∗p6 + 0.0000905893∗p5 −0.0043396583∗p4 + 0.1122961392∗p3 −1.7851777584∗p2 +
28.0422709316∗p + 38.0560267087 ;
75 cout << " | ( "<< s e t p r e c i s i o n (10) <<i<<" ) | "<<E<<" | "<< p <<" | " << endl ;
76 o u t f i l e << s e t p r e c i s i o n (12) << E << endl ; }
77 else i f ( a==13){
78 E = −0.0000013527∗p6 + 0.0001416543∗p5 −0.0061657168∗p4 + 0.1465320143∗p3 −2.1669027062∗p2 +
32.5225003906∗p + 42.2542439773 ;
79 cout << " | ( "<< s e t p r e c i s i o n (10) <<i<<" ) | "<<E<<" | "<< p <<" | " << endl ;
80 o u t f i l e << s e t p r e c i s i o n (12) << E << endl ; }
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81 //Dismissing A=14. . .
82 else i f ( a==14){
83 cout << "Train your mind to see the p o s i t i v e in every s i t u a t i o n "<< endl ; }
84 else i f ( a==15){
85 E = −0.0000026397∗p6 + 0.0002455236∗p5 −0.0095149104∗p4 + 0.2020229257∗p3 −2.6810657257∗p2 +
36.3976655724∗p + 42.9209091957 ;
86 cout << " | ( "<< s e t p r e c i s i o n (10) <<i<<" ) | "<<E<<" | "<< p <<" | " << endl ;
87 o u t f i l e << s e t p r e c i s i o n (12) << E << endl ; }
88 else i f ( a==16){
89 E = −0.0000021728∗p6 + 0.0002086695∗p5 −0.0083289183∗p4 + 0.1817978994∗p3 −2.4797973045∗p2 +
34.6060088414∗p + 42.2527126903 ;
90 cout << " | ( "<< s e t p r e c i s i o n (10) <<i<<" ) | "<<E<<" | "<< p <<" | " << endl ;
91 o u t f i l e << s e t p r e c i s i o n (12) << E << endl ; }
92 else i f ( a==17){
93 E = −0.0000044294∗p6 + 0.0003755346∗p5 −0.0132836210∗p4 + 0.2581423299∗p3 −3.1516142483∗p2 +
39.8534582220∗p + 44.1860760712 ;
94 cout << " | ( "<< s e t p r e c i s i o n (10) <<i<<" ) | "<<E<<" | "<< p <<" | " << endl ;
95 o u t f i l e << s e t p r e c i s i o n (12) << E << endl ; }
96 else { cout << "The sky above the port was the co l o r o f a Te lev i s i on , tuned to a death channel . . . "<<
endl ;
97 return 0 ;}}
98 cout << " −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−" << endl ; }
99 //Heide lberg scenario
100 else i f ( sce==’H ’ ) {
101 cout << "Please int roduce the Atomic Mass (8<A<17) o f the ion : "<< endl ;
102 c in >> a ;
103 //Flag for cases not yet implemented
104 i f (a<8 or a>17){ cout << "Patience i s a v i r tu e " << endl ; return 0 ;}
105 cout << "Def ine the plateau length (cm) : " << endl ;
106 c in >> x ;
107 cout << "Centered at which depth? (cm) : " << endl ;
108 c in >> z ;
109 cout << "Total number o f peaks to be generated : " << endl ;
110 c in >> y ;
111 cout << "\n\n" << endl ;
112 //Generating t a b l e
113 i f ( a==8){ ion=’B ’ ; }
114 i f ( a==9){ ion=’C ’ ; }
115 i f ( a==10){ ion=’C ’ ; }
116 i f ( a==11){ ion=’C ’ ; }
117 i f ( a==12){ ion=’C ’ ; }
118 i f ( a==13){ ion=’N ’ ; }
119 i f ( a==14){ ion=’O’ ; }
120 i f ( a==15){ ion=’O’ ; }
121 i f ( a==16){ ion=’O’ ; }
122 i f ( a==17){ ion=’F ’ ; }
123 cout << " _____________________"<<ion<<"−"<<a<<"__________________________ " << endl ;
124 cout << " |__Field___|_____Energy_(MeV/u)___|___Peak_Z_(cm)___| " << endl ;
125 // Implementing the new f i t data r e t r i e v ed from FLUKA simula t ions
126 for ( i =0; i<=y−1; i++){p = z − (x/2) +i ∗(x/(y−1) ) ;
127 p2 = p∗p ;
128 p3 = p∗p∗p ;
129 p4 = p∗p∗p∗p ;
130 i f ( a==8){
131 E = −0.000539868∗p4 + 0.0371249∗p3 − 1.03167∗p2 + 24.6565∗p + 63 .8477 ;
132 cout << " | ( "<< s e t p r e c i s i o n (10) <<i<<" ) | "<<E<<" | "<< p <<" | " << endl ;
133 o u t f i l e << s e t p r e c i s i o n (12) << E << endl ; }
134 else i f ( a==9){
135 E = −0.000539868∗p4 + 0.0371249∗p3 − 1.03167∗p2 + 24.6565∗p + 63 .8477 ;
136 cout << " | ( "<< s e t p r e c i s i o n (10) <<i<<" ) | "<<E<<" | "<< p <<" | " << endl ;
137 o u t f i l e << s e t p r e c i s i o n (12) << E << endl ; }
138 else i f ( a==10){
139 E = −0.000539868∗p4 + 0.0371249∗p3 − 1.03167∗p2 + 24.6565∗p + 63 .8477 ;
140 cout << " | ( "<< s e t p r e c i s i o n (10) <<i<<" ) | "<<E<<" | "<< p <<" | " << endl ;
141 o u t f i l e << s e t p r e c i s i o n (12) << E << endl ; }
142 else i f ( a==11){
143 E = −0.000539868∗p4 + 0.0371249∗p3 − 1.03167∗p2 + 24.6565∗p + 63 .8477 ;
144 cout << " | ( "<< s e t p r e c i s i o n (10) <<i<<" ) | "<<E<<" | "<< p <<" | " << endl ;
145 o u t f i l e << s e t p r e c i s i o n (12) << E << endl ; }
146 else i f ( a==12){
147 E = −0.000215611∗p4 + 0.0166102∗p3 − 0.57039∗p2 + 19.6732∗p + 72 . 444 ;
148 cout << " | ( "<< s e t p r e c i s i o n (10) <<i<<" ) | "<<E<<" | "<< p <<" | " << endl ;
149 o u t f i l e << s e t p r e c i s i o n (12) << E << endl ; }
150 else i f ( a==13){
151 E = −0.000215611∗p4 + 0.0166102∗p3 − 0.57039∗p2 + 19.6732∗p + 72 . 444 ;
152 cout << " | ( "<< s e t p r e c i s i o n (10) <<i<<" ) | "<<E<<" | "<< p <<" | " << endl ;
153 o u t f i l e << s e t p r e c i s i o n (12) << E << endl ; }
154 else i f ( a==14){
155 cout << "Maybe one day . "<< endl ; }
156 else i f ( a==15){
157 E = −0.000460215∗p4 + 0.0357108∗p3 − 1.09586∗p2 + 28.5532∗p + 73 .4068 ;
158 cout << " | ( "<< s e t p r e c i s i o n (10) <<i<<" ) | "<<E<<" | "<< p <<" | " << endl ;
159 o u t f i l e << s e t p r e c i s i o n (12) << E << endl ; }
160 else i f ( a==16){
161 E = −0.000202313∗p4 + 0.0169548∗p3 − 0.623042∗p2 + 23.1456∗p + 84 .8733 ;
162 cout << " | ( "<< s e t p r e c i s i o n (10) <<i<<" ) | "<<E<<" | "<< p <<" | " << endl ;
163 o u t f i l e << s e t p r e c i s i o n (12) << E << endl ; }
164 //Dismissing A=13 and A=14. . .
165 else { cout << "The sky above the port was the co l o r o f a Te lev i s i on , tunned to a death channel . . . "<<
endl ;
166 return 0 ;}}
167 cout << " −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−" << endl ; }
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168 //VOXEL scenario
169 else i f ( sce==’V ’ ) {
170 cout << "Please int roduce the Atomic Mass (8<A<17) o f the ion : "<< endl ;
171 c in >> a ;
172 //Flag for cases not yet implemented
173 i f (a<8 or a>17){ cout << "Patience i s a v i r tu e " << endl ; return 0 ;}
174 cout << "Def ine the plateau length (cm) : " << endl ;
175 c in >> x ;
176 cout << "Centered at which depth? (cm) : " << endl ;
177 c in >> z ;
178 cout << "Total number o f peaks to be generated : " << endl ;
179 c in >> y ;
180 cout << "\n\n" << endl ;
181 //Generating t a b l e
182 i f ( a==8){ ion=’B ’ ; }
183 i f ( a==9){ ion=’C ’ ; }
184 i f ( a==10){ ion=’C ’ ; }
185 i f ( a==11){ ion=’C ’ ; }
186 i f ( a==12){ ion=’C ’ ; }
187 i f ( a==13){ ion=’N ’ ; }
188 i f ( a==14){ ion=’O’ ; }
189 i f ( a==15){ ion=’O’ ; }
190 i f ( a==16){ ion=’O’ ; }
191 i f ( a==17){ ion=’F ’ ; }
192 cout << " _____________________"<<ion<<"−"<<a<<"__________________________ " << endl ;
193 cout << " |__Field___|_____Energy_(MeV/u)___|___Peak_Z_(cm)___| " << endl ;
194 // Implementing the new f i t data r e t r i e v ed from FLUKA simula t ions
195 for ( i =0; i<=y−1; i++){p = z − (x/2) +i ∗(x/(y−1) ) ;
196 p2 = p∗p ;
197 p3 = p∗p∗p ;
198 p4 = p∗p∗p∗p ;
199 i f ( a==8){
200 E = −0.000539868∗p4 + 0.0371249∗p3 − 1.03167∗p2 + 24.6565∗p + 63 .8477 ;
201 cout << " | ( "<< s e t p r e c i s i o n (10) <<i<<" ) | "<<E<<" | "<< p <<" | " << endl ;
202 o u t f i l e << s e t p r e c i s i o n (12) << E << endl ; }
203 else i f ( a==9){
204 E = −0.000539868∗p4 + 0.0371249∗p3 − 1.03167∗p2 + 24.6565∗p + 63 .8477 ;
205 cout << " | ( "<< s e t p r e c i s i o n (10) <<i<<" ) | "<<E<<" | "<< p <<" | " << endl ;
206 o u t f i l e << s e t p r e c i s i o n (12) << E << endl ; }
207 else i f ( a==10){
208 E = −0.000539868∗p4 + 0.0371249∗p3 − 1.03167∗p2 + 24.6565∗p + 63 .8477 ;
209 cout << " | ( "<< s e t p r e c i s i o n (10) <<i<<" ) | "<<E<<" | "<< p <<" | " << endl ;
210 o u t f i l e << s e t p r e c i s i o n (12) << E << endl ; }
211 else i f ( a==11){
212 E = −0.000539868∗p4 + 0.0371249∗p3 − 1.03167∗p2 + 24.6565∗p + 63 .8477 ;
213 cout << " | ( "<< s e t p r e c i s i o n (10) <<i<<" ) | "<<E<<" | "<< p <<" | " << endl ;
214 o u t f i l e << s e t p r e c i s i o n (12) << E << endl ; }
215 else i f ( a==12){
216 E = −0.000215611∗p4 + 0.0166102∗p3 − 0.57039∗p2 + 19.6732∗p + 72 . 444 ;
217 cout << " | ( "<< s e t p r e c i s i o n (10) <<i<<" ) | "<<E<<" | "<< p <<" | " << endl ;
218 o u t f i l e << s e t p r e c i s i o n (12) << E << endl ; }
219 else i f ( a==13){
220 E = −0.000215611∗p4 + 0.0166102∗p3 − 0.57039∗p2 + 19.6732∗p + 72 . 444 ;
221 cout << " | ( "<< s e t p r e c i s i o n (10) <<i<<" ) | "<<E<<" | "<< p <<" | " << endl ;
222 o u t f i l e << s e t p r e c i s i o n (12) << E << endl ; }
223 else i f ( a==14){
224 cout << "Maybe one day . "<< endl ; }
225 else i f ( a==15){
226 E = −0.000460215∗p4 + 0.0357108∗p3 − 1.09586∗p2 + 28.5532∗p + 73 .4068 ;
227 cout << " | ( "<< s e t p r e c i s i o n (10) <<i<<" ) | "<<E<<" | "<< p <<" | " << endl ;
228 o u t f i l e << s e t p r e c i s i o n (12) << E << endl ; }
229 else i f ( a==16){
230 E = −0.000202313∗p4 + 0.0169548∗p3 − 0.623042∗p2 + 23.1456∗p + 84 .8733 ;
231 cout << " | ( "<< s e t p r e c i s i o n (10) <<i<<" ) | "<<E<<" | "<< p <<" | " << endl ;
232 o u t f i l e << s e t p r e c i s i o n (12) << E << endl ; }
233 //Dismissing A=13 and A=14. . .
234 else { cout << "The sky above the port was the co l o r o f a Te lev i s i on , tunned to a death channel . . . "<<
endl ;
235 return 0 ;}}
236 cout << " −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−" << endl ; }
237 //Customized scenario
238 else i f ( sce==’P ’ ) {
239 cout << " Introduce the Atomic Mass o f the P r o j e c t i l e : "<< endl ;
240 c in >> a ;
241 cout << "And the atomic number : "<< endl ;
242 c in >> n ;
243 cout << "Def ine the plateau length (cm) : " << endl ;
244 c in >> x ;
245 cout << "Centered at which depth? (cm) : " << endl ;
246 c in >> z ;
247 cout << "Total number o f peaks to be generated : " << endl ;
248 c in >> y ;
249 cout << "\n\n" << endl ;
250 //Generating t a b l e
251 cout << " ___________________Z="<<n<<" ,A="<<a<<"_______________________ " << endl ;
252 cout << " |__Field___|_____Energy_(MeV/u)___|___Peak_Z_(cm)___| " << endl ;
253 // Implementing the new f i t data r e t r i e v ed from FLUKA simula t ions
254 for ( i =0; i<=y−1; i++){p = z − (x/2) +i ∗(x/(y−1) ) ;
255 p2 = p∗p ;
256 p3 = p∗p∗p ;
257 p4 = p∗p∗p∗p ;
258 p5 = p∗p∗p∗p∗p ;
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259 p6 = p∗p∗p∗p∗p∗p ;
260 i f (a>0){
261 //E = ( primus6 )∗p6 + ( primus5 )∗p5 + ( primus4 )∗p4 + ( primus3 )∗p3 + ( primus2 )∗p2 + ( primus1 )∗p + ( primus0 ) ;
262 cout << " | ( "<< s e t p r e c i s i o n (10) <<i<<" ) | "<<E<<" | "<< p <<" | " << endl ;
263 o u t f i l e << s e t p r e c i s i o n (12) << E << endl ; }
264 else { cout << "The sky above the port was the co l o r o f a Te lev i s i on , tunned to a death channel . . . "<<
endl ;
265 return 0 ;}}
266 cout << " −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−" << endl ; }
267 else { cout << "HAL 9000: Are you sure you ’ re making the r i gh t d e c i s i on ? I think we should stop . "<<
endl ; }
268 return 0 ;
269 return 0 ;}
supra.cpp: code providing the list of commands to produce SOBPs.
1 #include<std i o . h>
2 #include<s t d l i b . h>
3 #include<math . h>
4 #include<iostream>
5 #include<iomanip>
6 #include<str ing >
7 #include<fstream>
8 #define _USE_MATH_DEFINES
9 using namespace std ;
10 int main ( int argc , char ∗argv [ ] ) { int a , i , x , y , z ,w; char p lo t [ 5 0 ] ;
11 cout << "RSA−May2015−Suprasc r ip t " << endl ;
12 cout << "Total number o f S imulat ions /beam/dat f i l e s : " << endl ;
13 c in >> a ;
14 cout << " F i l e name : " << endl ;
15 c in >> plot ;
16 cout << "\n" << endl ;
17 //Send the r e s u l t s o f a l l f i l e s to a s i n g l e dat f i l e
18 cout << "paste " ;
19 x = 1 ;
20 y = 2 ;
21 for ( i =1; i<=a ; i++){ cout << plo t << s e t f i l l ( ’ 0 ’ ) << setw (2) << i <<" . dat " ; }
22 cout << " | awk \ ’{ pr in t " ;
23 cout << "$" << x << " , $" << y ;
24 for ( i =1; i<a ; i++){z = 4∗ i − 1 ;
25 cout <<" , $" << z ;}
26 w= 4∗a − 1 ;
27 //Take out the f i r s t l i n e and the bin information
28 cout << " , $" << w << "}\ ’ > bigdat . txt \n\n" << " t a i l −n+2 bigdat . txt > big . dat \n\ncut −d \" \"
−f 3− big . dat > nobin . dat \n\n" ;
29 //Retr ieve the l i n e s containing the maximum va lues
30 for ( i =1; i<a ; i++){ cout << "awk \ ’ $"<< i <<"> max { max = $"<< i <<" ; output = $0 } END { pr in t
output }\ ’ nobin . dat >> quad . dat && \n" ;}
31 cout <<"awk \ ’ $"<<a<<" > max { max = $"<< a <<" ; output = $0 } END { pr in t output }\ ’ nobin . dat >>
quad . dat\n\n" ;
32 f loat r ;
33 double norm ;
34 cout << "Def ine the usrb in p lo t rad ius \n" << endl ;
35 c in >> r ;
36 s e t p r e c i s i o n (10) ;
37 norm = 1 .0/ (M_PI∗ r ∗ r ∗1.602176462E−7) ;
38 cout<<f ixed<< "\nThe normal i zat ion f a c t o r i s : " << norm << endl ;
39 //Creating the vec tor for the normal izat ion
40 ofstream fout ;
41 fout . open ( " vector . dat" ) ;
42 for ( int i =0; i<a ; i++){ fout<<f ixed<<norm<< endl ; } ;
43 s t r i n g s lash , dat ;
44 //Use "\ t "
45 cout << "\nSeparator type ( in quotes ) \n" << endl ;
46 c in >> s l a sh ;
47 cout << "\nName of the output dat f i l e i s i v a l . dat by de f au l t \n" << endl ;
48 //R input
49 cout<<"\nA <− as . matrix ( read . tab l e (\" quad . dat \") ) \nV <− as . matrix ( read . tab l e (\" vector . dat \") ) \nx <−
s o l v e (A) %∗% V\nwrite . t ab l e (x , f i l e =\" i v a l . dat \" , sep="<< s l a sh <<" , co l . names = F, row . names =
F)"<< endl ;
50 s t r i n g u , v , col , t i t ;
51 char l og ;
52 char eps [ 2 0 ] ;
53 //Gnuplot input
54 cout << "\nGnuplot\n\ nHor izonta l l im i t s separated by :\ n" << endl ;
55 c in >> u ;
56 cout << "\ nVer t i ca l l im i t s separated by :\ n" << endl ;
57 c in >> v ;
58 cout << "\nChoose the name of the eps f i l e p lo t \n" << endl ;
59 c in >> eps ;
60 cout << "\nPlease s e l e c t the gnuplot co lor , w i s e ly . . . \ n" << endl ;
61 c in >> co l ;
62 cout << "\n . . . and the i np l o t t i t l e ( in quotes ) \n" << endl ;
63 c in >> t i t ;
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64 cout << "\nLog s c a l e y? (y or n) \n" << endl ;
65 c in >> log ;
66 cout<<"\n\ nset termina l p o s t s c r i p t eps enhanced co l o r s i z e 4 , 3 font ’ He lvet ica , 16 ’ s o l i d lw
3"<<"\ nset output \""<<eps<<"\"\ nset g r id "<<"\ nset yrange [ "<<v<<" ] "<<"\ nset
xrange [ "<<u<<" ]\ nset x l abe l ’Depth in water (cm) ’\ nset y l abe l ’ Dose (Gy) ’ " ;
67 i f ( log==’y ’ ) {cout<<"\ nset log y\n" ;}
68 else cout<<"\n" ;
69 cout<<" p lo t ’ b ig . dat ’ us 1 : ( "<<M_PI<<" ∗1.602176462E−7∗(" ;
70 for ( int i =3; i<2+a ; i++){
71 cout<<" ( $"<<i<<" )∗" ;
72 const int LINE_TO_FIND = i −2;
73 s t r i n g l i n e ;
74 i f s t r eam f ( " i v a l . dat" ) ;
75 for ( int k=0; k<LINE_TO_FIND; k++){ g e t l i n e ( f , l i n e ) ; }
76 cout<< l ine <<"+" ; } ;
77 int q = a + 2 ;
78 cout<<" ( $"<<q<<" )∗" ;
79 const int LINE_TO_FIND = a ;
80 s t r i n g l i n e ;
81 i f s t r eam f ( " i v a l . dat" ) ;
82 for ( int k=0; k<LINE_TO_FIND; k++){ g e t l i n e ( f , l i n e ) ; }
83 cout<< l i n e <<" ) ) w steps lw 1 l c rgb ’ "<< co l <<" ’ t i t l e " << t i t << endl ;
84 cout<<"\nepstopdf "<<eps<<endl ;
85 return 0 ;}
The data for the FLUKA simulations’ input is obtained using the energies retrieved with the
SOBPGen.cpp code, and respective fit. The supra.cpp program is then applied to obtain the SOBP.
This procedure still requires the user to apply the data output as input, sequentially in bash,
R and gnuplot scripts. For simplicity, a single code was created, in the form sequential bash shell
script to manipulate the data and plot the final result. The script used two programs: infra1.cpp
and infra2.cpp).
Script infra.sh:
#!/bin/bash
#infrascript
g++ infra1.cpp −o infra1 &&
make infra1 &&
./infra1 &&
chmod +x supra.sh &&
./supra.sh &&
Rscript script.r &&
g++ infra2.cpp −o infra2 &&
make infra2 &&
./infra2
gnuplot gnuscript.gp &&
Directory environment example:
[rdossant@krazny−cern−ch local]\$ ls −1 | sort −r
infra.sh
infra2.cpp
infra1.cpp
Carbonized_plot30.dat
Carbonized_plot29.dat
Carbonized_plot28.dat
Carbonized_plot27.dat
Carbonized_plot26.dat
Carbonized_plot25.dat
Carbonized_plot24.dat
Carbonized_plot23.dat
Carbonized_plot22.dat
Carbonized_plot21.dat
Carbonized_plot20.dat
Carbonized_plot19.dat
Carbonized_plot18.dat
Carbonized_plot17.dat
Filling in correctly the parameters asked, a plot will be automatically generated.
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infra1.cpp. First stage:
1 #include<std i o . h>
2 #include<s t d l i b . h>
3 #include<math . h>
4 #include<iostream>
5 #include<iomanip>
6 #include<str ing >
7 #include<fstream>
8 #define _USE_MATH_DEFINES
9 using namespace std ;
10 int main ( int argc , char ∗argv [ ] ) { int a , i , x , y , z ,w; char p lo t [ 5 0 ] ;
11 cout << "RSA−Jun2015−I n f r a . cpp (1/2) " << endl ;
12 cout << "Total number o f f i e l d dat f i l e s : " << endl ;
13 c in >> a ;
14 cout << " F i l e name : " << endl ;
15 c in >> plot ;
16 //Send the r e s u l t s o f a l l f i e l d s to a s i n g l e dat f i l e ( fu ture quad . dat )
17 ofstream fout ;
18 fout . open ( " supra . sh" ) ;
19 fout << "#!/bin /bash\n"<<"# supra s c r i p t \n\n"<<"paste " ;
20 x = 1 ;
21 y = 2 ;
22 for ( i =1; i<=a ; i++){ fout << plot << s e t f i l l ( ’ 0 ’ ) << setw (2) << i <<" . dat " ; }
23 fout << " | awk \ ’{ pr in t " ;
24 fout << "$" << x << " , $" << y ;
25 for ( i =1; i<a ; i++){z = 4∗ i − 1 ;
26 fout <<" , $" << z ;}
27 w= 4∗a − 1 ;
28 //Take out the f i r s t l i n e and the bin information
29 fout << " , $" << w << "}\ ’ > bigdat . txt \n\n" << " t a i l −n+2 bigdat . txt > big . dat \n\ncut −d \" \"
−f 3− big . dat > nobin . dat \n\n" ;
30 //Retr ieve the l i n e s containing the maximum va lues
31 for ( i =1; i<a ; i++){ fout << "awk \ ’ $"<< i <<"> max { max = $"<< i <<" ; output = $0 } END { pr in t
output }\ ’ nobin . dat >> quad . dat && \n" ;}
32 fout <<"awk \ ’ $"<<a<<" > max { max = $"<< a <<" ; output = $0 } END { pr in t output }\ ’ nobin . dat >>
quad . dat\n\n" ;
33 fout . c l o s e ( ) ;
34 //Now focus in vec . dat
35 f loat l , r , s ;
36 double norm ;
37 cout << "\nDefine the length o f the usrbin−1D window ( squared ) . . . " << endl ;
38 c in >> l ;
39 cout << " . . . the mater ia l dens i ty ( g/cm3) . . . " << endl ;
40 c in >> r ;
41 cout << " . . . and the SOBP ’ s DAP value (Gy. cm2) " << endl ;
42 c in >> s ;
43 s e t p r e c i s i o n (10) ;
44 norm = (1 .0∗ s∗ r ) /( l ∗ l ∗1.602176462E−7) ;
45 cout<<f ixed<< "\nThe normal i zat ion f a c t o r i s : " << norm << endl ;
46 //Creating the vec tor for the normal izat ion
47 fout . open ( " vector . dat" ) ;
48 for ( int i =0; i<a ; i++){ fout<<f ixed<<norm<< endl ; } ;
49 fout . c l o s e ( ) ;
50 s t r i n g s lash , dat ;
51 //Use "\ t "
52 cout << "\nSeparator type i s tab ( use quotes ) " << endl ;
53 c in >> s l a sh ;
54 fout . open ( " s c r i p t . r " ) ;
55 //R input
56 fout<<"#!/ usr /bin /Rscr ipt \nA <− as . matrix ( read . tab l e (\" quad . dat \") ) \nV <−
as . matrix ( read . tab l e (\" vector . dat \") ) \nx <− s o l v e (A) %∗%
V\nwrite . t ab l e (x , f i l e =\" i v a l . dat \" , sep="<< s l a sh <<" , co l . names = F, row . names = F)"<< endl ;
57 fout . c l o s e ( ) ;
58 return 0 ;}
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infra2.cpp. Second stage:
1 #include<std i o . h>
2 #include<s t d l i b . h>
3 #include<math . h>
4 #include<iostream>
5 #include<iomanip>
6 #include<str ing >
7 #include<fstream>
8 #define _USE_MATH_DEFINES
9 using namespace std ;
10 int main ( int argc , char ∗argv [ ] ) { int a ; s t r i n g u , v , col , t i t ; char l og ; f loat l , r ; char eps [ 2 0 ] ;
11 //Gnuplot input
12 cout << "\n RSA−Jun2015−I n f r a . cpp (2/2) \n Gnuplot \n Number o f f i e l d s : " << endl ;
13 c in >> a ;
14 cout << "Fie ld window l im i t l ( Area=l x l ) : " << endl ;
15 c in >> l ;
16 cout << "Mater ia l dens i ty : " << endl ;
17 c in >> r ;
18 cout << "Hor i zonta l l im i t s separated by : " << endl ;
19 c in >> u ;
20 cout << "Ve r t i c a l l im i t s separated by : " << endl ;
21 c in >> v ;
22 cout << "Choose the name of the eps f i l e p lo t " << endl ;
23 c in >> eps ;
24 cout << "Please s e l e c t the gnuplot co lor , w i s e ly . . . " << endl ;
25 c in >> co l ;
26 cout << " . . . and the i np l o t t i t l e ( in quotes ) " << endl ;
27 c in >> t i t ;
28 cout << "Log s c a l e y? (y or n) " << endl ;
29 c in >> log ;
30 ofstream fout ;
31 fout . open ( " gnusc r ip t . gp" , std : : i o s : : app ) ;
32 fout <<"#!/ usr /bin / gnuplot "<<endl ;
33 fout<<" se t termina l p o s t s c r i p t eps enhanced co l o r s i z e 4 , 4 font ’ He lvet ica , 16 ’ s o l i d lw 1"<<"\ nset
output \""<<eps<<" . eps \"\ nset g r id "<<"\ nset yrange [ "<<v<<" ] "<<"\ nset xrange [ "<<u<<" ]\ nset
x l abe l ’Depth in water (cm) ’\ nset y l abe l ’DAP (Gy. cm^2) ’ " ;
34 i f ( log==’y ’ ) { fout<<"\ nset log y\n" ;}
35 else fout<<"\n" ;
36 fout<<" p lo t ’ b ig . dat ’ us 1 : ( ( "<<l<<"/"<<r<<" )∗"<<l<<" ∗1.602176462E−7∗(" ;
37 for ( int i =3; i<2+a ; i++){ fout<<" ( $"<<i<<" )∗" ;
38 const int LINE_TO_FIND = i −2;
39 s t r i n g l i n e ;
40 i f s t r eam f ( " i v a l . dat" ) ;
41 for ( int k=0; k<LINE_TO_FIND; k++){ g e t l i n e ( f , l i n e ) ; }
42 fout<< l ine <<"+" ; } ;
43 int q = a + 2 ;
44 fout<<" ( $"<<q<<" )∗" ;
45 const int LINE_TO_FIND = a ;
46 s t r i n g l i n e ;
47 i f s t r eam f ( " i v a l . dat" ) ;
48 for ( int k=0; k<LINE_TO_FIND; k++){ g e t l i n e ( f , l i n e ) ; }
49 fout<< l i n e <<" ) ) w steps lw 1 l c rgb ’ "<< co l <<" ’ t i t l e " << t i t << endl ;
50 fout . c l o s e ( ) ;
51 fout . open ( " i n f r a . sh" , std : : i o s : : app ) ;
52 fout <<" epstopdf "<<eps<<" . eps &&"<<endl ;
53 fout <<"gnome−open "<<eps<<" . pdf &&"<<endl ;
54 // fou t <<"rm −r f b i g . dat i v a l . dat quad . dat b i gda t . t x t nobin . dat gnuscr ip t . gp s c r i p t . r "<<eps<<".eps
vec tor . dat ∗ . o &&"<<endl ;
55 fout <<" sed −n ’1 ,13p ’ i n f r a . sh > i n f r a . sh . tmp &&"<<endl ;
56 fout <<"cp i n f r a . sh . tmp i n f r a . sh &&"<<endl ;
57 fout <<"rm −r f i n f r a . sh . tmp"<<endl ;
58 fout . c l o s e ( ) ;
59 return 0 ;}
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Script0 Description
1
2 #!/bin/bash
3 #Script0
4 #Define beam type and input name
5 printf ’\n%s\n\n’ ’Generate and simulate various inputs with
50<E<450 MeV/u’
6 echo −n "Z: "
7 read Z
8 echo −n "A: "
9 read A &&
10 echo "Input name: "
11 read I &&
12 sed −i "s/HI−PROPE 6. 12./HI−PROPE
$Z. $A./g" $I.inp &&
13 #Multiply inputs
14 cp $I.inp $I−1_aa.inp;
15 #Abbreviated
16 cp $I.inp $I−1_dw.inp &&
17 #Generate energies in 50−450 MeV/n steps
18 sed −i ’s/keywordE/ 0.50 /g’ $I−1_aa.inp;
19 #Abbreviated
20 sed −i ’s/keywordE/ 0.450 /g’ $I−1_dw.inp &&
21 #Running inputs in short queue
22 SHORTY=/soft/flair/utils/qshort.sh
23 RUN=/soft/flukadev/flutil/rfluka
24 CARRASCO=$PWD/carrasco &&
25 echo "short queue: " $SHORTY
26 echo "full ldpmqmd executable location: " $CARRASCO
27 echo "Input name: " $I−1_i+
28 printf ’\n%s\n\n’ ’Just to verify last one...’
29 {
30 $SHORTY $RUN −e $CARRASCO −N0 −M10 $I−1_aa &&
31 #Abbreviated
32 $SHORTY $RUN −e $CARRASCO −N0 −M10 $I−1_dv &&
33 } &> /dev/null
34 $SHORTY $RUN −e $CARRASCO −N0 −M10 $I−1_dw
35 $
Requisites: a valid (HEAVYION) FLUKA in-
put.
The script will then automatically create
100 copies of such input, with:
1. User–defined A and Z to identify
the primary particle.
2. Different energy for each copy
— 100 steps of 4 MeV/u within a
50 and 450 MeV/u interval.
Following the simulations’ end, each of the 100 binning detectors must be plotted, creating 100
.dat files to be employed as input for the next script.
Out of these 100 .dat files, some energy and ion type combinations can lead to ranges surpassing
the length of the phantom (30 cm), creating artifacts. Only the valid cases out of 100 peaks were
picked up, the validity was ensured by plotting each individual .dat file in flair and verifying the
result.
The next script collects the 100 .dat files’ Bragg Peak positions and evaluates their position
against the corresponding beam energy as shown in figure B. This results in a polynomial fit, whose
parameters are promptly optimized with gnuplot to a 6th order polynomial which was verified to
correspond to a high fit quality.
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Script1
1 #!/bin/bash
2 #Script1 −− Identify the dat plots
3 printf ’\n%s\n\n’ ’Data processing, fit and plot generation’
4 echo "Input name: "
5 read I &&
6 #Take data from dat files
7 awk ’BEGIN{x=0;while(x<=9){print "sort −grk3 ’$I’_plot0"x".dat | tail −n +1 |head −1
>> adamantium.dat" >> "tempo.sh";x++}}’ OFMT=’%.15f’ &&
8 awk ’BEGIN{x=10;while(x<=99){print "sort −grk3 ’$I’_plot"x".dat | tail −n +1 |head −1
>> adamantium.dat" >> "tempo.sh";x++}}’ OFMT=’%.15f’ &&
9 sh tempo.sh &&
10 cat adamantium.dat
11 rm −rf tempo.sh &&
12 #Process data and add energy info
13 awk ’BEGIN {x=0; while(++x<=101){print 2*(x*2+23)}; exit}’ >> "adamantine.dat" &&
14 awk ’{getline f1 <"adamantine.dat" ; print f1,($1+$2)/2.0}’ OFMT=’%.15f’ <
adamantium.dat > adamant.dat &&
15 rm −rf adamantium.dat; rm −rf adamantine.dat &&
16 cat adamant.dat
17 #Creating gnuplot script
18 echo "Type of beam: "
19 read N &&
20 printf ’%s\n%s\n%s\n%s\n%s\n%s\n%s\n%s\n%s\n%s\n%s\n%s\n%s\n%s\n%s\n%s\n%s\n’ ’set
terminal postscript eps enhanced color size 6, 6 font "Helvetica,24" solid lw 1’
’set title "Fitting plot for ’$N’"’ ’set grid’ ’set size ratio 0.5’ ’set xrange
[0:30]’ ’set yrange [0:500]’ ’set xlabel "Depth (cm)"’ ’set ylabel "Initial
kinetic Energy (MeV/u)"’ ’set key top left font "Helvetica,16" Left ’ ’g(x) = h +
i*x + j*x**2 + k*x**3 + l*x**4 + m*x**5 + n*x**6’ ’fit [3:30] g(x) "adamant.dat"
u 2:1 via h,i,j,k,l,m,n’ ’ti =
sprintf("%.10f+%.10fx+\n%.10fx^{2}+%.10fx^{3}+\n%.10fx^{4}+%.10fx^{5}+\n%.10fx^{6}",
h, i, j, k, l, m, n)’ ’set output "gnufit.eps"’ ’plot "adamant.dat" us 2:1 w p pt
12 ps 1 lc rgb "dark−red" title "Bragg Peak location", g(x) w lines lw 2 lc rgb
"purple" t ti’ ’show variables’ ’set print "tmp.dat"’ ’print h,i,j,k,l,m,n’ >>
gnuscript.gp &&
21 #Now fitting with gnuplot...
22 gnuplot gnuscript.gp &&
23 epstopdf gnufit.eps &&
24 evince gnufit.pdf &&
25 rm −rf gnufit.eps; rm −rf adamant.dat; rm −rf gnuscript.gp; rm −rf gnufit.gp
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Terminal and graphic output
Data processing, fit and plot generation
Input name:
bare
0.71 0.72 2.16617918 0.0645973906
#Abbreviated, this is the original data in dat files
29.66 29.67 0.140467152 0.940728366
...
50 0.715000000000000
#Abbreviated, energy and Bragg Peak position
430 29.664999999999999
Type of beam:
B−8
#Convergence handled by gnuplot:
Iteration 0
#Abbreviated
Iteration 12
WSSR : 0.343896 delta(WSSR)/WSSR : −3.81237e−06
delta(WSSR) : −1.31106e−06 limit for stopping : 1e−05
lambda : 6.98552e−05
After 12 iterations the fit converged.
final sum of squares of residuals : 0.343896
rel. change during last iteration : −3.81237e−06
degrees of freedom (FIT_NDF) : 73
rms of residuals (FIT_STDFIT) = sqrt(WSSR/ndf) : 0.068636
variance of residuals (reduced chisquare) = WSSR/ndf : 0.0047109
Final set of parameters Asymptotic Standard Error
======================= ==========================
h = 38.8988 +/− 0.4093 (1.052%)
i = 28.7176 +/− 0.2314 (0.8057%)
j = −1.8451 +/− 0.04847 (2.627%)
k = 0.117861 +/− 0.004902 (4.159%)
l = −0.0046373 +/− 0.0002566 (5.532%)
m = 9.86864e−05 +/− 6.679e−06 (6.768%)
n = −8.65719e−07 +/− 6.833e−08 (7.893%)
#Abbreviated
ti = "38.8987935615+28.7175754188x+\n−1.8451014685x^{2}
+0.1178606612x^{3}+\n−0.0046372990x^{4}+0.0000986864x^{5}+\n−0.0000008657x^{6}"
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Figure B: Automatically generated fit plot, with parameters.
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Below 75 MeV/u, the fit diverges. Despite that, the SOBPs that will be generated in this work
are all beyond the 2.5 cm ranges in water, where the fit is adequate.
To pass the converged fit parameters to the Bragg Peak generator code, another code is required:
Script2 Output
1 #!/bin/bash
2 #Script2
3 #Write fit parameters to bpgen
4 cp −r bgen.cpp bpgenx.cpp &&
5 printf ’\n%s\n’ ’Unlock and apply
customization:’
6 sed −i ’s/\/\/E/ E/g’ bpgenx.cpp &&
7 p6="$(cut −d’ ’ −f7 < tmp.dat)" &&
8 echo "${p6}" &&
9 sed −i ’s/primus6/’${p6}’/g’ bpgenx.cpp
&&
10 p5="$(cut −d’ ’ −f6 < tmp.dat)" &&
11 echo "${p5}" &&
12 sed −i ’s/primus5/’${p5}’/g’ bpgenx.cpp
&&
13 p4="$(cut −d’ ’ −f5 < tmp.dat)" &&
14 echo "${p4}" &&
15 sed −i ’s/primus4/’${p4}’/g’ bpgenx.cpp
&&
16 p3="$(cut −d’ ’ −f4 < tmp.dat)" &&
17 echo "${p3}" &&
18 sed −i ’s/primus3/’${p3}’/g’ bpgenx.cpp
&&
19 p2="$(cut −d’ ’ −f3 < tmp.dat)" &&
20 echo "${p2}" &&
21 sed −i ’s/primus2/’${p2}’/g’ bpgenx.cpp
&&
22 p1="$(cut −d’ ’ −f2 < tmp.dat)" &&
23 echo "${p1}" &&
24 sed −i ’s/primus1/’${p1}’/g’ bpgenx.cpp
&&
25 p0="$(cut −d’ ’ −f1 < tmp.dat)" &&
26 echo "${p0}" &&
27 sed −i ’s/primus0/’${p0}’/g’ bpgenx.cpp
&&
28 #execute bpgen
29 g++ bpgenx.cpp −o bpgenx &&
30 rm −rf tmp.dat &&
31 make bpgenx &&
32 ./bpgenx
Append fitting factors to Bragg Peak generator
make: ‘bpgenx’ is up to date.
RSA−Jul2016_3.0−SOBPgen
Choose the letter corresponding to the desired
irradiation environment;
Basic − FLUKA Calculations with Beam on Water Phantom
(B)
HIT − Incremented according to Heildelberg’s setup (H)
VOXEL − Voxel instead of water phantom with
Heildelberg’s setup (V)
Customized − For personalized geometries (P)
P
Introduce the Atomic Mass of the Projectile:
8
And the atomic number:
5
Define the plateau length (cm):
3
Centered at which depth? (cm):
10
Total number of peaks to be generated:
9
___________________Z=5,A=8_______________________
|__Field___|_____Energy_(MeV/u)___|___Peak_Z_(cm)___|
| (0) | 201.916055 | 8.5 |
| (1) | 207.0673879 | 8.875 |
| (2) | 212.1372985 | 9.25 |
| (3) | 217.131463 | 9.625 |
| (4) | 222.0549953 | 10 |
| (5) | 226.9124914 | 10.375 |
| (6) | 231.7080716 | 10.75 |
| (7) | 236.445421 | 11.125 |
| (8) | 241.1278292 | 11.5 |
−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
Which results in the database bpgen.cpp. Its output, in text format, contains the energies
required for each Bragg Peak. These values are then appended to the source.f, for HIT–like
simulations, in the following manner:
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Description Script3
An executable hosting folder (exe) with three
type–files is needed:
1. Source.f – Fortran routine
2. Phasespace – File to be called
by source.f, containing the phases-
pace/energy beam parameters.
3. Makefile – Typical script to create the
executable from the Fortran file (using
ldpm3qmd).
The script3, on the right side, will then multi-
ply the exe folders, and:
• Convert the kinetic energies, originally
in MeV/u, into GeV for each phasespace
file.
• Create different source.f routines, from
the type–set, with an automatically de-
fined path.
• Fill each phasespace model file, with en-
ergies calculated from bpgen.cpp
• Compile and create executables.
1 #!/bin/bash
2 #Script3
3 #Introduce Energy values in source.f
4 printf ’\n%s\n\n’ ’Set Source.f Energy Parameters’
5 #Create a file for each energy (at HIT only 16 are used)
6 cp −r exe exe1; cp −r exe exe2; cp −r exe exe3; cp −r exe
exe4; cp −r exe exe5; cp −r exe exe6; cp −r exe exe7;
cp −r exe exe8; cp −r exe exe9; cp −r exe exe10; cp
−r exe exe11; cp −r exe exe12; cp −r exe exe13; cp
−r exe exe14; cp −r exe exe15 &&
7 #Convert the energy values from MeV/u to GeV
8 echo −n "A: "
9 read A &&
10 awk ’{print ($1*’$A’/1000),$2}’ OFMT=’%.8E’ Energy.dat >
energy.dat &&
11 cd exe; sed −i "s@keyword1@$(pwd)@" source.f; cd ..
12 #Abbreviated
13 cd exe15; sed −i "s@keyword1@$(pwd)@" source.f; cd ..
14 s1="$(awk ’NR==1’ energy.dat)"; echo "${s1}"; cd exe; sed
−i "s@keyword2@${s1}@" s4fluka.txt; cd ..
15 #Abbreviated
16 s16="$(awk ’NR==16’ energy.dat)"; echo "${s16}"; cd exe15;
sed −i "s@keyword2@${s16}@" s4fluka.txt; cd ..
17 # Executable makers
18 cd exe; make clean all; cd ..
19 #Abbreviated
20 cd exe15; make clean all; cd ..
With the executables created, the inputs can be set with the adequate energies for simulation
in a specific geometry, analogous to script0.
Script4 Description
1 #!/bin/bash
2 #Script4
3 #Define beam type and identify input
4 printf ’\n%s\n\n’ ’Generate and simulate 16 inputs (or other
number of peaks) with a proper energy/phase space’
5 echo "Input name: "
6 read I &&
7 sed −i "s/HI−PROPE 6. 12./HI−PROPE $Z.
$A./g" $I.inp &&
8 #Deactivate BEAMPOS, use a limit energy and activate source card
9 sed −i "s/BEAMPOS/SOURCE\n*BEAMPOS/g" $I.inp &&
10 sed −i "s/keywordE/1000.0 /g" $I.inp &&
11 sed −i "s/START 1E5/START 1E6/g" $I.inp &&
12 #Multiply for 16 inputs (unique energies)
13 cp $I.inp $I−1_aa.inp; cp $I.inp $I−1_ab.inp;
14 #Abbreviated and run procedure
15 $NORMAN $RUN −e $CARRASCO/exe/carb1 −N0 −M10 $I−1_aa &&
16 #Abbreviated } &> /dev/null
17 $NORMAN $RUN −e $CARRASCO/exe15/carb1 −N0 −M10 $I−1_ap
Requisites: An (HEAVYION) FLUKA input,
equivalent∗ to the one used before.
1. Create the right amount of edited
inputs, preparing them to be used
with source.f.
2. Single input → Unique Energy →
One Peak.
3. Run each input coupled with the
corresponding executables.
The transport, physics, and geometry parameters should remain identical to those used in the
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last steps. Otherwise the simulation could lack consistence. The scoring, on the other hand, may
be adapted, according to the user needs.
After the simulation, the results for ENERGY (or DOSE) deposition per primary particle are re-
trieved at the correct positions of the isoenergetic layer and lie in the base of the SOBP generation.
The last step is the definition of the particle intensity value for each peak, for attaining the right
dose magnitude in the SOBP. This is accomplished with:
Script5 Script6
Produce an output (ival.dat) contain-
ing the values of intensity for achieving
a SOBP, with a defined dose, and gen-
erate 1D plots.
1 #!/bin/bash
2 #infrascript
3 g++ infra1.cpp −o infra1 &&
4 make infra1 &&
5 ./infra1 &&
6 chmod +x supra.sh &&
7 ./supra.sh &&
8 Rscript script.r &&
9 g++ infra2.cpp −o infra2 &&
10 make infra2 &&
11 ./infra2
12 gnuplot gnuscript.gp &
Uses the ival.dat to produce 1D plots
or 2D maps, for different quantities be-
sides Energy Deposition (e.g. Annihila-
tion Events at Rest).
1 #!/bin/bash
2 #ultrascript
3 g++ ultra.cpp −o ultra &&
4 make ultra &&
5 ./ultra &&
6 chmod +x altra.sh &&
7 ./altra.sh &&
8 gnuplot gnusrbinx.gp &
Applying these programs, a plot of the corresponding output is obtained, as well as the number of
particles IS calculated to achieve the envisaged dose level in the SOBP. The IS values are appended
to the “ival.dat” file.
Provided the correct approximations were used for the beam line elements, the spots initial
kinetic energy, Bragg Peak positions and number of ions calculated should match those of the
research TPS data. An example of that agreement can be appreciated looking into table 5.2. As
for the RIβ+, these could not be compared with the research TPS data but the isoenergetic layers
kinetic energy values and number of ions calculated can be seen in table A.
Finally, for a PET simulation, “ival.dat” content must be included directly in START, for
the reconstruction requires every particle history to be included so that the coincidences can be
properly recorded. In fact, it requires not only the appropriate number of histories, these also need
to be independent which hinders the use of biasing techniques. Such constraint, result in a big CPU
burden and prevents the routine application of this method in clinical workflow.
ultra.cpp. Program to plot the SOBP data from the USRBIN.
1 #include<std i o . h>
2 #include<s t d l i b . h>
3 #include<math . h>
4 #include<iostream>
5 #include<iomanip>
6 #include<str ing >
7 #include<fstream>
8 #define _USE_MATH_DEFINES
9 using namespace std ;
10 int main ( int argc , char ∗argv [ ] ) { int a , i , x , y ,w, z ; s t r i n g u , v , col , t i t ; char l og ; char dim ; char nome [ 5 0 ] ;
11 cout << "\nRSA−Aug2015−u l t r a . cpp\n"<< endl ;
12 cout << "SOBP Ann ih i l l a t i on Map USRBIN plo t generator "<< endl ;
13 cout << "Choose 1 f o r an 1D USRBIN or 2 f o r a 2D USRBIN"<< endl ;
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14 c in >> dim ;
15 i f (dim==’ 2 ’ ) {
16 cout << "\nNumber o f P r i s t i n e Peaks in the SOBP: " << endl ;
17 c in >> a ;
18 cout << "Common f i l e name : " << endl ;
19 c in >> nome ;
20 ofstream fout ;
21 fout . open ( " a l t r a . sh" , std : : i o s : : app ) ;
22 fout << "#!/bin /bash\n"<<"# a l t r a s c r i p t \n\n"<<"paste " ;
23 x = 1 ;
24 y = 2 ;
25 for ( i =1; i<=a ; i++){ fout << nome << s e t f i l l ( ’ 0 ’ ) << setw (2) << i <<" . dat " ; }
26 fout << " | awk \ ’{ pr in t " ;
27 fout << "$" << x << " , $" << y ;
28 for ( i =1; i<a ; i++){z = 4∗ i − 1 ;
29 fout <<" , $" << z ;}
30 w= 4∗a − 1 ;
31 fout << " , $" << w << "}\ ’ > to t a l b i n . dat \n\n" ;
32 fout . c l o s e ( ) ;
33 f loat l , h ;
34 char eps [ 2 0 ] ;
35 cout << "Minimum value in co l o r s c a l e : " << endl ;
36 c in >> l ;
37 cout << "Maximum value in co l o r s c a l e : " << endl ;
38 c in >> h ;
39 cout << "Name of the output f i l e : " << endl ;
40 c in >> eps ;
41 fout . open ( " gnusrbinx . gp" , std : : i o s : : app ) ;
42 fout <<"#!/ usr /bin / gnuplot "<<endl ;
43 fout <<" se t termina l p o s t s c r i p t eps enhanced co l o r \ nset output \""<<eps<<" . eps \"\ nset t i t l e
’ ’\ nunset g r id \ nset x l abe l ’Z (cm) ’\ nset x t i c s \ nset y l abe l ’X (cm) ’\ nset y t i c s \ nset cb l abe l
’ ’\ nset c b t i c s \nunset l o g s c a l e x\nunset l o g s c a l e y\nunset l o g s c a l e z\ nset l o g s c a l e cb\ nset
cbrange [ "<<l<<" : "<<h<<" ]\ nunset l o g s c a l e x2\nunset l o g s c a l e y2\ nset s i z e r a t i o 1\ nset key
de f au l t \ nset s t y l e l i n e 1 l t −1 lw 1\ nset cbrange [ "<<l<<" : "<<h<<" ]\ nset co lorbox v e r t i c a l \ nset
pm3d map e x p l i c i t c o rn e r s 2 c o l o r c1\ nset pa l e t t e de f ined (0 0 .0 0 .0 0 .5 ,1 0 .0 0 .0 1 .0 ,2 0 .0
0 .5 1 .0 ,3 0 .0 1 .0 1 .0 ,4 0 .5 1 .0 0 .5 ,5 1 .0 1 .0 0 .0 ,6 1 .0 0 .5 0 .0 ,7 1 .0 0 .0 0 .0 ,8 0 .5 0 .0
0 .0 ) \ nset pa l e t t e maxcolors 200\ nset l o g s c a l e cb"<< endl ;
44 fout <<" sp l o t ’ t o t a l b i n . dat ’ us 1 : 2 : ( " ;
45 for ( int i =3; i<2+a ; i++){
46 fout<<" ( $"<<i<<" )∗" ;
47 const int LINE_TO_FIND = i −2;
48 s t r i n g l i n e ;
49 i f s t r eam f ( " i v a l . dat" ) ;
50 for ( int k=0; k<LINE_TO_FIND; k++){
51 g e t l i n e ( f , l i n e ) ; }
52 fout<< l ine <<"+" ; } ;
53 int q = a + 2 ;
54 fout<<" ( $"<<q<<" )∗" ;
55 const int LINE_TO_FIND = a ;
56 s t r i n g l i n e ;
57 i f s t r eam f ( " i v a l . dat" ) ;
58 for ( int k=0; k<LINE_TO_FIND; k++){
59 g e t l i n e ( f , l i n e ) ; }
60 fout<< l i n e <<" ) w image n o t i t l e " << endl ;
61 fout . c l o s e ( ) ;
62 fout . open ( " u l t r a . sh" , std : : i o s : : app ) ;
63 fout <<" epstopdf "<<eps<<" . eps &&"<<endl ;
64 fout <<"gnome−open "<<eps<<" . pdf &&"<<endl ;
65 fout <<" sed −n ’1 ,9p ’ u l t r a . sh > u l t r a . sh . tmp &&"<<endl ;
66 fout <<"cp u l t r a . sh . tmp u l t r a . sh &&"<<endl ;
67 fout <<"rm −r f u l t r a . sh . tmp"<<endl ;
68 fout . c l o s e ( ) ; }
69 else i f (dim==’ 1 ’ ) { cout << "\nNumber o f P r i s t i n e Peaks in the SOBP: " << endl ;
70 c in >> a ;
71 cout << "Common f i l e name : " << endl ;
72 c in >> nome ;
73 ofstream fout ;
74 fout . open ( " a l t r a . sh" , std : : i o s : : app ) ;
75 fout << "#!/bin /bash\n"<<"# a l t r a s c r i p t \n\n"<<"paste " ;
76 x = 1 ;
77 y = 2 ;
78 for ( i =1; i<=a ; i++){ fout << nome << s e t f i l l ( ’ 0 ’ ) << setw (2) << i <<" . dat " ; }
79 fout << " | awk \ ’{ pr in t " ;
80 fout << "$" << x << " , $" << y ;
81 for ( i =1; i<a ; i++){z = 4∗ i − 1 ;
82 fout <<" , $" << z ;}
83 w= 4∗a − 1 ;
84 fout << " , $" << w << "}\ ’ > to t a l b i n . dat \n\n" << " t a i l −n+2 to t a l b i n . dat > bin . dat \n\n" ; ;
85 fout . c l o s e ( ) ;
86 char eps [ 2 0 ] ;
87 cout << "Hor i zonta l l im i t s separated by : " << endl ;
88 c in >> u ;
89 cout << "Ve r t i c a l l im i t s separated by : " << endl ;
90 c in >> v ;
91 cout << "Please s e l e c t the gnuplot co lor , w i s e ly . . . " << endl ;
92 c in >> co l ;
93 cout << " . . . and the i np l o t t i t l e ( in quotes ) " << endl ;
94 c in >> t i t ;
95 cout << "Log s c a l e y? (y or n) " << endl ;
96 c in >> log ;
97 cout << "Name of the output f i l e : " << endl ;
98 c in >> eps ;
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99 fout . open ( " gnusrbinx . gp" , std : : i o s : : app ) ;
100 fout <<"#!/ usr /bin / gnuplot "<<endl ;
101 fout<<" se t termina l p o s t s c r i p t eps enhanced co l o r s i z e 4 , 4 font ’ He lvet ica , 16 ’ s o l i d lw 1"<<"\ nset
output \""<<eps<<" . eps \"\ nset g r id "<<"\ nset yrange [ "<<v<<" ] "<<"\ nset xrange [ "<<u<<" ]\ nset
x l abe l ’Depth in water (cm) ’\ nset y l abe l ’DAP (Gy. cm^2) ’ " ;
102 i f ( log==’y ’ ) { fout<<"\ nset log y\n" ;}
103 else fout<<"\n" ;
104 fout <<" p lo t ’ bin . dat ’ us 1 : ( " ;
105 for ( int i =3; i<2+a ; i++){ fout<<" ( $"<<i<<" )∗" ;
106 const int LINE_TO_FIND = i −2;
107 s t r i n g l i n e ;
108 i f s t r eam f ( " i v a l . dat" ) ;
109 for ( int k=0; k<LINE_TO_FIND; k++){ g e t l i n e ( f , l i n e ) ; }
110 fout<< l ine <<"+" ; } ;
111 int q = a + 2 ;
112 fout<<" ( $"<<q<<" )∗" ;
113 const int LINE_TO_FIND = a ;
114 s t r i n g l i n e ;
115 i f s t r eam f ( " i v a l . dat" ) ;
116 for ( int k=0; k<LINE_TO_FIND; k++){ g e t l i n e ( f , l i n e ) ; }
117 fout<< l i n e <<" ) w steps lw 1 l c rgb ’ "<< co l <<" ’ t i t l e " << t i t << endl ;
118 fout . c l o s e ( ) ;
119 fout . open ( " u l t r a . sh" , std : : i o s : : app ) ;
120 fout <<" epstopdf "<<eps<<" . eps &&"<<endl ;
121 fout <<"gnome−open "<<eps<<" . pdf &&"<<endl ;
122 fout <<" sed −n ’1 ,9p ’ u l t r a . sh > u l t r a . sh . tmp &&"<<endl ;
123 fout <<"cp u l t r a . sh . tmp u l t r a . sh &&"<<endl ;
124 fout <<"rm −r f u l t r a . sh . tmp"<<endl ;
125 fout . c l o s e ( ) ; }
126 else { cout << "HAL 9000: Are you sure you ’ re making the r i gh t d e c i s i on ? I think we should stop . "<< endl ; }
127 return 0 ;}
For the three geometries analyzed in the present work, and nine ion species, the program
bpgen.cpp generates energy values to create SOBPs based on FLUKA simulations with different
characteristics. Also, for a customized geometry, and provided enough simulated results (within
the desired energy range) are provided, the code can deliver fitted data to create the SOBP. An
example of the calculated polynomial expressions can be appreciated in the next page, while a
visual representation is provided in figure C.
As mentioned already in chapter 3, if the phantom is very heterogeneous over the lateral inte-
gration limits the number of ions calculated will not converge correctly and other approaches should
be used, such as the evolutionary algorithms refered to in chapter 5.
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Example of the list of polynomial fit expressions (E vs z) for the basic scenario without beam
line elements, as applied in bpgen.cpp, with the respective curves plotted below in figure C.
EB-8 = −8.657 × 10
−7
z
6
+ 9.869 × 10−5z5 − 4.637 × 10−3z4 + 0.1178606612z3 − 1.8451014685z2 + 28.7175754188z + 38.8987935615
EC-9 = −1.827 × 10
−6
z
6
+ 1.813 × 10−4z5 − 7.492 × 10−3z4 + 0.1692761372z3 − 2.3847886850z2 + 34.2141873721z + 42.6552189447
EC-10 = −1.279 × 10
−6
z
6
+ 1.367 × 10−4z5 − 6.041 × 10−3z4 + 0.1449100813z3 − 2.1470493289z2 + 31.8644522456z + 40.7708279408
EC-11 = −7.885 × 10
−7
z
6
+ 9.130 × 10−5z5 − 4.371 × 10−3z4 + 0.1134971616z3 − 1.8199914643z2 + 29.1918996333z + 40.4020030546
EC-12 = −7.794 × 10
−7
z
6
+ 9.059 × 10−5z5 − 4.340 × 10−3z4 + 0.1122961392z3 − 1.7851777584z2 + 28.0422709316z + 38.0560267087
EN-13 = −1.353 × 10
−6
z
6
+ 1.417 × 10−4z5 − 6.166 × 10−3z4 + 0.1465320143z3 − 2.1669027062z2 + 32.5225003906z + 42.2542439773
EO-15 = −2.640 × 10
−6
z
6
+ 2.455 × 10−4z5 − 9.515 × 10−3z4 + 0.2020229257z3 − 2.6810657257z2 + 36.3976655724z + 42.9209091957
EO-16 = −2.173 × 10
−6
z
6
+ 2.087 × 10−4z5 − 8.329 × 10−3z4 + 0.1817978994z3 − 2.4797973045z2 + 34.6060088414z + 42.2527126903
EF-17 = −4.429 × 10
−6
z
6
+ 3.755 × 10−4z5 − 1.328 × 10−2z4 + 0.2581423299z3 − 3.1516142483z2 + 39.8534582220z + 44.1860760712
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Figure C: Polynomial expressions plotted for the different ions, without beam line elements.
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Appendix B
PET implementation description
The Siemens Biograph mCT PET/CT is a CE-labelled model regarded as having a high sensitivity,
making use of thick LSO crystals and an extended axial FOV. The scanner parameters are described
below in table B.
Table B: Siemens Biograph mCT PET device general parameters[Jak11, STP08].
Patented PET Detector Assembly Biograph (TrueV)
Detector Material LSO
Crystal Dimensions 0.4×0.4×2 (cm)
Crystals per detector block 169 (1×13×13)
Number of detector blocks 192 (48×4)
Photomultiplier tubes 4 per block
Detector ring radius 42.1 cm
Detectors per ring 624 (48×13)
Number of detector rings 52 (4×13)
Total number of detectors 32448 (1×13×13×48×4)
Transaxial FOV 60.5 cm
Axial FOV 21.6 cm
Number of image planes 109 (52 crystals + 3 artificial)×2–1
Plane spacing 2 mm
PET Data Acquisition/Processing Biograph (TrueV)
Coincidence time resolution 500 ps
Coincidence window 4.5 ns
Its scintillator material is characterized by a relatively high light output, effective Z, and density.
In spite of that, LSO crystals are a (known) additional source of background, affecting the quality
of reconstructed images, an effect mitigated by both the increased counts and corrective factors
in reconstruction algorithms. In validation studies, to certify the models’ performance, a source
of noise could be applied (e.g. simulating a 176Lu source) to model the background[Poo15]. This
approach was not followed, as it was not deemed necessary for the goal of this work which focused
in the comparison among the signals induced by different ion species.
The PET scanner structural elements, in the different stages of the construction process, are
illustrated in the next page as seen in flair. The unitary element is the scintillation crystal detector,
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Table C: Siemens Biograph mCT PET device post–processing parameters[Jak11]
Feature (dimensions in cm, time in ns) Value
Number of ring steps (segments of the ring) 48
Number of blocks per ring step (block line in y, z) 1, 1
Ring radius & field of view 42.1, 21.6
Number of crystals per block in x,y,z directions 1, 13, 55 (de facto 52)
Crystal dimension inside the block (z-axial, y-transaxial, x-radial) y = 0.4, z = 0.4
Separation between adjacent crystals, in x, y, z directions y = 0.005, z = 0.005
Arc correction On
Maximum ring difference 109 (includes artificial)
Number of segments 9
Axial span number 11
Angular sinogram mashing Off
Time coincidence window for coincidence pairs 4.1
Coincidence dead time 500
Postprocessing parameters
*# Parameters for BIO
*# Number of ring steps (segments of the ring)
NMODUL = 48
*# Number of blocks per ring step (block line in y,z)
NYBLOC = 1
NZBLOC = 1
*# Radio and field of view of the ring
RADFOV = 42.10000
ZZZFOV = 21.6
*# Number of crystals per block in x,y,z directions
NXCRYS = 1
NYCRYS = 13
NZCRYS = 52
*# Dimensions of cristals inside the block (z = axial, y =
transaxial, x = radial) in cm
YYYCRY = 0.400000
ZZZCRY = 0.400000
*# Separation between adjacent crystals in x,y,z directions in
cm
YSEPCR = 0.005000
ZSEPCR = 0.005000
*# Arc correction (on = 1, off = 0)
NUMARC = 1
*# Maximum Ring Difference (Default = rings−1)
MAXRDF = 109
*# Number of segments (Default = 2*rings−1)
NSEGMN = 9
*# Axial span number (Default = 1 (off))
NMSPAN = 11
*# Angular sinogram mashing (Default = 0 (off))
NMMASH = 0
*# Output file unit number (positive ascii, negative binary)
LUNPET = 41
*# Time coincidence window for coincidence pairs [ns]
TCWPET = 4.5
*# Coincidence dead−time [ns] (don’t confuse with the singles
dead−time)
* If > 0 : Non−paralyzable dead time
* The new dead−time period is the one of the old hit
* If < 0 : Paralyzable dead time
* The dead−time is restarted, the new one is the
* old hit DT plus the DT of the new hit
DTMPET = 100.0
Required FLUKA input cards
*...+....1....+....2....+....3....+....4....+....5....+....6....+....7....+....
Initialization card for PET parameters:
#1 : Minimum region number of PET crystals
#2 : Minimum lattice number of PET crystals
#3 : Number of modules per ring
#4 : Number of crystals per module in X direction
#5 : Number of crystals per module in Y direction
#6 : Number of crystals per module in Z direction
USRICALL PET00000 1. 48. 1. 13. 52.
DIMEN
Initialization card for PET parameters:
#1: Output unit (negative for binary, positive for ASCII)
#2: Ewindow (set as E0−dw, E0+dw with E0=511 keV) [GeV]
#3: Ewindow (set as E0−dw, E0+dw with E0=511 keV) [GeV]
#4: Minimum acquisition time [s]
#5: Maximum acquisition time [s]
#6: Time resolution of the detector [ns]
USRICALL 41. 4.35E-04 6.5E-04 0. 1E+99
.14 SCORE
1: Pulse time of the detector [ns]
2: Dead time of the detector [ns] (positive: Non-paralyzable,
negative: paralyzable, 0: not considered[default])
USRICALL 50. 500. SCORE2
Call user routine mgdraw.f to dump info about energy
deposition and time
USERDUMP 100. 40. 0.0 1. hits
Arc correction can be applied to account for the effect of the shape of the scanner to the radial bin
size. Maximum ring difference describes the range of rings that will participate in the generation of
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LORs. Span and Mashing factor refer to the reduction of axial and angular sampling, respectively.
Segment number option will affect the number of segments de facto used in the 3D reconstruction.
Additionally, in the post processing folder of the PET routines, the Michelogram dimensions in
(IFLHDR) must be tuned according to the PET scanner model employed. For the PET Biograph
mCT, the optimal parameters considered were:
— MAXSGM: 9
— MAXRNG: 109
— MAXCRI: 416
Where MAXSEG, MAXRNG and MAXCRI are the maximum number of segments, rings and crystals
to be taken into account in the Michelogram, respectively.
USERDUMP. Processing script for beam–time structure and PET acquisition time (modified)
1 #!/ bin/bash
2 #Code was cut ted for USERDUMP1 only . . . for presentat ion reasons
3 #Cutting header
4 t a i l −n+3 ∗ aa001_fort . 41 > f i l t a a y &&
5 #Print ing the time and Parent i so tope data
6 awk ’{ p r i n t $1 " " $12 " " $17 } ’ f i l t a a y > f i l t a aw &&
7 #Contro l led Random Number generation . . .
8 awk ’{ p r i n t $1 } ’ f i l t a aw > tmp1 &&
9 #Preserve random number cor re l a t i on with ID
10 awk ’{ tempo=$1 /( ’ $ (awk ’END{ pr in t } ’ tmp1) ’+ ’$ (awk ’NR==1’ tmp1) ’ ) ; printf "%0.1E\n" ,
tempo } ’ tmp1 > rand1 &&
11 #Take out the garbage
12 rm −r f tmp∗ &&
13 #Join Random numbers and Times in the same f i l e , for the subsequent operation
14 cut −f 2 f i l t a aw >> tmp &&
15 cut −f 1 rand1 | paste tmp − >> f i l t a a x &&
16 rm −r f tmp rand1 &&
17 #take out the garbage
18 rm −r f f i l t a ∗w &&
19 #Apply Beam time Structure . . . Note to s e l f . . . carbon =/= oxygen
20 awk ’{ printf ( "%i %1.19E %1.19E \n" , $1 , $2 , $3 ) } ’ f i l t a a x > f i l t a a z &&
21 #Join the correc t times to the main data l i s t
22 paste f i l t a a y f i l t a a z > f i l t a a v &&
23 #Take garbage out
24 rm −r f f i l t a ∗z &&
25 rm −r f f i l t a ∗y &&
26 rm −r f f i l t a ∗x &&
27 #Create data s e t s in o r i g i na l format with correc t beam time s t ruc ture s
28 awk ’{ printf ( "%13s%13s%13s%13s%8s%8s%8s%8s%32s%32s%32s%32s%32s%32s%32s%32s%32s%32s%32s
29 %10s%10s \n" , $1 , $2 , $3 , $4 , $5 , $6 , $7 , $8 , $9 , $10 , $11 , $23 , $13 , $14 , $15 , $16 , $24 ,
30 $18 , $19 , $20 , $21 ) } ’ f i l t a a v >f i l t a a u &&
31 #Create new s in g l e f i l e for the f i l t e r i n g by PET acqu i s i t i on times
32 sed −n ’1 ,2p ’ Carbonized−1_aa001_fort . 41 > Carbonized−1_aa001_fort . 42 &&
33 awk ’ $12 >= 4.3E11 { pr in t $0 } ’ f i l t a a u > tmp &&
34 awk ’ $12 <= 1.93E12 { pr in t $0 } ’ tmp >> Carbonized−1_aa001_fort . 42 &&
35 rm −r f tmp &&
36 #Take garbage out
37 rm −r f f i l t a ∗v &&
38 rm −r f f i l t a ∗u
Appendix C
Effect of reversing SOBP layers
The layer delivery sequence from the lowest to the highest energy penalizes online PET acquisitions
since the most energetic isoenergetic layers compose the vast majority of the total beam particles
delivered (∼ 30% of which in the last layer). Consequently, the signal acquired from β+ emitters
generated within the online PET acquisition time could be in theory improved if the beam delivery
sequence is inverted, since the effect of biological washout is not being accounted for in this work.
In this way, the contribution from the signal induced by the more relevant isoenergetic layers will
be taken into account for the reconstruction.
In order to evaluate the effect that a reverted sequence would have in the online PET signal
acquisition the total event output previously obtained was reprocessed using the scripts developed
in this work, but with an inverse SOBP order, the resulting plot can be seen in figure D. The total
PET acquisition time was kept as 130 s and the intensity value of each isoenergetic layer was also
preserved.
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Figure D: Comparison between online PET signal acquisition obtained from SOBPs with a reverted and “standard”
energy layer delivery order. The counts pertaining the reverted SOBPs correspond to open symbols and appear primed
in the legend.
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The improvement verified with RIβ+ can be ascribed to an increase in acquired signal from
additional isotope decays, namely 15O in the case of 15O ion beam and 11C and 10C in the case of
11C ion irradiation, as shown in table D.
Table D: Coincidence events filtered by parent isotope in the online PET acquisition with a reverted SOBP, and
respective variation with respect to the values previously reported in table 5.5 (in italics).
Acquisition Ion beam 8B 9C 10C 11C 12N 13N 13O 14O 15O
11C 34403 8413 158484 148409 3212 2450 485 3368 77123
Online 12C 19840 3297 27202 18341 4225 2326 376 3037 72412
15O 22285 5854 31293 9498 8345 8163 2863 34019 670745
16O 15888 2917 18619 8682 3903 3028 743 5414 99769
11C +106 +5 +55578 +73253 +2 +1442 0 +1739 +42924
Variation 12C +55 +4 +10213 +10404 +2 +1356 -2 +1115 +40671
15O -23 +3 +8337 +4642 +18 +3690 +3 +13271 +246009
16O -10 +54 +5144 +4320 +8 +1429 0 +2353 +45297
Applying the same methodology used in table 5.6, one can observe a substantial improvement
in online range verification when the SOBP order is reverted, as displayed in table E. In fact, while
the stable ion beams results are still affected by the background noise, the RIβ+ maximum lies
within ∼ 1 mm of the distal edge of the SOBP. Particularly, 15O ∆W50% and distal fall off values
are comparable to the offline PET coincidence event counts results observed in table 5.6, but with
a fraction of the acquisition time only.
Table E: Characterization of coincidence event counts and the SOBP dose profile in an online PET acquisition
scenario with a standard and a reversed SOBP.
Dataset Characteristic 11C 12C 15O 16O
Ions delivered 6.93× 108 6.61× 108 4.44× 108 4.31× 108
Dose SOBP Proximal edge [cm] 8.71± 0.1 8.72± 0.1 8.70± 0.1 8.80± 0.1
Distal edge [cm] 11.63± 0.1 11.63± 0.1 11.64± 0.1 11.63± 0.1
Online (standard)
max. value 20407 16301† 26823 14492†
Coincidence max. position [cm] 10.3± 0.1 20.7± 0.1† 10.3± 0.1 20.7± 0.1†
event counts ∆W90% [cm] 2.3± 0.1 — 2.3± 0.1 —
(PET) ∆W50% [cm] 16.3± 0.1 — 4.1± 0.1 —
Distal fall–off [mm] 97± 1 — 91± 1 —
Online (reversed)
max. value 31795 16444† 63880 15704
Coincidence max. position [cm] 11.5± 0.1 20.7± 0.1† 11.7± 0.1 11.1± 0.1
event counts ∆W90% [cm] 0.7± 0.1 — 0.5± 0.1 —
(PET) ∆W50% [cm] 3.2± 0.1 — 1.7± 0.1 —
Distal fall–off [mm] 88± 1 — 10± 1 —
† Inconclusive due to the high background level.
Appendix D
Magnetic Rigidity
A secondary beam, such as in HIMAC, is subject to contamination with different fragments upon
extraction. These follow the same curvature of the deflected beam, as the magnetic field acts on
the ions, an effect that is characterized by a unique value of the magnetic Rigidity (maximum of
8.13 [Tm] for the secondary beam line),
Bρ =
p
q
[Tm] (1)
Where B is the magnetic field, p the momentum [kg m s−1], q the charge [C], and ρ the gyroradius
[m]. Different combinations of ion energy, mass and charge may then result in similar magnetic
rigidities, ultimately leading to the presence of “impurities” in the extracted beam.
Even though the overall experimental impurity levels are very low for both 11C and 15O beams,
their impact on the “fragmentation tail dose” after the Bragg Peak, could still be of relevance, hence
the need to characterize these fragments.
Firstly, to identify these fragments the combinations of mass, charge and energy that lead to
equivalent gyroradius value must be found, as the magnetic field is constant. However, it should be
noted that, at hadrontherapy energies, relativistic effects need to be accounted for. Thus, defining
the kinetic Energy (T ) as
E = T +m0c
2 =
√
p2c2 +m2pc
4, (2)
where m0 is the rest mass and mp the mass of the projectile. Since p is related to E by
E2 = p2c2 + (m0c
2)2 ⇔ p =
√
E2 − (m0c2)2
c2
.
Inserting E from equation 2, in the above expression, it follows that
p =
√
(T +m0c2)2 − (m0c2)2
c2
⇔ p = 1
c
√
T 2 + 2Tm0c2
Substituting in equation 1, it leads to
Bρ =
1
qc
√
T 2 + 2Tm0c2. (3)
As Bρ will be used as a constant term, the following manipulation can be applied:
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(Bρ)2 =
T 2 + 2Tm0c
2
q2c2
.
Simplifying using; [p] ≡ [MeV/c] [T] ≡ [MeV/u] [m] ≡ [MeV/c2].
In order to compute more easily the above mentioned equation, the atomic mass number (A),
charge number (Z) will be singled out to identify different impurities.
Assuming that the total rest mass can be expressed approximately as m0 ≈ 931.4940954 × A
[MeV/c2], disregarding the minor effects of binding energy, the following relation is valid:
(Bρ)2 ∼ A
2T 2 + 2TAm0
Z2
∼ TA(TA+ 2× 931.4940954×A)
Z2
.
Comparing two different ion species of equal Bρ, their relationship is
A2
Z2
T (T + 2× 931.4940954) = A
′2
Z ′2
T ′(T ′ + 2× 931.4940954),
Where the primed values are impurity ions attributes. Therefore, solving for T ′ becomes simply
a quadratic polynomial problem, implemented in the following code. The code produces a matrix of
“possible” impurity kinetic energies for Z and A up to 10 and 20, respectively. This can be used to
map their variation depending on the principal extracted ion characteristics, and reproduce possible
“contaminant” beams in future simulations for a better agreement with experimental data.
riggy.cpp. Rigidity code.
1 #include <std i o . h>
2 #include <math . h>
3 #include <iostream>
4 #include <s t d l i b . h>
5 #include <iomanip>
6 #include <st r ing>
7 #include <fstream>
8 using namespace std ;
9 int main ( ) { std : : o f stream o u t f i l e ; o u t f i l e . open ( " l o l . dat" , std : : ios_base : : app ) ; int A1 , A2 ,
Z1 , Z2 ; double T1 , a , b , c , d , g , T2 ;
10 p r i n t f ( "Enter Kinet i c Energy o f the p r i n c i p a l ion : " ) ;
11 s can f ( "%l f " ,&T1) ;
12 p r i n t f ( "Enter Atomic Mass o f the p r i n c i p a l ion : " ) ;
13 s can f ( "%i " ,&A1) ;
14 p r i n t f ( "Enter Atomic Number o f the p r i n c i p a l ion : " ) ;
15 s can f ( "%i " ,&Z1) ;
16 g = −T1∗A1∗(T1∗A1+2∗931.4940954∗A1) /(Z1∗Z1) ;
17 for (A2=1;A2<=20;A2++){a=A2∗A2 ; b=2∗A2∗931.4940954∗A2 ;
18 for (Z2=1;Z2<=10;Z2++){c = Z2∗Z2∗g ; d=b∗b−4∗a∗c ;T2 =(−b+sqr t (d) ) /(2∗ a ) ;
19 i f (Z2 > A2) {T2=0;}
20 cout<< s e t p r e c i s i o n (5) <<T2<<" " ;
21 o u t f i l e << s e t p r e c i s i o n (5) << T2<< " " ; }
22 o u t f i l e << endl ;
23 cout<<"\n" ; }
24 return 0 ;}
Four examples of these maps are plotted in figure E, for the RIβ+ extracted during the experi-
ment. Some of the “possible” beam contaminants with CSDA ranges higher than the stable primary
beam are identified in table F.
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Figure E: Kinetic energy values of possible impurities with equivalent magnetic rigidity as the extracted beam.
Table F: Possible beam contaminants in 11C (∼ 7%) and 15O (∼ 3%), according to their energy and CSDA
depth values, obtained from efltst.f FLUKA routine. The species shadowed in lilac color have CSDA depth values
beyond that of the primary beam.
11C (190 MeV/u) 15O (254.5 MeV/u)
Species E (MeV/u) CSDA (cm) E (MeV/u) CSDA (cm)
2H 161.9 36.0385 226.7 64.3124
3H 75.2 13.9305 106.9 26.0914
3He 272.8 33.0046 376.0 55.9278
4He 161.9 18.1098 226.7 32.2585
6Li 161.9 12.0327 226.7 21.4607
7Li 121.4 8.47837 171.1 15.4650
7Be 206.9 12.0486 287.7 21.0140
9Be 130.0 6.92581 182.9 12.5485
8B 243.1 11.5843 336.5 19.8769
10B 161.9 7.22605 226.7 12.8800
11B 135.6 5.83192 190.6 10.5433
12B 115.1 4.76924 162.4 8.71964
9C 272.8 10.970 376.1 18.5893
10C 225.9 8.88616 313.4 15.3604
11C 190.0 7.27772 264.9 12.7887
12C 161.8 6.02273 226.7 10.7369
12N — — 298.3 12.4748
13N — — 258.9 10.6824
13O — — 327.5 12.0633
14O — — 287.6 10.4968
15O — — 254.5 9.17193
16O — — 226.7 8.05248
Introducing this information in the simulation could allow the estimation of the production of
these fragments from the primary beam interaction with the inter–target material.
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